CA2747355C - Method for making silicone hydrogel contact lenses - Google Patents
Method for making silicone hydrogel contact lenses Download PDFInfo
- Publication number
- CA2747355C CA2747355C CA 2747355 CA2747355A CA2747355C CA 2747355 C CA2747355 C CA 2747355C CA 2747355 CA2747355 CA 2747355 CA 2747355 A CA2747355 A CA 2747355A CA 2747355 C CA2747355 C CA 2747355C
- Authority
- CA
- Canada
- Prior art keywords
- formula
- divalent radical
- alkyl
- acrylamide
- radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F283/00—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
- C08F283/12—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polysiloxanes
- C08F283/124—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polysiloxanes on to polysiloxanes having carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
- C08G77/26—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen nitrogen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
Abstract
A method for producing silicone hydrogel contact lenses and silicon hydrogel contact lens thereof. The method comprising the steps of: providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces; introduce a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing (meth)acrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05 % to about 1.5 % by weight of a photoinitiator, wherein the lens forming material is characterized by having an ability to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within about 100 seconds; and irradiating, under a spatial limitation of actinic radiation, the lens-forming material in the mold for a time period of about 120 seconds or less, so as to crosslink the lens-forming material to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
Description
31394-91(S) METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES
TECHNICAL FIELD OF THE INVENTION
The present invention is related to a method for making silicone hydrogel contact lenses, in particular, under spatial limitation of actinic radiation. In addition, the present invention is related to silicone hydrogel contact lenses made according to the method of invention.
BACKGROUND
In recent years, soft silicone hydrogel contact lenses become more and more popular because of their high oxygen permeability and comfort. However, all commercially available silicone hydrogel contact lenses are produced according to a conventional cast molding technique involving use of disposable plastic molds and a mixture of monomers in the presence or absence of macromers. However, disposable plastic molds inherently have unavoidable dimensional variations, because, during injection-molding of plastic molds, fluctuations in the dimensions of molds can occur as a result of fluctuations in the production process (temperatures, pressures, material properties), and also because the resultant molds may undergo non-uniformly shrinking after the injection molding. These dimensional changes in the mold may lead to fluctuations in the parameters of contact lenses to be produced (peak refractive index, diameter, basic curve, central thickness etc.) and to a low fidelity in duplicating complex lens design.
Such disadvantages encountered in a conventional cast-molding technique can be overcome by using the so-called Lightstream TechnologyTm (CIBA Vision), as illustrated in U.S. Patent Nos. 5,508,317, 5,789,464, 5,849,810, and 6,800,225.
The Lightstream TechnologyTm involves (1) a lens-forming composition which is typically a solution of one or more substantially purified prepolymer with ethylenically unsaturated groups and which generally is substantially free of monomers and crosslinking agents with a small molecular weight, (2) reusable molds produced in high precision, and (3) curing under a spatial limitation of actinic radiation (e.g., UV). Lenses produced according to the Lightstream TechnologyTm can have high consistency and high fidelity to the original lens design, because of use of reusable, high precision molds. In addition, contact lenses with high quality can be produced at relatively lower cost due to the short curing time and a high production yield.
In order to apply the Lightstream Technologyn" in making silicone hydrogel contact lenses, silicone-containing prepolymers have been developed, as described in U.S. patent Nos. 7,091,283 and 6,039,913, in U.S. patent application publication Nos.
Al, 2008/0143958 Al, 2008/0143003 Al, 2008/0231798 Al, and 2008/0234457 Al, and in 31394-91(S) U.S. patent application Nos. 12/313,546, 61/114,216 and 61/114,228.
However, the Lightstream TechnologyTm has not been applied to make silicone hydrogel contact lenses from a monomer mixture of a lens-forming material. Therefore, there is still a need for a method for making silicone hydrogel contact lenses from a monomer mixture of lens-forming materials according to the Lightstream TechnologyTm.
SUMMARY OF THE INVENTION
In one aspect, the invention provides a method for producing silicone hydrogel contact lenses. The method comprises the steps of: providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces; introduce a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing (meth)acrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5%
by weight of a photoinitator, wherein the lens forming material is characterized by having an ability to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within about seconds; and irradiating, under a spatial limitation of actinic radiation, the lens-forming material in the mold for a time period of about 120 seconds or less, so as to crosslink the lens-forming material to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
In another aspect, the invention provide a lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation. The lens-forming composition comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing acrylate or acrylamide or methacrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5% by weight of a photoinitator, provided that the total amount of all methacrylate monomer(s) in the lens-forming composition is less than about 10% by weight and is sufficient low so as to provide the lens forming composition with a characteristics of being able to be cured by an UV light having an UV-intensity of about 4.1 mW/cm2 within a time period of less than about 100 seconds.
TECHNICAL FIELD OF THE INVENTION
The present invention is related to a method for making silicone hydrogel contact lenses, in particular, under spatial limitation of actinic radiation. In addition, the present invention is related to silicone hydrogel contact lenses made according to the method of invention.
BACKGROUND
In recent years, soft silicone hydrogel contact lenses become more and more popular because of their high oxygen permeability and comfort. However, all commercially available silicone hydrogel contact lenses are produced according to a conventional cast molding technique involving use of disposable plastic molds and a mixture of monomers in the presence or absence of macromers. However, disposable plastic molds inherently have unavoidable dimensional variations, because, during injection-molding of plastic molds, fluctuations in the dimensions of molds can occur as a result of fluctuations in the production process (temperatures, pressures, material properties), and also because the resultant molds may undergo non-uniformly shrinking after the injection molding. These dimensional changes in the mold may lead to fluctuations in the parameters of contact lenses to be produced (peak refractive index, diameter, basic curve, central thickness etc.) and to a low fidelity in duplicating complex lens design.
Such disadvantages encountered in a conventional cast-molding technique can be overcome by using the so-called Lightstream TechnologyTm (CIBA Vision), as illustrated in U.S. Patent Nos. 5,508,317, 5,789,464, 5,849,810, and 6,800,225.
The Lightstream TechnologyTm involves (1) a lens-forming composition which is typically a solution of one or more substantially purified prepolymer with ethylenically unsaturated groups and which generally is substantially free of monomers and crosslinking agents with a small molecular weight, (2) reusable molds produced in high precision, and (3) curing under a spatial limitation of actinic radiation (e.g., UV). Lenses produced according to the Lightstream TechnologyTm can have high consistency and high fidelity to the original lens design, because of use of reusable, high precision molds. In addition, contact lenses with high quality can be produced at relatively lower cost due to the short curing time and a high production yield.
In order to apply the Lightstream Technologyn" in making silicone hydrogel contact lenses, silicone-containing prepolymers have been developed, as described in U.S. patent Nos. 7,091,283 and 6,039,913, in U.S. patent application publication Nos.
Al, 2008/0143958 Al, 2008/0143003 Al, 2008/0231798 Al, and 2008/0234457 Al, and in 31394-91(S) U.S. patent application Nos. 12/313,546, 61/114,216 and 61/114,228.
However, the Lightstream TechnologyTm has not been applied to make silicone hydrogel contact lenses from a monomer mixture of a lens-forming material. Therefore, there is still a need for a method for making silicone hydrogel contact lenses from a monomer mixture of lens-forming materials according to the Lightstream TechnologyTm.
SUMMARY OF THE INVENTION
In one aspect, the invention provides a method for producing silicone hydrogel contact lenses. The method comprises the steps of: providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces; introduce a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing (meth)acrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5%
by weight of a photoinitator, wherein the lens forming material is characterized by having an ability to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within about seconds; and irradiating, under a spatial limitation of actinic radiation, the lens-forming material in the mold for a time period of about 120 seconds or less, so as to crosslink the lens-forming material to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
In another aspect, the invention provide a lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation. The lens-forming composition comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing acrylate or acrylamide or methacrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5% by weight of a photoinitator, provided that the total amount of all methacrylate monomer(s) in the lens-forming composition is less than about 10% by weight and is sufficient low so as to provide the lens forming composition with a characteristics of being able to be cured by an UV light having an UV-intensity of about 4.1 mW/cm2 within a time period of less than about 100 seconds.
31394-91(S) According to still another aspect of the present invention, there is provided a method for producing silicone hydrogel contact lenses, comprising the steps of: (I) providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces; (II) introducing a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises (a) from 5% to 60% by weight of I)1( a hydrophilic amide-type vinylic monomer having partial formula of ¨N¨c¨c=C1-12 in which X is a covalent bond, hydrogen, or a methyl radical, (b) from 5% to 50%
by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) yiL_ /R3 \R4 (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) \ I
4y ( cH2)--si¨A3 P
(2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are CI-Cs alkyl, phenyl, benzyl, or a radical of formula (3) BI
-0-Si--B3 (3) 2a 31394-91(S) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3), (c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) Q-X1-G1-PDMS-G2+X2-Q) r (4) in which r is 1; G1 and G2 independent of each other are a linear or branched C1¨C10 ' alkylene divalent radical, a divalent radical of formula 4alk-04---alk¨
q in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a C1¨C6 alkylene divalent radical, or a divalent radical of formula ¨R'1¨X4--E¨X6¨R'2¨
in which R'1 and R'2 independent of each other are a linear or branched C1¨C10 alkylene divalent radical or a divalent radical of formula 4a1W-04- q--alk¨
as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting IT 7 7 1? '7' 1? 7' 0 II
of¨O¨, ¨N¨, ¨C¨N¨, ¨N¨C¨, ¨N¨C¨NH¨, ¨HN¨C¨N¨, ¨0¨C¨NH¨, II II II II II
-HN-C-0-, -S-C-NH-, -0-C-, -C-0-, -S-, and -HN-C-S- in which R' is H or C1-C8alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain; X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, ¨0¨, R 0 R' R' 0 R' 0 0 R' 0 0 I ti I I II I II II I ii II
-N-, ¨C¨N¨, ¨N¨C¨, ¨N¨C¨NH¨, ¨HN¨C¨N¨, ¨0¨C¨NH¨, -HN-C-0-, II II II II
¨s¨C¨NH¨, -0-C-, -C-0-, ¨S¨, and -HN-C-S- in which R' is H or C1-C8 alkyl; PDMS is a polysiloxane divalent radical of formula (5) ¨Di--1--Ui¨D24U2 D3)\11 (0 (5) in which v is 0 or 1, co is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula ¨R'1¨X4¨E¨X6¨R'2¨ as defined above or 2b 31394-91(S) a divalent radical of formula 4a1k1-04¨alk¨
as defined above, and D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of -(CH2CH20)t-CH2CH2- in which t is an integer of 3 to 40, -CF2-(0CF2)a-(0CF2CF2)b-OCF2- in which a and b independent of each other are an integer of to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) R3 4 R5 I [R7 I R9 gi-0 ___________________________ gi-0 __ gl __ 144 146 m 148 P A10 (6) in which R3, R4, R5, R6, R7, Rg, R9 and R10, independently of one another, are alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), or -alk-(OCH2CH2)n-ORii in which alk is C1-C6-alkylene divalent radical, R11 is C1-C6 alkyl and n is an integer from Ito 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q
is an ethylenically unsaturated group of formula (7) -4-4¨A54) ( Z2-4C-=C/
q2 I \
R14 R16 (7) in which Z1 and Z2 independent of each other are a linear or branched C1-C12 alkylene divalent radical, a linear or branched C1-C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH20)d-CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is -0- or ¨N¨ in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen; and R15 and independent of each other are hydrogen, C,-C4 alkyl, phenyl, carboxy, halogen, or a radical of ¨c-x3-R17 in which X3 is -0-, ¨N¨ as defined above or -S-- and R17 is a 2c 31394-91(S) C1¨C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical, and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the monomer mixture can be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within seconds; and (Ill) irradiating, under a spatial limitation of actinic radiation, the monomer mixture in the mold for a time period of 120 seconds or less, so as to crosslink the monomer mixture to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
According to yet another aspect of the present invention, there is provided a lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation, comprising: (a) from 5% to 60% by weight of a hydrophilic amide-type vinylic Iox monomer having partial formula of ¨N¨C¨C=CH2 in which X is a covalent bond, hydrogen, or a methyl radical; (b) from 5% to 50% by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) yN/R3 ( 1 ) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) 4y dm ( cH2 1)7, A2 (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) 2d 31394-91(S) (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3); (c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) Q-X1-G1-PDMS-G24-X2-Q) (4) in which r is 1; G1 and G2 independent of each other are a linear or branched alkylene divalent radical, a divalent radical of formula ¨(-alk'¨O4-alk¨ in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a alkylene divalent radical, or a divalent radical of formula ¨R'1¨X4¨E¨X8¨R'2¨
in which R'1 and R'2 independent of each other are a linear or branched C1-C10 alkylene divalent radical or a divalent radical of formula ¨(-alk'-0-alk¨ as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting '7' ii of ¨0¨, -N-, -C-N-, -N-C-, -N-C-NH-, -HN-C-N-, -0-C-NH-, -HN-C-0-, -S-C-NH-, -0-C-, -C-0-, ¨S¨, and -HN-C-S- in which R' is H or C1-C8 alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain; X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, ¨0¨, R' 0 R R' 0 R' 0 0 R' 0 0 II I I II I II II I II II
-N-, -C-N-, -N-C-, -N-C-NH-, -HN-C-N-, -0-C-NH-, -HN-C-0--, -S-C-NH-, -0-C-, -C-0-, ¨S¨, and -HN-C-S- in which R' is H or C1-C8 alkyl; PDMS is a polysiloxane divalent radical of formula (5) ¨D1+ui¨D2---(-U2 D3) vi (5) 2e 31394-91(S) in which v is 0 or 1, co is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula ¨R'1¨X4¨E¨X5¨R'2¨ as defined above or a divalent radical of formula 4a1k1-04¨alk¨ as defined above, and D1, D2 and independently of each other are a divalent radical selected from the group consisting of ¨(CH2CH20)t¨CH2CH2¨ in which t is an integer of 3 to 40, -CF2¨(0CF2)a¨
(0CF2CF2)b¨OCF2¨ in which a and b independent of each other are an integer of 0 to provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) Fi?3ri 7 -Si-0 S1-0 __________________________ Si 144 m 148 P 1410 (6) 10 in which R3, R4, R5, R6, R7, Rg, R9 and R10, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(Ci-C18-alkyl), cyano(C1-C12-alkyl), or ¨alk¨(OCH2CH2)n¨OR11 in which alk is C1-C6-alkylene divalent radical, R11 is C1-C8 alkyl and n is an integer from Ito 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q is an ethylenically unsaturated group of formula (7) qi q2 Z2-)? =C( R14 R16 (7) in which Z1 and Z2 independent of each other are a linear or branched Ci-C12 alkylene divalent radical, a linear or branched C1¨C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH20)d¨CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is ¨0¨ or ¨N¨ in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen; and R15 and 2f 31394-91(S) independent of each other are hydrogen, C1-C4 alkyl, phenyl, carboxy, halogen, or a 0 R' radical of --c-x3-R17 in which X3 is -0-, ¨N¨ as defined above or -S- and R17 is a CI-Cu alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical;
and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the lens forming composition is characterized by having an ability to be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within 100 seconds.
2g The invention provides in a further aspect contact lenses obtained according to a method of the invention.
DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Generally, the nomenclature used herein and the laboratory procedures are well known and commonly employed in the art. Conventional methods are used for these procedures, such as those provided in the art and various general references.
Where a term is provided in the singular, the inventors also contemplate the plural of that term. The nomenclature used herein and the laboratory procedures described below are those well known and commonly employed in the art.
"Contact Lens" refers to a structure that can be placed on or within a wearer's eye.
A contact lens can correct, improve, or alter a user's eyesight, but that need not be the case. A contact lens can be of any appropriate material known in the art or later developed, and can be a soft lens, a hard lens, or a hybrid lens. A "silicone hydrogel contact lens" refers to a contact lens comprising a silicone hydrogel material.
A "hydrogel" or "hydrogel material" refers to a polymeric material which can absorb at least 10 percent by weight of water when it is fully hydrated.
A "silicone hydrogel" refers to a silicone-containing hydrogel obtained by copolymerization of a polymerizable composition comprising at least one silicone-containing monomer or at least one silicone-containing macromer or at least one crosslinkable silicone-containing prepolymer.
A "monomer mixture" refers to a composition comprising at least about 20% by weight of one or more vinylic monomers.
"Hydrophilic," as used herein, describes a material or portion thereof that will more readily associate with water than with lipids.
A "vinylic monomer" refers to a low molecular weight compound that has one sole ethylenically unsaturated group. Low molecular weight typically means average molecular weights less than 700 Da!tons.
The term "olefinically unsaturated group" or "ethylenicaly unsaturated group"
is employed herein in a broad sense and is intended to encompass any groups containing a >C=C< group. Exemplary ethylenically unsaturated groups include without limitation acryloyl, methacryloyl, allyl, vinyl, styrenyl, or other C=C containing groups.
As used herein, "actinically" in reference to curing, crosslinking or polymerizing of a polymerizable composition, a prepolymer or a material means that the curing (e.g., crosslinked and/or polymerized) is performed by actinic irradiation, such as, for example, UV irradiation, ionizing radiation (e.g. gamma ray or X-ray irradiation), microwave irradiation, and the like. Thermal curing or actinic curing methods are well-known to a person skilled in the art.
An "amide-type vinylic monomer" refers to a vinylic monomer comprising one sole lox ethylenically unsaturated radical of ¨N¨C¨C=C1-12 in which X is a covalent bond, hydrogen, or a methyl radical (¨CH3).
The term "(meth)acrylamide" refers to acrylamide or methacrylamide.
The term "acrylamide monomer" refers to a vinylic monomer having an ethylenically I ii Y
unsaturated radical of ¨N¨C¨C=CH2.
The term "methacrylamide monomer" refers to a vinylic monomer having an Io YI-13 II ethylenically unsaturated radical of ¨N¨C¨C=CH2.
The term "acrylate monomer" refers to a vinylic monomer having an ethylenically OH
II I
unsaturated radical of ¨0¨C¨C=CH2.
The term "methacrylate monomer" refers to a vinylic monomer having an ethylenically unsaturated radical of ¨0¨C¨C=CH2.
A "polysiloxane-containing vinylic monomer or macromer" refers to a vinylic monomer or macromer containing at least one ehtylenically unsaturated group and a Ri I
--Esi¨of-I
divalent radical of R2 n in which R1 and R2 are independently a monovalent C1-C10 alkyl, a monovalent C1-C10 aminoalkyl, a monovalent of C1-C10 hydroxyalkyl, C1-C10 ether, C1-C10 fluoroalkyl, C1-C10 fluoroether or C6-C18 aryl radical, ¨alk¨(OCH2CH2)m-0R3, in which alk is C1-C6 alkylene divalent radical, R3 is hydrogen or C1-C6 alkyl, and m is an integer of from 1 to 10; n is an integer of 3 or higher.
The term "fluid" as used herein indicates that a material is capable of flowing like a liquid.
A "hydrophobic vinylic monomer" refers to a vinylic monomer which can be polymerized to form a polymer that is insoluble in water and can absorb less than 10 percent by weight water.
A "vinylic macromer" refers to a medium and high molecular weight compound which comprises one or more ethylenically unsaturated groups. Medium and high molecular weight typically means average molecular weights greater than 700 Daltons.
A "prepolymer" refers to a starting polymer which contains two or more ethylenically unsaturated groups and can be cured (e.g., crosslinked) actinically to obtain a crosslinked polymer having a molecular weight much higher than the starting polymer.
A "silicone-containing prepolymer" refers to a prepolymer which contains silicone.
"Molecular weight" of a polymeric material (including monomeric or macromeric materials), as used herein, refers to the number-average molecular weight unless otherwise specifically noted or unless testing conditions indicate otherwise.
"Polymer" means a material formed by polymerizing one or more monomers.
As used herein, the term "ethylenically functionalized" in reference to a copolymer or a compound is intended to describe that one or more actinically crosslinkable groups have been covalently attached to a copolymer or compound through the pendant or terminal functional groups of the copolymer or the compound according to a coupling process.
As used herein, the term "multiple" refers to three or more.
A "photoinitiator" refers to a chemical that initiates radical crosslinking/polymerizing reaction by the use of light. Suitable photoinitiators include, without limitation, benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide, 1-hydroxycyclohexyl phenyl ketone, Darocur0 types, and Irgacure0 types, preferably Darocur0 1173, and Irgacure0 2959.
A "polymerizable UV-absorbing agent" refers to a compound comprising an ethylenically-unsaturated group and a UV-absorbing moiety or a latent UV-absorbing moiety.
A "UV-absorbing moiety" refers to an organic functional group which can absorb or screen out UV radiation in the range from 200 nm to 400 nm as understood by a person skilled in the art.
A "polymerizable latent UV-absorbing agent" refers to a compound comprising an ethylencially unsaturated group and a UV-absorbing moiety which has been protected by a labile function group so that its absorption coefficients of UV radiation in the wavelength region from 200 nm to 400 nm are about 50% or less, preferably 70% or less, more preferably about 90% or less of those of the UV-absorbing moiety without the protected labile function group.
The term "labile functional group" means a protective functional group which can be removed (cleaved) from another functional group being protected by the labile functional group.
A "spatial limitation of actinic radiation" refers to an act or process in which energy radiation in the form of rays is directed by, for example, a mask or screen or combinations thereof, to impinge, in a spatially restricted manner, onto an area having a well defined 31394-91(S) peripheral boundary. A spatial limitation of UV radiation is obtained by using a mask or screen having a radiation (e.g.,UV) permeable region, a radiation (e.g., UV) impermeable region surrounding the radiation-permeable region, and a projection contour which is the boundary between the radiation-impermeable and radiation-permeable regions, as schematically illustrated in the drawings of U.S. Patent Nos. 6,800,225 (Figs.
1-11), and 6,627,124 (Figs. 1-9), 7,384,590 (Figs. 1-6), and 7,387,759 (Figs. 1-6).
The mask or screen allows to spatially projects a beam of radiation (e.g., UV radiation) having a cross-sectional profile defined by the projection contour of the mask or screen. The projected beam of radiation (e.g., UV
radiation) limits radiation (e.g., UV radiation) impinging on a lens-forming material located in the path of the projected beam from the first molding surface to the second molding surface of a mold. The resultant contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the sectional profile of the projected UV beam (i.e., a spatial limitation of radiation). The radiation used for the crosslinking is a radiation energy, especially UV radiation, gamma radiation, electron radiation or thermal radiation, the radiation energy preferably being in the form of a substantially parallel beam in order on the one hand to achieve good restriction and on the other hand efficient use of the energy.
In the conventional cast-molding process, the first and second molding surface of a mold are pressed against each other to form a circumferential contact line which defines the edge of a result contact lens. Because the close contact of the molding surfaces can damage the optical quality of the molding surfaces, the mold cannot be reused.
In contrast, in the Lightstream Technologirm, the edge of a resultant contact lens is not defined by the contact of the molding surfaces of a mold, but instead by a spatial limitation of radiation.
Without any contact between the molding surfaces of a mold, the mold can be used repeatedly to produce high quality contact lenses with high reproducibility.
"Dye" means a substance that is soluble in a lens-forming fluid material and that is used to impart color. Dyes are typically translucent and absorb but do not scatter light.
A "pigment" means a powdered substance that is suspended in a lens-forming fluid material in which it is insoluble.
A "hydrophilic surface" in reference to a silicone hydrogel material or a contact lens means that the silicone hydrogel material or the contact lens has a surface hydrophilicity characterized by having an averaged water contact angle of about 90 degrees or less, preferably about 80 degrees or less, more preferably about 70 degrees or less, more preferably about 60 degrees or less.
An "average contact angle" refers to a water contact angle (advancing angle measured by Wilhelmy Plate method), which is obtained by averaging measurements of at least 3 individual contact lenses.
An "antimicrobial agent", as used herein, refers to a chemical that is capable of decreasing or eliminating or inhibiting the growth of microorganisms such as that term is known in the art. Preferred examples of antimicrobial agent include without limitation silver salts, silver complexes, silver nanoparticles, silver-containing zeolites, and the likes "Silver nanoparticles" refer to particles which is made essentially of silver metal and have a size of less than 1 micrometer.
The "oxygen transmissibility" of a lens, as used herein, is the rate at which oxygen will pass through a specific ophthalmic lens. Oxygen transmissibility, Dk/t, is conventionally expressed in units of barrers/mm, where t is the average thickness of the material [in units of mm] over the area being measured and "barrer/mm" is defined as:
[(cm3 oxygen) / (cm2)(sec)(mm Hg)] x 10-The intrinsic "oxygen permeability", Dk, of a lens material does not depend on lens thickness. Intrinsic oxygen permeability is the rate at which oxygen will pass through a material. Oxygen permeability is conventionally expressed in units of barrers, where "barrer" is defined as:
[(cm3 oxygen)(mm) / (cm2)(sec)(mm Hg)] x 10-1 These are the units commonly used in the art. Thus, in order to be consistent with the use in the art, the unit "barrer" will have the meanings as defined above. For example, a lens having a Dk of 90 barrers ("oxygen permeability barrers") and a thickness of 90 microns (0.090 mm) would have a Dk/t of 100 barrers/mm (oxygen transmissibility barrers/mm). In accordance with the invention, a high oxygen permeability in reference to a material or a contact lens characterized by apparent oxygen permeability of at least 40 barrers or larger measured with a sample (film or lens) of 100 microns in thickness according to a coulometric method described in Examples.
The "ion permeability" through a lens correlates with both the lonoflux Diffusion Coefficient and the lonoton Ion Permeability Coefficient.
The lonoflux Diffusion Coefficient, D, is determined by applying Fick's law as follows:
D = - n' / (A x dc/dx) where n' = rate of ion transport [mol/min]; A = area of lens exposed [mm2]; D
= lonoflux Diffusion Coefficient [mm2/min] ; dc = concentration difference [mol/L]; dx =
thickness of lens [mm].
by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) yiL_ /R3 \R4 (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) \ I
4y ( cH2)--si¨A3 P
(2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are CI-Cs alkyl, phenyl, benzyl, or a radical of formula (3) BI
-0-Si--B3 (3) 2a 31394-91(S) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3), (c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) Q-X1-G1-PDMS-G2+X2-Q) r (4) in which r is 1; G1 and G2 independent of each other are a linear or branched C1¨C10 ' alkylene divalent radical, a divalent radical of formula 4alk-04---alk¨
q in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a C1¨C6 alkylene divalent radical, or a divalent radical of formula ¨R'1¨X4--E¨X6¨R'2¨
in which R'1 and R'2 independent of each other are a linear or branched C1¨C10 alkylene divalent radical or a divalent radical of formula 4a1W-04- q--alk¨
as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting IT 7 7 1? '7' 1? 7' 0 II
of¨O¨, ¨N¨, ¨C¨N¨, ¨N¨C¨, ¨N¨C¨NH¨, ¨HN¨C¨N¨, ¨0¨C¨NH¨, II II II II II
-HN-C-0-, -S-C-NH-, -0-C-, -C-0-, -S-, and -HN-C-S- in which R' is H or C1-C8alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain; X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, ¨0¨, R 0 R' R' 0 R' 0 0 R' 0 0 I ti I I II I II II I ii II
-N-, ¨C¨N¨, ¨N¨C¨, ¨N¨C¨NH¨, ¨HN¨C¨N¨, ¨0¨C¨NH¨, -HN-C-0-, II II II II
¨s¨C¨NH¨, -0-C-, -C-0-, ¨S¨, and -HN-C-S- in which R' is H or C1-C8 alkyl; PDMS is a polysiloxane divalent radical of formula (5) ¨Di--1--Ui¨D24U2 D3)\11 (0 (5) in which v is 0 or 1, co is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula ¨R'1¨X4¨E¨X6¨R'2¨ as defined above or 2b 31394-91(S) a divalent radical of formula 4a1k1-04¨alk¨
as defined above, and D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of -(CH2CH20)t-CH2CH2- in which t is an integer of 3 to 40, -CF2-(0CF2)a-(0CF2CF2)b-OCF2- in which a and b independent of each other are an integer of to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) R3 4 R5 I [R7 I R9 gi-0 ___________________________ gi-0 __ gl __ 144 146 m 148 P A10 (6) in which R3, R4, R5, R6, R7, Rg, R9 and R10, independently of one another, are alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), or -alk-(OCH2CH2)n-ORii in which alk is C1-C6-alkylene divalent radical, R11 is C1-C6 alkyl and n is an integer from Ito 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q
is an ethylenically unsaturated group of formula (7) -4-4¨A54) ( Z2-4C-=C/
q2 I \
R14 R16 (7) in which Z1 and Z2 independent of each other are a linear or branched C1-C12 alkylene divalent radical, a linear or branched C1-C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH20)d-CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is -0- or ¨N¨ in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen; and R15 and independent of each other are hydrogen, C,-C4 alkyl, phenyl, carboxy, halogen, or a radical of ¨c-x3-R17 in which X3 is -0-, ¨N¨ as defined above or -S-- and R17 is a 2c 31394-91(S) C1¨C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical, and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the monomer mixture can be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within seconds; and (Ill) irradiating, under a spatial limitation of actinic radiation, the monomer mixture in the mold for a time period of 120 seconds or less, so as to crosslink the monomer mixture to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
According to yet another aspect of the present invention, there is provided a lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation, comprising: (a) from 5% to 60% by weight of a hydrophilic amide-type vinylic Iox monomer having partial formula of ¨N¨C¨C=CH2 in which X is a covalent bond, hydrogen, or a methyl radical; (b) from 5% to 50% by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) yN/R3 ( 1 ) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) 4y dm ( cH2 1)7, A2 (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) 2d 31394-91(S) (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3); (c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) Q-X1-G1-PDMS-G24-X2-Q) (4) in which r is 1; G1 and G2 independent of each other are a linear or branched alkylene divalent radical, a divalent radical of formula ¨(-alk'¨O4-alk¨ in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a alkylene divalent radical, or a divalent radical of formula ¨R'1¨X4¨E¨X8¨R'2¨
in which R'1 and R'2 independent of each other are a linear or branched C1-C10 alkylene divalent radical or a divalent radical of formula ¨(-alk'-0-alk¨ as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting '7' ii of ¨0¨, -N-, -C-N-, -N-C-, -N-C-NH-, -HN-C-N-, -0-C-NH-, -HN-C-0-, -S-C-NH-, -0-C-, -C-0-, ¨S¨, and -HN-C-S- in which R' is H or C1-C8 alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain; X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, ¨0¨, R' 0 R R' 0 R' 0 0 R' 0 0 II I I II I II II I II II
-N-, -C-N-, -N-C-, -N-C-NH-, -HN-C-N-, -0-C-NH-, -HN-C-0--, -S-C-NH-, -0-C-, -C-0-, ¨S¨, and -HN-C-S- in which R' is H or C1-C8 alkyl; PDMS is a polysiloxane divalent radical of formula (5) ¨D1+ui¨D2---(-U2 D3) vi (5) 2e 31394-91(S) in which v is 0 or 1, co is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula ¨R'1¨X4¨E¨X5¨R'2¨ as defined above or a divalent radical of formula 4a1k1-04¨alk¨ as defined above, and D1, D2 and independently of each other are a divalent radical selected from the group consisting of ¨(CH2CH20)t¨CH2CH2¨ in which t is an integer of 3 to 40, -CF2¨(0CF2)a¨
(0CF2CF2)b¨OCF2¨ in which a and b independent of each other are an integer of 0 to provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) Fi?3ri 7 -Si-0 S1-0 __________________________ Si 144 m 148 P 1410 (6) 10 in which R3, R4, R5, R6, R7, Rg, R9 and R10, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(Ci-C18-alkyl), cyano(C1-C12-alkyl), or ¨alk¨(OCH2CH2)n¨OR11 in which alk is C1-C6-alkylene divalent radical, R11 is C1-C8 alkyl and n is an integer from Ito 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q is an ethylenically unsaturated group of formula (7) qi q2 Z2-)? =C( R14 R16 (7) in which Z1 and Z2 independent of each other are a linear or branched Ci-C12 alkylene divalent radical, a linear or branched C1¨C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH20)d¨CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is ¨0¨ or ¨N¨ in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen; and R15 and 2f 31394-91(S) independent of each other are hydrogen, C1-C4 alkyl, phenyl, carboxy, halogen, or a 0 R' radical of --c-x3-R17 in which X3 is -0-, ¨N¨ as defined above or -S- and R17 is a CI-Cu alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical;
and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the lens forming composition is characterized by having an ability to be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within 100 seconds.
2g The invention provides in a further aspect contact lenses obtained according to a method of the invention.
DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Generally, the nomenclature used herein and the laboratory procedures are well known and commonly employed in the art. Conventional methods are used for these procedures, such as those provided in the art and various general references.
Where a term is provided in the singular, the inventors also contemplate the plural of that term. The nomenclature used herein and the laboratory procedures described below are those well known and commonly employed in the art.
"Contact Lens" refers to a structure that can be placed on or within a wearer's eye.
A contact lens can correct, improve, or alter a user's eyesight, but that need not be the case. A contact lens can be of any appropriate material known in the art or later developed, and can be a soft lens, a hard lens, or a hybrid lens. A "silicone hydrogel contact lens" refers to a contact lens comprising a silicone hydrogel material.
A "hydrogel" or "hydrogel material" refers to a polymeric material which can absorb at least 10 percent by weight of water when it is fully hydrated.
A "silicone hydrogel" refers to a silicone-containing hydrogel obtained by copolymerization of a polymerizable composition comprising at least one silicone-containing monomer or at least one silicone-containing macromer or at least one crosslinkable silicone-containing prepolymer.
A "monomer mixture" refers to a composition comprising at least about 20% by weight of one or more vinylic monomers.
"Hydrophilic," as used herein, describes a material or portion thereof that will more readily associate with water than with lipids.
A "vinylic monomer" refers to a low molecular weight compound that has one sole ethylenically unsaturated group. Low molecular weight typically means average molecular weights less than 700 Da!tons.
The term "olefinically unsaturated group" or "ethylenicaly unsaturated group"
is employed herein in a broad sense and is intended to encompass any groups containing a >C=C< group. Exemplary ethylenically unsaturated groups include without limitation acryloyl, methacryloyl, allyl, vinyl, styrenyl, or other C=C containing groups.
As used herein, "actinically" in reference to curing, crosslinking or polymerizing of a polymerizable composition, a prepolymer or a material means that the curing (e.g., crosslinked and/or polymerized) is performed by actinic irradiation, such as, for example, UV irradiation, ionizing radiation (e.g. gamma ray or X-ray irradiation), microwave irradiation, and the like. Thermal curing or actinic curing methods are well-known to a person skilled in the art.
An "amide-type vinylic monomer" refers to a vinylic monomer comprising one sole lox ethylenically unsaturated radical of ¨N¨C¨C=C1-12 in which X is a covalent bond, hydrogen, or a methyl radical (¨CH3).
The term "(meth)acrylamide" refers to acrylamide or methacrylamide.
The term "acrylamide monomer" refers to a vinylic monomer having an ethylenically I ii Y
unsaturated radical of ¨N¨C¨C=CH2.
The term "methacrylamide monomer" refers to a vinylic monomer having an Io YI-13 II ethylenically unsaturated radical of ¨N¨C¨C=CH2.
The term "acrylate monomer" refers to a vinylic monomer having an ethylenically OH
II I
unsaturated radical of ¨0¨C¨C=CH2.
The term "methacrylate monomer" refers to a vinylic monomer having an ethylenically unsaturated radical of ¨0¨C¨C=CH2.
A "polysiloxane-containing vinylic monomer or macromer" refers to a vinylic monomer or macromer containing at least one ehtylenically unsaturated group and a Ri I
--Esi¨of-I
divalent radical of R2 n in which R1 and R2 are independently a monovalent C1-C10 alkyl, a monovalent C1-C10 aminoalkyl, a monovalent of C1-C10 hydroxyalkyl, C1-C10 ether, C1-C10 fluoroalkyl, C1-C10 fluoroether or C6-C18 aryl radical, ¨alk¨(OCH2CH2)m-0R3, in which alk is C1-C6 alkylene divalent radical, R3 is hydrogen or C1-C6 alkyl, and m is an integer of from 1 to 10; n is an integer of 3 or higher.
The term "fluid" as used herein indicates that a material is capable of flowing like a liquid.
A "hydrophobic vinylic monomer" refers to a vinylic monomer which can be polymerized to form a polymer that is insoluble in water and can absorb less than 10 percent by weight water.
A "vinylic macromer" refers to a medium and high molecular weight compound which comprises one or more ethylenically unsaturated groups. Medium and high molecular weight typically means average molecular weights greater than 700 Daltons.
A "prepolymer" refers to a starting polymer which contains two or more ethylenically unsaturated groups and can be cured (e.g., crosslinked) actinically to obtain a crosslinked polymer having a molecular weight much higher than the starting polymer.
A "silicone-containing prepolymer" refers to a prepolymer which contains silicone.
"Molecular weight" of a polymeric material (including monomeric or macromeric materials), as used herein, refers to the number-average molecular weight unless otherwise specifically noted or unless testing conditions indicate otherwise.
"Polymer" means a material formed by polymerizing one or more monomers.
As used herein, the term "ethylenically functionalized" in reference to a copolymer or a compound is intended to describe that one or more actinically crosslinkable groups have been covalently attached to a copolymer or compound through the pendant or terminal functional groups of the copolymer or the compound according to a coupling process.
As used herein, the term "multiple" refers to three or more.
A "photoinitiator" refers to a chemical that initiates radical crosslinking/polymerizing reaction by the use of light. Suitable photoinitiators include, without limitation, benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide, 1-hydroxycyclohexyl phenyl ketone, Darocur0 types, and Irgacure0 types, preferably Darocur0 1173, and Irgacure0 2959.
A "polymerizable UV-absorbing agent" refers to a compound comprising an ethylenically-unsaturated group and a UV-absorbing moiety or a latent UV-absorbing moiety.
A "UV-absorbing moiety" refers to an organic functional group which can absorb or screen out UV radiation in the range from 200 nm to 400 nm as understood by a person skilled in the art.
A "polymerizable latent UV-absorbing agent" refers to a compound comprising an ethylencially unsaturated group and a UV-absorbing moiety which has been protected by a labile function group so that its absorption coefficients of UV radiation in the wavelength region from 200 nm to 400 nm are about 50% or less, preferably 70% or less, more preferably about 90% or less of those of the UV-absorbing moiety without the protected labile function group.
The term "labile functional group" means a protective functional group which can be removed (cleaved) from another functional group being protected by the labile functional group.
A "spatial limitation of actinic radiation" refers to an act or process in which energy radiation in the form of rays is directed by, for example, a mask or screen or combinations thereof, to impinge, in a spatially restricted manner, onto an area having a well defined 31394-91(S) peripheral boundary. A spatial limitation of UV radiation is obtained by using a mask or screen having a radiation (e.g.,UV) permeable region, a radiation (e.g., UV) impermeable region surrounding the radiation-permeable region, and a projection contour which is the boundary between the radiation-impermeable and radiation-permeable regions, as schematically illustrated in the drawings of U.S. Patent Nos. 6,800,225 (Figs.
1-11), and 6,627,124 (Figs. 1-9), 7,384,590 (Figs. 1-6), and 7,387,759 (Figs. 1-6).
The mask or screen allows to spatially projects a beam of radiation (e.g., UV radiation) having a cross-sectional profile defined by the projection contour of the mask or screen. The projected beam of radiation (e.g., UV
radiation) limits radiation (e.g., UV radiation) impinging on a lens-forming material located in the path of the projected beam from the first molding surface to the second molding surface of a mold. The resultant contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the sectional profile of the projected UV beam (i.e., a spatial limitation of radiation). The radiation used for the crosslinking is a radiation energy, especially UV radiation, gamma radiation, electron radiation or thermal radiation, the radiation energy preferably being in the form of a substantially parallel beam in order on the one hand to achieve good restriction and on the other hand efficient use of the energy.
In the conventional cast-molding process, the first and second molding surface of a mold are pressed against each other to form a circumferential contact line which defines the edge of a result contact lens. Because the close contact of the molding surfaces can damage the optical quality of the molding surfaces, the mold cannot be reused.
In contrast, in the Lightstream Technologirm, the edge of a resultant contact lens is not defined by the contact of the molding surfaces of a mold, but instead by a spatial limitation of radiation.
Without any contact between the molding surfaces of a mold, the mold can be used repeatedly to produce high quality contact lenses with high reproducibility.
"Dye" means a substance that is soluble in a lens-forming fluid material and that is used to impart color. Dyes are typically translucent and absorb but do not scatter light.
A "pigment" means a powdered substance that is suspended in a lens-forming fluid material in which it is insoluble.
A "hydrophilic surface" in reference to a silicone hydrogel material or a contact lens means that the silicone hydrogel material or the contact lens has a surface hydrophilicity characterized by having an averaged water contact angle of about 90 degrees or less, preferably about 80 degrees or less, more preferably about 70 degrees or less, more preferably about 60 degrees or less.
An "average contact angle" refers to a water contact angle (advancing angle measured by Wilhelmy Plate method), which is obtained by averaging measurements of at least 3 individual contact lenses.
An "antimicrobial agent", as used herein, refers to a chemical that is capable of decreasing or eliminating or inhibiting the growth of microorganisms such as that term is known in the art. Preferred examples of antimicrobial agent include without limitation silver salts, silver complexes, silver nanoparticles, silver-containing zeolites, and the likes "Silver nanoparticles" refer to particles which is made essentially of silver metal and have a size of less than 1 micrometer.
The "oxygen transmissibility" of a lens, as used herein, is the rate at which oxygen will pass through a specific ophthalmic lens. Oxygen transmissibility, Dk/t, is conventionally expressed in units of barrers/mm, where t is the average thickness of the material [in units of mm] over the area being measured and "barrer/mm" is defined as:
[(cm3 oxygen) / (cm2)(sec)(mm Hg)] x 10-The intrinsic "oxygen permeability", Dk, of a lens material does not depend on lens thickness. Intrinsic oxygen permeability is the rate at which oxygen will pass through a material. Oxygen permeability is conventionally expressed in units of barrers, where "barrer" is defined as:
[(cm3 oxygen)(mm) / (cm2)(sec)(mm Hg)] x 10-1 These are the units commonly used in the art. Thus, in order to be consistent with the use in the art, the unit "barrer" will have the meanings as defined above. For example, a lens having a Dk of 90 barrers ("oxygen permeability barrers") and a thickness of 90 microns (0.090 mm) would have a Dk/t of 100 barrers/mm (oxygen transmissibility barrers/mm). In accordance with the invention, a high oxygen permeability in reference to a material or a contact lens characterized by apparent oxygen permeability of at least 40 barrers or larger measured with a sample (film or lens) of 100 microns in thickness according to a coulometric method described in Examples.
The "ion permeability" through a lens correlates with both the lonoflux Diffusion Coefficient and the lonoton Ion Permeability Coefficient.
The lonoflux Diffusion Coefficient, D, is determined by applying Fick's law as follows:
D = - n' / (A x dc/dx) where n' = rate of ion transport [mol/min]; A = area of lens exposed [mm2]; D
= lonoflux Diffusion Coefficient [mm2/min] ; dc = concentration difference [mol/L]; dx =
thickness of lens [mm].
The lonoton Ion Permeability Coefficient, P, is then determined in accordance with the following equation:
In( 1 - 2C(t)/C(0) ) = -2APt / Vd where: C(t) = concentration of sodium ions at time tin the receiving cell;
C(0) = initial concentration of sodium ions in donor cell; A = membrane area, i.e., lens area exposed to cells; V = volume of cell compartment (3.0 ml); d = average lens thickness in the area exposed; P = permeability coefficient.
An lonoflux Diffusion Coefficient, D, of greater than about 1.5 x 10-6 mm2/min is preferred, while greater than about 2.6 x 10-6 mm2/min is more preferred and greater than about 6.4 x 10-6 mm2/min is most preferred.
It is known that on-eye movement of the lens is required to ensure good tear exchange, and ultimately, to ensure good corneal health. Ion permeability is one of the predictors of on-eye movement, because the permeability of ions is believed to be directly proportional to the permeability of water.
In general, the invention is directed to a method for making silicone hydrogel contact lenses from a monomer mixture based on the Lightstream TechnologyTm.
The invention is partly based on the unexpected discovery that by selecting certain classes of vinylic monomers in preparing a monomer mixture for making silicone hydrogel contact lenses, the curing time of the monomer mixture in a mold can be greatly reduced so as to make the monomer mixture suitable for making silicone hydrogel contact lenses based on the Lightstream TechnologyTm. It is believed that a relatively longer curing time may adversely affect the quality of lens edge of contact lenses made according to the Lightstream TechnologyTm and can increase the product cost by lowering the production output. Although one might be able to shorten the curing time of a monomer mixture by increasing the curing light intensity and/or the concentration of a photoinitiator in the monomer mixture, the high curing light intensity and high photoinitiator concentration have limits and may not be sufficient to reduce the curing time enough for the Lightstream TechnologyTm. Further, these measures may cause resultant lenses with undesirable physical properties, such as, for example, fragile and high content of extractable due to unpolymerized monomers. With a monomer mixture of the invention, the curing time can be substantially reduced, for example, less than 30 seconds at a curing light intensity of about 4.0 mW/cm2. Silicone hydrogel contact lenses made from such monomer mixture according to the Lightstream Technology can have high lens edge quality and relatively low lens production cost because of the relatively short curing time.
The present invention, in one aspect, provides a method for producing silicone hydrogel contact lenses. The method comprises the steps of: providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining 31394-91(S) the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces; introduce a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing (meth)acrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5% by weight of a photoinitator, wherein the lens forming material is characterized by having an ability to be cured by a UV light having a UV-intensity of about 4.1 mW/cm2 within about 100 seconds; and irradiating, under a spatial limitation of actinic radiation, the lens-forming material in the mold for a time period of about 120 seconds or less, so as to crosslink the lens-forming material to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
Examples of reusable molds suitable for spatial limitation of radiation include without limitation those disclosed in U.S. Patent Nos. 6,800,225, 6,627,124, 7,384,590, and 7,387,759.
For example, a preferred reusable mold comprises a first mold half having a first molding surface and a second mold half having a second molding surface. The two mold halves of the preferred reusable mold are not touching each other, but there is a thin gap of annular design arranged between the two mold halves. The gap is connected to the mold cavity formed between the first and second molding surfaces, so that excess monomer mixture can flow into the gap. It is understood that gaps with any design can be used in the invention.
In a preferred embodiment, at least one of the first and second molding surfaces is permeable to a crosslinking radiatione.g., UV radiation). More preferably, one of the first and second molding surfaces is permeable to a crosslinking radiation (e.g., UV
radiation) while the other molding surface is poorly permeable to the crosslinking radiation (e.g., UV
radiation). For example, one of the mold halves can be made of a UV-permeable material, while the other mold half can be made of a material containing UV absorbing materials, such as, for example carbon black, as described in U.S. Patent Nos. 7,387,759 and 7,384,590.
The reusable mold preferably comprises a mask which is fixed, constructed or arranged in, at or on the mold half having the radiation-permeable molding surface. The mask is impermeable or at least of poor permeability compared with the permeability of the radiation-permeable molding surface. The mask extends inwardly right up to the mold 31394-91(S) cavity and surrounds the mold cavity so as to screen all areas behind the mask with the exception of the mold cavity.
Where the curing radiation is UV light, the mask may preferably be a thin chromium layer, which can be produced according to processes as known, for example, in photo and UV lithography. Other metals or metal oxides may also be suitable mask materials. The mask can also be coated with a protective layer, for example of silicon dioxide if the material used for the mould or mould half is quartz.
Alternatively, the mask can be a masking collar made of a material comprising a UV-absorber and substantially blocks curing energy therethrough as described in U.S.
Patent No. 7,387,759. In this preferred embodiment, the mold half with the mask comprises a generally circular disc-shaped transmissive portion and a masking collar having an inner diameter adapted to fit in close engagement with the transmissive portion, wherein said transmissive portion is made from an optically clear material and allows passage of curing energy therethrough, and wherein the masking collar is made from a material comprising a UV-blocker and substantially blocks passage of curing energy therethrough, wherein the masking collar generally resembles a washer or a doughnut, with a center hole for receiving the transmissive portion, wherein the transmissive portion is pressed into the center opening of the masking collar and the masking collar is mounted within a bushing sleeve.
Reusable molds can be made of quartz, glass, sapphire, CaF2, a cyclic olefin copolymer (such as for example, Topas COC grade 8007-S10 (clear amorphous copolymer of ethylene and norbornene) from Ticona GmbH of Frankfurt, Germany and Summit, New Jersey, Zeonex and Zeonor from Zeon Chemicals LP, Louisville, KY), polymethylmethacrylate (PMMA), polyoxymethylene from DuPont (Delrin), Ultem (polyetherimide) from G.E. Plastics, PrimoSpire , etc.. Because of the reusability of the mold halves, a relatively high outlay can be expended at the time of their production in order to obtain molds of extremely high precision and reproducibility. Since the mold halves do not touch each other in the region of the lens to be produced, i.e.
the cavity or actual molding surfaces, damage as a result of contact is ruled out. This ensures a high service life of the molds, which, in particular, also ensures high reproducibility of the contact lenses to be produced and high fidelity to the lens design.
Any hydrophilic amide-type vinylic monomers can be used in the invention.
Examples of hydrophilic amide-type vinylic monomers include without limitation acrylamidoglycolic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid or salt thereof, (3-acrylamidopropyl)trimethylammonium chloride, 3-acryloylamino-1-propanol, N-(butoxymethyl)acrylamide, N-tert-butylacrylamide, diacetone acrylamide, N,N-dimethylacrylamide, N-[3-(dimethylamino)propyl]methacrylamide, N-hydroxyethyl acrylamide, N-(hydroxymethyl)acrylamide, N-(isobutoxymethyl)acrylamide, N-isopropylacrylamide, N-isopropylmethacrylamide, methacrylamide, N-phenylacrylamide, N-[Tris(hydroxymethyl)methyl]acrylamide, N-methyl-3-methylene-2-pyrrolidone, and mixtures thereof. Preferably, the hydrophilic amide-type vinylic monomer is N,N-dimethylacrylamide (DMA), N,N-dimethylmethacrylamide (DMMA), 2-acrylamidoglycolic acid monohydrate, 3-acryloylamino-1-propanol, N-hydroxyethyl acrylamide, N-[T ris(hy dr oxy m ethy 1)m ethy I]a cry lamid e , N-methyl-3-methylene-2-pyrrolidone, and mixtures thereof.
It is found that a siloxane-containing vinylic monomer, especially a vinylic monomer having a tris(trialkylsilyloxy)silylalkyl group (for example, such as, tris(trimethylsilyloxy)-silylpropyl methacrylate (TRIS)), is critical to the elimination of optical defects derived from handling during manufacturing, especially when curing the monomer mixture in a mold within a relatively short time (e.g., less than about 300 seconds) with a UV
light. When TRIS is eliminated from a monomer mixture for making silicone hydrogel contact lenses, resultant lenses would develop permanent deformations (optics defects) due to handling.
Such deformation or optical defect refers to permanent folding marks observed on the lens by a Contact Lens Optical Quality Analyzer (CLOQA) after the lens is folded manually as described in Example 1. But, when TRIS is present, resultant lenses exhibit a 'healing' effect that eliminated the optical defects (i.e., the folding marks become transient and can disappear after a short time period, e.g., about 15 minutes or less). However, a monomer mixture comprising TRIS have a relatively long curing time. It is found that by replacing TRIS with a (meth)acrylamide having a tris(trimethylsilyloxy)silylalkyl group, the curing of a monomer mixture can be significantly reduced while still eliminating optical defects caused by handling during manufacturing.
Any siloxane-containing (meth)acrylamide monomers can be used in the invention.
Preferably, a siloxane-containing (meth)acrylamide monomer is represented by formula (1) y........ /R3 N
\
R R4 (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1¨ C6 alkyl, or a monovalent radical of formula (2) Ai *4Y 0) ( CH2)¨Si¨A3 m P i A2 (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) Bi I
¨0¨Si¨B3 I
B2 (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3).
Examples of siloxane-containing (meth)acrylamide monomers of formula (1) include without limitation N4tris(trimethylsiloxy)silylpropyl]methacrylamide, N4tris(trimethylsiloxy)-silylpropyl]acrylamide, N4tris(dimethylpropylsiloxy)silylpropyl]acrylamide, N-[tris(dimethylpropylsiloxy)silylpropyl]methacrylamide, N-[tris(dimethylphenylsiloxy)silylpropyl] acrylamide, N-[tris(dimethylphenylsiloxy)silylpropyl]methacrylamide, N-[tris(dimethylethylsiloxy)silylpropyl]acrylamide, Nqtris(dimethylethylsiloxy)silylpropyl]
methacrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propy1)-2-methyl acrylamide; N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl) acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl]-2-methyl acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl] acrylamide; N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propy1)-2-methyl acrylamide; N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl)acrylamide; N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]-2-methyl acrylamide; N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]acrylamide; N-[2-hydroxy-3-(3-(t-butyldimethylsilyppropyloxy)propyl]-2-methyl acrylamide; N42-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide; N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl acrylamide; N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide. Most preferred siloxane-containing (meth)acrylamide monomers of formula (1) are Nqtris(trimethylsiloxy)silylpropyl]acrylamide and N[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide.
Any polysiloxane-containing vinylic monomer or macromer" refers to a vinylic monomer or macromer containing at least one ehtylenically unsaturated group and a 31394-91(S) *-hi¨Of*
divalent radical of R2 n in which R1 and R2 are independently a monovalent C10 alkyl, a monovalent C1-C10 aminoalkyl, a monovalent of C1-C10 hydroxyalkyl, C1-C10 ether, C1-C10fluoroalkyl, C1-C10 fluoroether or C6-C18 aryl radical, ¨alk¨(OCH2CH2),/,--0R3, in which alk is Cl-C6 alkylene divalent radical, R3 is hydrogen or C1-C6 alkyl, and m is an integer of from 1 to 10; n is an integer of 3 or higher. Examples of such vinylic monomers or macromers are monomethacrylated or monoacrylated polydimethylsiloxanes of various molecular weight (e.g., mono-3-methacryloxypropyl terminated, mono-butyl terminated polydimethylsiloxane or mono-(3-methacryloxy-2-hydroxypropylm)propyl terminated, mono-butyl terminated polydimethylsiloxane); dimethacrylated or diacrylated polydimethylsiloxanes of various molecular weight; vinyl carbonate-terminated polydimethylsiloxanes; vinyl carbamate-terminated polydimethylsiloxane; vinyl terminated polydimethylsiloxanes of various molecular weight; methacrylamide-terminated polydimethylsiloxanes; acrylamide-terminated polydimethylsiloxanes; acrylate-terminated polydimethylsiloxanes; methacrylate-terminated polydimethylsiloxanes; bis-3-methacryloxy-2-hydroxypropyloxypropyl polydimethylsiloxane; N, N, N', N'-tetrakis(3-methacryloxy-2-hyclroxypropyl)-alpha,omega-bis-3-aminopropyl-polydimethylsiloxane;
polysiloxanylalkyl (meth)acrylic monomers; siloxane-containing macromer selected from the group consisting of Macromer A, Macromer B, Macromer C, and Macromer D described in US
5,760,100;
the reaction products of glycidyl methacrylate with amino-functional polydimethylsiloxanes; hydroxyl-fu nctionalized siloxane-containing vinylic monomers or macromers; polysiloxane-containing macromers disclosed in U.S. Patent Nos. 4,136,250, 4,153,641, 4,182,822, 4,189,546, 4,343,927, 4,254,248, 4,355,147, 4,276,402, 4,327,203, 4,341,889, 4,486,577, 4,543,398, 4,605,712, 4,661,575, 4,684,538, 4,703,097, 4,833,218, 4,837,289, 4,954,586, 4,954,587, 5,010,141, 5,034,461, 5,070,170, 5,079,319, 5039,761, 5,346,946, 5,358,995, 5,387,632, 5,416,132, 5,451,617, 5,486,579, 5,962,548, 5,981,675, 6,039,913, and 6,762,264;
polysiloxane-containing macromers disclosed in U.S.
Patent Nos. 4,259,467, 4,260,725, and 4,261,875.
Di and triblock macromers consisting of polydimethylsiloxane and polyalkyleneoxides could also be of utility. For example one might use methacrylate end capped polyethyleneoxide-block-polydimethylsiloxane-block-polyethyleneoxide to enhance oxygen permeability. Suitable monofunctional hydroxyl-functionalized siloxane-containing vinylic monomers/macromers and suitable multifunctional hydroxyl-functionalized siloxane-containing vinylic monomers/macromers are commercially available from Gelest, Inc, Morrisville, PA.
In a preferred embodiment, the monomer mixture comprises a polysiloxane-containing vinylic macromer of formula (4) o¨X1¨G1¨PDMS¨G2 X2¨Q) r (4) in which r is an integer of 0 or 1;
G1 and G2 independent of each other is a linear or branched C1-C10 alkylene divalent radical, a divalent radical of a4 1k1-0)¨alk¨i q n which q is an integer of from 1 to 5 and alk and alk' independent of each other is a C1-C6 alkylene divalent radical, or a divalent radical of -R'1-X.4-E-X5-R'2- in which R'1 and R'2 independent of each other is a linear or branched C1-C10 alkylene divalent radical or a divalent radical of 4alki-04¨alk¨
ci as defined above, X4 and X5 independent of each other are a IT 0 R' II I R' 0 I II
linkage selected from the group consisting of-O-, ¨N¨, ¨C¨N¨, ¨N¨C¨, R' 0 OR 0 0 0 I II II I II II II
¨N¨C¨NH¨, ¨HN¨C¨N¨, ¨0¨C¨NH¨, ¨HN¨C-0¨, ¨S¨C¨NH¨, II II II
¨0¨C¨, ¨C-0¨, -S-, and ¨HN¨C¨S¨ in which R' is H or C1-C8alkyl, E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain;
X1 and X2 independent of each other are a linkage selected from the group consisting R' OR' R' 0 R' 0 OR
II II II II II
¨0¨C¨NH¨, ¨HN¨C-0¨, ¨S¨C¨NH¨, ¨0¨C¨, ¨C-0¨, -S-, and o ii ¨HN¨C¨S¨ in which R' is H or C1-C8 alkyl;
PDMS is a polysiloxane divalent radical of formula (5) ¨Di-[-Ui¨D24U2¨D3).
(5) in which V is 0 or 1, CO is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of -R'1-X.4-E-X5-R'2- as defined above or a a¨(-1-0)¨alk¨
divalent radical of 1k q as defined above, D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of -(CH2CH20)1-CH2CH2- in which t is an integer of 3 to 40, -CF2-31394-91(S) (0CF2)a¨(0CF2CF2)b¨OCF2¨ in which a and b independent of each other is an integer of 0 to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) R3 R51 R7 Rg ¨Si-0j, 01 s, 0 ____________________ s, in I
R4 R6 Rg P Rio (6) in which R3, R4, R6', R6, R7, R3, R9 and Rio, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4- alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), ¨alk¨(OCH2CH2)a¨OR11 in which alk is C1-C6-alkylene divalent radical, Rii is C1-C6 alkyl and n is an integer from 1 to 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of Di, D2 and D3 is represented by formula (6); and Q is an organic radical containing an ethylenically unsaturated group.
Preferably, Q is an ethylenically unsaturated group of formula (7) ¨+Zi¨A5-4Z24¨C=C/
ql C12 1 \
R14 R16 (7) in which Zi and Z2 independent of each other are a linear or branched C1¨C12 alkylene divalent radical, a linear or branched C1¨C12 alkylene divalent radical having one or more hydroxyl groups, a radical of ¨(CH2CH20)d¨CH2CH2¨ in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or Ci-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is ¨0¨ or ¨N¨ in which R' is H or C1-C8 alkyl; qi and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, CI-at alkyl or halogen; R15 and R16 independent of each other are hydrogen, C1-C4 alkyl, 0 R' phenyl, carboxy, halogen, or a radical of ¨c¨X3¨R17 in which X3 IS ¨0¨, ¨N¨ as defined above or ¨S¨ and R17 is a C1¨C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical.
A polysiloxane-containing vinylic macromer of formula (4) can be prepared according to any known procedures, for example, those described in U.S. patent Nos.
4,136,250, 4,486,577, 4,605,712, 5,034,461, 5,416,132, and 5,760,100.
A photoinitiator can initiate free radical polymerization and/or crosslinking by the use of light. Suitable photoinitiators are benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide, 1-hydroxycyclohexyl phenyl ketone and Darocur and Irgacure types, preferably Darocur 1173 , lrgacure 369 , lrgacure 379 , and Irgacure 2959O.
31394-91(S) Examples of benzoylphosphine oxide initiators include 2,4,6-trimethylbenzoyldiphenylophosphine oxide (TP0); bis-(2,6-dichlorobenzoy1)-4-N-propylphenylphosphine oxide; and bis-(2,6-dichlorobenzoyI)-4-N-butylphenylphosphine oxide. Reactive photoinitiators which can be incorporated, for example, into a macromer or can be used as a special monomer are also suitable. Examples of reactive photoinitiators are those disclosed in EP 632 329. The polymerization can then be triggered off by actinic radiation, for example light, in particular UV light of a suitable wavelength. The spectral requirements can be controlled accordingly, if appropriate, by addition of suitable photosensitizers In accordance with the present invention, the monomer mixture can also comprise additional hydrophilic vinylic monomer other than amid-type vinylic monomer.
Nearly any hydrophilic vinylic monomer can be used in the invention. Suitable hydrophilic vinylic monomers are, without this being an exhaustive list, hydroxyl-substituted lower alkyl (C1 to C6) acrylates and methacrylates, hydroxyl-substituted lower alkyl vinyl ethers, N-vinylpyrrole, N-vinyl-2-pyrrolidone, 2-vinyloxazoline, 2-vinyl-4,4'-dialkyloxazolin-5-one, 2-and 4-vinylpyridine, olefinically unsaturated carboxylic acids having a total of 3 to 6 carbon atoms, amino(lower alkyl)- (where the term "amino" also includes quaternary ammonium), mono(lower alkylamino)(lower alkyl) and di(lower alkylamino)(lower alkyl)acrylates and methacrylates, ally! alcohol, N-vinyl alkylamide, N-vinyl-N-alkylamide, and the like. Among the preferred hydrophilic vinylic monomers are 2-hydroxyethylmethacrylate (HEMA), 2-hydroxyethyl acrylate (HEA), hydroxypropyl acrylate, hydroxypropyl methacrylate (HPMA), trimethylammonium 2-hydroxy propylmethacrylate hydrochloride, Aminopropyl methacrylate hydrochloride, dimethylaminoethyl methacrylate (DMAEMA), glycerol methacrylate (GMA), N-vinyl-2-pyrrolidone (NVP), allyl alcohol, vinylpyridine, acrylic acid, a Craralkoxy polyethylene glycol (meth)acrylate having a weight average molecular weight of from 200 to 1500, methacrylic acid, N-vinyl formamide, N-vinyl acetamide, N-vinyl isopropylamide, N-vinyl-N-methyl acetamide, allyl alcohol, and N-vinyl caprolactam. More preferably, the hydrophilic vinylic monomer other than amide-type vinylic monomer is an acrylate monomer.
A monomer mixture of the invention can also comprises a hydrophobic monomer different from the siloxane-containing vinylic monomer. By incorporating a certain amount of hydrophobic vinylic monomer in a monomer mixture, the mechanical properties (e.g., modulus of elasticity) of the resultant polymer may be improved. Nearly any hydrophobic vinylic monomer can be used in the actinically polymerizable composition for preparing the intermediary copolymer with pendant or terminal functional groups. Examples of preferred hydrophobic vinylic monomers include methylacrylate, ethyl-acrylate, propylacrylate, isopropylacrylate, cyclohexylacrylate, 2-ethylhexylacrylate, methylmethacrylate, ethylmethacrylate, propylmethacrylate, vinyl acetate, vinyl propionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyl toluene, vinyl ethyl ether, perfluorohexylethyl-thio-carbonyl-aminoethyl-methacrylate, isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoro-isopropyl methacrylate, hexafluorobutyl methacrylate.
It is understood that if the hydrophilic vinylic monomer other than amide-type vinylic monomer or hydrophobic vinylic monomer present in the monomer mixture is a methacrylate monomer, the total amount of methacrylate monomers is less than about 10% by weight, preferably, less than about 8% by weight, even more preferably less than about 5% by weight, most preferably less than about 1% by weight. Preferably, their amount is sufficient low so as to provide the lens forming composition with a characteristics of being able to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within a time period of less than about 100 seconds.
In accordance with the invention, the UV source can be a Hamamatsu UV lamp manufactured by Hamamatsu K.K.. Light from the source is passed down a light guide and through a 330nm cut-off filter manufactured by DOnnschicht Technik GmbH
Germany. The intensity of light that passes through the optical arrangement is preferably measured with a ESE radiometer manufactured by ESE GmbH / Germany.
In a preferred embodiment, the monomer mixture comprises a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent. By having a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent in the monomer mixture, silicone hydrogel lenses with UV-absorbing capability can be obtained. Such lenses may protect to some extent corneal from damages caused by ultra-violet ("UV") radiation.
Any suitable polymerizable UV-absorbing agents can be used in the invention.
Preferably, a polymerizable UV-absorbing agent comprises a benzotriazole-moiety or a benzophenone-moiety. Examples of preferred polymerizable UV absorbers include without limitation 2-(2-hydroxy-5-vinylphenyI)-2H-benzotriazole, 2-(2-hydroxy-5-acrylyloxyphenyI)-2H-benzotriazole, 2-(2-hydroxy-3-methacrylamido methyl-5-tert octylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyI)-5-chlorobenzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyI)-5-methoxybenzotriazole, 2-(2'-hydroxy-5'-methacryloxypropy1-3'-t-butyl-phenyl)-5-chlorobenzotriazo le, 2-(2'-hydroxy-5'-methacryloxyethylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacryloxypropylphenyl)benzotriazole, 2-hydroxy-4-acryloxy alkoxy benzophenone, 2-hydroxy-4-methacryloxy alkoxy benzophenone, allyI-2-hydroxybenzophenone, 2-hydroxy-4-methacryloxy benzophenone.
A polymerizable latent UV-absorbing agent can be prepared from a polymerizable UV-absorbing agent described above according to any known method known to a person skilled in the art. For example, a benzotriazole-moiety or a benzophenone-moiety can be reacted with a protected labile group to convert a UV-absorbing moiety into a latent UV-absorbing moiety.
For a benzotriazole-type of UV-absorbing agent, the hydroxyl radical of the phenol moiety in a benzotriazole moiety can be replaced with a protective labile group to render the agent essentially non-UV absorbing (i.e., the protective group essentially shifts the absorption properties of the compound so that the agent does not absorb as strongly in the 280 to 400 nm range). Examples of protective labile groups include without limitation acetyl radical, acetylalkylsilane, alkylether, and alkylester. These protective groups can be converted back to a hydroxyl radical according to any known method after the lens is cured, thus rendering the lens UV-absorbing. For example, removal of protective labile groups can be performed by soaking the cured lens in saturated bicarbonate solution and heating.
Similarly, at least one hydroxyl radical of the phenolic radical of a benzophenone moiety can be replaced with one of the aforementioned protective labile groups to form a latent UV-absorbing moiety. The latent UV-absorbing moiety can be converted to a UV-absorbing moiety by removing the protective labile group.
A polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent is generally is present in the monomer mixture in an amount sufficient to render a contact lens, which is obtained from the curing of the monomer mixture and is subjected to treatment to convert latent UV-absorbing moieties if applicable, absorbing at least about 80 percent of the UV light in the range of from about 280 nm to about 370 nm that impinges on the lens. A person skilled in the art will understand that the specific amount of UV-absorbing agent used in the monomer mixture will depend on the molecular weight of the UV-absorbing agent and its extinction coefficient in the range from about 280 to about 370 nm. In accordance with the invention, the monomer mixture comprises about 0.2%
to about 5.0%, preferably about 0.5% to about 2.5%, by weight of a UV-absorbing agent.
Where the monomer mixture comprises a polymerizable UV-absorbing agent, a benzoylphosphine oxide photoinitiator is preferably used as the photoinitiator in the invention. Preferred benzoylphosphine oxide photoinitiators include without limitation 2,4,6-trimethylbenzoyldiphenylophosphine oxide; bis-(2,6-dichlorobenzoyI)-4-N-propylphenylphosphine oxide; and bis-(2,6-dichlorobenzoyI)-4-N-butylphenylphosphine oxide. It is understood that any photoinitiators other than benzoylphosphine oxide initiators can be used in the invention.
A monomer mixture of the invention can further comprise an antimicrobial agent, preferably antimicrobial metal nanoparticles, more preferably silver nanoparticles.
In accordance with the present invention, a monomer mixture can further comprise various components, such as cross-linking agents, a chain transfer agent, initiator, inhibitors, fillers, visibility tinting agents (e.g., dyes, pigments, or mixtures thereof), a bioactive agent, a leachable lubricant, and the like, as known to a person skilled in the art.
Cross-linking agents are compounds having two or more ethylenically unsaturated groups and having a molecular weight of less than 700 Da!tons. Crosslinking agents may be used to improve structural integrity and mechanical strength. Examples of cross-linking agents include without limitation tetra(ethyleneglycol) diacrylate, tri(ethyleneglycol) diacrylate, ethyleneglycol diacylate, di(ethyleneglycol) diacrylate, tetraethyleneglycol dimethacrylate, triethyleneglycol dimethacrylate, ethyleneglycol dimethacylate, di(ethyleneglycol) dimethacrylate, trimethylopropane trimethacrylate, pentaerythritol tetramethacrylate, bisphenol A dimethacrylate, vinyl methacrylate, ethylenediamine dimethyacrylamide, glycerol dimethacrylate, triallyl isocyanurate, triallyl cyanurate, allylmethacrylate, and combinations thereof. A preferred cross-linking agent is tetra(ethyleneglycol) diacrylate, tri(ethyleneglycol) diacrylate, ethyleneglycol diacrylate, di(ethyleneglycol) diacrylate, triallyl isocyanurate, or triallyl cyanurate.
The amount of a cross-linking agent used is expressed in the weight content with respect to the total polymer and is preferably in the range from about 0.05%
to about 4%, and more preferably in the range from about 0.1% to about 2%.
Examples of preferred pigments include any colorant permitted in medical devices and approved by the FDA, such as D&C Blue No. 6, D&C Green No. 6, D&C Violet No. 2, carbazole violet, certain copper complexes, certain chromium oxides, various iron oxides, phthalocyanine green, phthalocyanine blue, titanium dioxides, etc. See Marmiom DM
Handbook of U.S. Colorants for a list of colorants that may be used with the present invention. A more preferred embodiment of a pigment include (C.I. is the color index no.), without limitation, for a blue color, phthalocyanine blue (pigment blue 15:3, al. 74160), cobalt blue (pigment blue 36, al. 77343), Toner cyan BG (Clariant), Permajet blue B2G
(Clariant); for a green color, phthalocyanine green (Pigment green 7, al.
74260) and chromium sesquioxide; for yellow, red, brown and black colors, various iron oxides; PR122, PY154, for violet, carbazole violet; for black, Monolith black C-K (CIBA
Specialty Chemicals).
The bioactive agent incorporated in the polymeric matrix is any compound that can prevent a malady in the eye or reduce the symptoms of an eye malady. The bioactive agent can be a drug, an amino acid (e.g., taurine, glycine, etc.), a polypeptide, a protein, a nucleic acid, or any combination thereof. Examples of drugs useful herein include, but are not limited to, rebamipide, ketotifen, olaptidine, cromoglycolate, cyclosporine, nedocromil, levocabastine, lodoxamide, ketotifen, or the pharmaceutically acceptable salt or ester thereof. Other examples of bioactive agents include 2-pyrrolidone-5-carboxylic acid (PCA), alpha hydroxyl acids (e.g., glycolic, lactic, malic, tartaric, mandelic and citric acids and salts thereof, etc.), linoleic and gamma linoleic acids, and vitamins (e.g., B5, A, B6, etc.).
Examples of leachable lubricants include without limitation mucin-like materials (e.g., polyglycolic acid) and non-crosllinkable hydrophilic polymers (i.e., without ethylenically unsaturated groups).
Any hydrophilic polymers or copolymers without any ethylenically unsaturated groups can be used as leachable lubricants. Preferred examples of non-crosslinkable hydrophilic polymers include, but are not limited to, polyvinyl alcohols (PVAs), polyamides, polyimides, polylactone, a homopolymer of a vinyl lactam, a copolymer of at least one vinyl lactam in the presence or in the absence of one or more hydrophilic vinylic comonomers, a homopolymer of acrylamide or methacrylamide, a copolymer of acrylamide or methacrylamide with one or more hydrophilic vinylic monomers, polyethylene oxide (i.e., polyethylene glycol (PEG)), a polyoxyethylene derivative, poly-N-N-dimethylacrylamide, polyacrylic acid, poly 2 ethyl oxazoline, heparin polysaccharides, polysaccharides, and mixtures thereof.
The number-average molecular weight Mn of the non-crosslinkable hydrophilic polymer is preferably from 5,000 to 500,000, more preferably from 10,000 to 300,000, even more preferably from 20,000 to 100,000.
In accordance with the invention, a lens-forming material is a composition which can be a solution or a melt at a temperature from about 20 C to about 85 C.
Preferably, a lens-forming material is a solution of all desirable components in water, or an organic solvent, or a mixture of water and one or more organic solvents.
A monomer mixture of the invention can be prepared by dissolving all of the desirable components in any suitable solvent known to a person skilled in the art. Example of suitable solvents includes without limitation, water, tetrahydrofuran, tripropylene glycol methyl ether, dipropylene glycol methyl ether, ethylene glycol n-butyl ether, ketones (e.g., acetone, methyl ethyl ketone, etc.), diethylene glycol n-butyl ether, diethylene glycol methyl ether, ethylene glycol phenyl ether, propylene glycol methyl ether, propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol n-propyl ether, dipropylene glycol n-propyl ether, tripropylene glycol n-butyl ether, propylene glycol n-butyl ether, dipropylene glycol n-butyl ether, tripropylene glycol n-butyl ether, propylene glycol phenyl ether dipropylene glycol dimetyl ether, polyethylene glycols, polypropylene glycols, ethyl acetate, butyl acetate, amyl acetate, methyl lactate, ethyl lactate, i-propyl lactate, methylene chloride, 2-butanol, 1-propanol, 2-propanol, menthol, cyclohexanol, cyclopentanol and exonorborneol, 2-pentanol, 3-pentanol, 2-hexanol, 3-hexanol, 3-methyl-2-butanol, 2-heptanol, 2-octanol, 2-nonanol, 2-decanol, 3-octanol, norborneol, tert-butanol, tert-amyl, alcohol, 2-methyl-2-pentanol, 2,3-dimethyl-2-butanol, 3-methyl-3-pentanol, 1-methylcyclohexanol, 2-methyl-2-hexanol, 3,7-dimethy1-3-octanol, 1-chloro-2-methyl-2-propanol, 2-methyl-2-heptanol, 2-methyl-2-octanol, 2-2-methyl-2-nonanol, 2-methyl-2-decanol, 3-methyl-3-hexanol, 3-methyl-3-heptanol, 4-methyl-4-heptanol, 3-methyl-3-octanol, 4-methyl-4-octanol, 3-methyl-3-nonanol, 4-methyl-4-nonanol, 3-methyl-3-octanol, 3-ethyl-3-hexanol, 3-methyl-3-heptanol, 4-ethyl-4-heptanol, 4-propy1-4-heptanol, 4-isopropyl-4-heptanol, 2,4-dimethyl-2-pentanol, 1-methylcyclopentanol, 1-ethylcyclopentanol, 1-ethylcyclopentanol, 3-hydroxy-3-methyl-1-butene, 4-hydroxy-4-methyl-1-cyclopentanol, 2-phenyl-2-propanol, 2-methoxy-2-methyl-2-propanol 2,3,4-trimethy1-3-pentanol, 3,7-dimethy1-3-octanol, 2-phenyl-2-butanol, 2-methyl-1-phenyl-2-propanol and 3-ethyl-3-pentanol, 1-ethoxy-2-propanol, 1-methyl-2-propanol, t-amyl alcohol, isopropanol, 1-methyl-2-pyrrolidone, N,N-dimethylpropionamide, dimethyl formamide, dimethyl acetamide, dimethyl propionamide, N-methyl pyrrolidinone, and mixtures thereof.
In a preferred embodiment, the monomer mixture of the invention comprises: (1) from about 5% to about 60% by weight, preferably from about 10% to about 50%
by weight, even more preferably from about 15% to about 45% by weight, even more preferably from about 20% to about 40% by weight, of a hydrophilic amide-type vinylic monomer; (2) from about 5% to about 50% by weight, preferably from about 10%
to about 40% by weight, more preferably from about 15% to about 30% by weight, of a siloxane-containing acrylate or acrylamide or methacrylamide monomer; (3) from about 5%
to about 50%, preferably from about 10% to about 40% by weight, more preferably from about 15%
to about 35% by weight, of a polysiloxane-containing vinylic macromer; (4) from about 0.05% to about 1.5% by weight, preferably from about 0.1% to 1.3% by weight, more preferably from about 0.5% to about 1.1% by weight, of a photoinitiator; and (5) from 0 to 5% by weight, preferably from about 0.2% to 5% by weight, more preferably from about 0.5% to about 2.5% by weight, of a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent. The foregoing range combinations are presented with the proviso that the listed components and any additional components add up to 100% by weight.
In accordance with the invention, the monomer mixture can be introduced (dispensed) into a cavity formed by a mold according to any known methods.
After the monomer mixture is dispensed into the mold, it is polymerized to produce a contact lens. Crosslinking may be initiated by exposing the monomer mixture in the mold to a spatial limitation of actinic radiation to crosslink the polymerizable components in the monomer mixture. The crosslinking according to the invention may be effected in a very short time, e.g. in about 120 seconds, preferably in about 80 seconds, more preferably 31394-91(S) in 50 about seconds, even more preferably in about 30 seconds, and most preferably in to 30 seconds.
Opening of the mold so that the molded lens can be removed from the mold may take place in a manner known per se.
5 The molded contact lens can be subject to lens extraction to remove unpolymerized vinylic monomers and macromers. The extraction solvent can be any solvent known to a person skilled in the art. Examples of suitable extraction solvent are those described above for preparing monomer mixtures. After extraction, lenses can be hydrated in a water or an aqueous solution of a wetting agent (e.g., a hydrophilic polymer).
The molded contact lenses can further subject to further processes, such as, for example, surface treatment (for example, such as, plasma treatment, chemical treatments, the grafting of hydrophilic monomers or macromers onto the surface of a lens, Layer-by-layer coating, etc.); packaging in lens packages with a packaging solution which can contain about 0.005% to about 5% by weight of a wetting agent (e.g., a hydrophilic polymer described above) and/or a viscosity-enhancing agent (e.g., methyl cellulose (MC), ethyl cellulose, hydroxymethylcellulose, hydroxyethyl cellulose (H EC), hydroxypropylcellulose (HPC), hydroxypropylmethyl cellulose (HPMC), or a mixture thereof);
sterilization; and the like.
Preferred surfaces treatments are LbL coating such as those described in US
Patent Ser. No. 6,451,871, 6,719,929, 6,793,973, 6,811,805, 6,896,926 and plasma treatment. A preferred plasma treatment is those processes in which an ionized gas is applied to the surface of an article as described in U.S. Pat. Nos. 4,312,575 and 4,632,844.
A contact lens of the invention has an oxygen permeability of preferably at least about 40 barrers, more preferably at least about 60 barrers, even more preferably at least about 80 barrers. In accordance with the invention, an oxygen permeability is an apparent (directly measured when testing a sample with a thickness of about 100 microns) oxygen permeability according to procedures described in Examples.
A contact lens of the invention has an elastic modulus of about 2.0 MPa or less, preferably about 1.5 MPa or less, more preferably about 1.2 or less, even more preferably from about 0.4 MPa to about 1.0 MPa.
A contact lens of the invention further has an lonoflux Diffusion Coefficient, D, of, preferably at least about 1.5 x 10-6 mm2/min, more preferably at least about 2.6 x 10-6 mm2/min, even more preferably at least about 6.4 x 10-6 mm2/min.
A contact lens of the invention further has a water content of preferably from about 15% to about 70%, more preferably from about 20% to about 50% by weight when fully 31394-91(S) hydrated. The water content of a silicone hydrogel contact lens can be measured according to Bulk Technique as disclosed in US5,849,811.
In another aspect, the invention provide a lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation. The lens-forming composition comprises at least one hydrophilic vinylic monomer, at least one siloxane-containing vinylic monomer selected from the group consisting of siloxane-containing acrylate, siloxane-containing acrylamide, siloxane-containing methacrylamide, and a mixture thereof, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5% by weight of a photoinitator, provided that the total amount of all methacrylate monomer(s) in the lens-forming composition is less than about 10% by weight and is sufficient low so as to provide the lens forming composition with a characteristics of being able to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within a time period of less than about 100 seconds.
In a preferred embodiment, the siloxane-containing vinylic monomer is a siloxane-containing acrylamide, a siloxane-containing methacrylamide or mixture thereof.
In a more preferred embodiment, the siloxane-containing vinylic monomer is a siloxane-containing acrylamide.
All of the various embodiments of the monomer mixture of the invention described above can be used in this aspect of the invention.
In a further aspect, the invention provides a silicone hydrogel contact lens obtained by the method of the invention.
All of the various embodiments of the molds, monomer mixture, and spatial limitation of radiation, and contact lens of the invention described above can be used in this aspect of the invention.
The previous disclosure will enable one having ordinary skill in the art to practice the invention. In order to better enable the reader to understand specific embodiments and the advantages thereof, reference to the following non-limiting examples is suggested.
However, the following examples should not be read to limit the scope of the invention.
Example 1 Oxygen Permeability Measurements The oxygen permeability of a lens and oxygen transmissibility of a lens material is determined according to a technique similar to the one described in U.S.
Patent No.
5,760,100 and in an article by Winterton et al., (The Cornea: Transactions of the World Congress on the Cornea 111, H.D. Cavanagh Ed., Raven Press: New York 1988, pp273-31394-91(S) 280). Oxygen fluxes (J) are measured at 34 C in a wet cell (i.e., gas streams are maintained at about 100%
relative humidity) using a Dk1000 instrument (available from Applied Design and Development Co., Norcross, GA), or similar analytical instrument. An air stream, having a known percentage of oxygen (e.g., 21%), is passed across one side of the lens at a rate of about 10 to 20 cm3 /min., while a nitrogen stream is passed on the opposite side of the lens at a rate of about 10 to 20 cm3 /min. A sample is equilibrated in a test media (i.e., saline or distilled water) at the prescribed test temperature for at least 30 minutes prior to measurement but not more than 45 minutes. Any test media used as the overlayer is equilibrated at the prescribed test temperature for at least 30 minutes prior to measurement but not more than 45 minutes. The stir motor's speed is set to 1200 50 rpm, corresponding to an indicated setting of 400 15 on the stepper motor controller. The barometric pressure surrounding the system, Pmeasured, is measured. The thickness (t) of the lens in the area being exposed for testing is determined by measuring about 10 locations with a Mitotoya micrometer VL-50, or similar instrument, and averaging the measurements. The oxygen concentration in the nitrogen stream (i.e., oxygen which diffuses through the lens) is measured using the DK1000 instrument. The apparent oxygen permeability of the lens material, Dkapp, is determined from the following formula:
Dkapp =Jt/(Poxygen) where J=oxygen flux [microliters 02 /cm2 -minute]
Poxygen :--(Pmeasured -Pwater vapor)=(%02 in air stream) [mm Hg]=partial pressure of oxygen in the air stream Pmeasured =barometric pressure (mm Hg) Pwater vapor =0 mm Hg at 34 C (in a dry cell) (mm Hg) Pwater vapor =40 mm Hg at 34 C (in a wet cell) (mm Hg) t=average thickness of the lens over the exposed test area (mm) Dkapp is expressed in units of barrers.
The oxygen transmissibility (Dk /t) of the material may be calculated by dividing the oxygen permeability (Dkapp) by the average thickness (t) of the lens.
Ion Permeability Measurements The ion permeability of a lens is measured according to procedures described in U.S. Patent No. 5,760,100. The values of ion permeability reported in the following examples are relative ionoflux diffusion coefficients (D/Drat) in reference to a lens material, Alsacorr, as reference material. Alsacorr has an ionoflux diffusion coefficient of 0.314X10-3 mm2/minute.
Water Contact Angle (WCA) Measurements Water contact angle (WCA) measurements are performed by the sessile drop method with a DSA 10 drop shape analysis system from Kruss GmbH, Germany with pure water (Fluka, surface tension 72.5 mN/m at 20 C). For measurement purposes a contact lens is taken off the storage solution with tweezers and excess storage solution is removed by gentle shaking. The contact lens are placed on the male part of a lens mold and gently blotted with a dry and clean cloth. A water droplet (approximately 1 pl) is then dosed on the lens apex, and the change of the contact angle over time of this water droplet (WCA(t), circle fitting mode) is monitored. The WCA is calculated by the extrapolation of the graph WCA(t) to t = 0.
Folding Mark Determination A Contact Lens Optical Quality Analyzer (CLOQA) is developed to determine optical distortions caused by surface deformations and other defects in the contact lens, based on the principle of the Foucault knife-edge test. A person skilled in the art understands how to select, align and arrange various optics elements to create collimating light, to illuminate a contact lens, and to capture an image with a device (for example, such as, a CCD camera). The test involves illuminating the contact lens with a near-collimated light, placing a Foucault knife edge near the focal point, moving the knife-edge to block off most of the focused light, and capturing the image of contact lens with a device, for example CCD camera behind the Foucault knife edge. Where there is no optical distortion in the contact lens, all light rays passing through the contact lens come to focus at the knife edge and most of the well-focused light will be blocked off. For areas outside the optical zone which has no focusing function, the knife-edge will block the light from half of the lens to make it dark, while the other half appear bright. If the contact lens has no optical distortions in its optical zone, the whole optical zone will be uniformly dark or bright depending on how much light is blocked by the knife-edge. Where there are optical distortions on the contact lens, light passing through such areas in general does not fall into the main focus and may be either blocked by the knife edge (appearing dark) or pass through freely (appearing bright). The level of contrast not only depends on the amplitude of the distortion, but also depends on the fine position of the knife-edge.
The defective areas appear as contrast features in the CLOQA image. The knife-edge test with CLOQA
is designed as a qualitative testing device for optical distortions in the optical zone.
Folding mark study is carried out as follows. Three autoclaved and/or not autoclaved contact lenses are used in the study. First, images of the contact lenses are taken with the CLOQA. Second, each lens is folded with fingers twice (creating two perpendicular fold lines) and then its image is taken immediately with the CLOQA. Third, the image of each contact lens about 15 minutes after folding is taken with the CLOQA.
Three types of CLOQA images are obtained: original one (i.e., without folding), immediately after folding, and about 15 minutes after folding. The folding mark study allows to determine the appearance of the folding line changing over time.
Example 2 Preparation of Polysiloxane Vinylic Macromer I with Terminal Acrylamide Groups In a 4-L beaker, 24.13 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloxane (Shin-Etsu, MW ca. 11500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 14.5 g of acryloyl chloride are dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.175 mEq/g of C=C double bonds.
Preparation of Polysiloxane Vinylic Macromer ll with Terminal Acrylamide Groups In a 4-L beaker, 61.73 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloaxane (Shin-Etsu, MW ca. 4500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 36.6 g of acryloyl chloride is dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.435 mEq/g of C=C double bonds.
Preparation of Polysiloxane Vinylic Macromer III with Terminal Acrylamide Groups In a 4-L beaker, 24.13 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloxane (Shin-Etsu, MW ca. 11500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 14.5 g of acryloyl chloride are dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.175 mEq/g of C=0 double bonds.
Preparation of Polysiloxane Vinylic Macromer IV with Terminal Acrylamide Groups In a 4-L beaker, 61.73 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloaxane (Shin-Etsu, MW ca. 4500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 36.6 g of acryloyl chloride is dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.435 mEq/g of C=C double bonds.
Example 3 Preparation of Chain-Extended Polydimethylsiloxane Vinylic Macromer with Terminal Methacrylate Groups (CE-PDMS Macromer) In the first step, a,w-bis(2-hydroxyethoxypropyl)-polydimethylsiloxane (Mn =
2000, Shin-Etsu, KF-6001a) is capped with isophorone diisocyanate by reacting 49.85 g of a,w-bis(2-hydroxyethoxypropyl)-polydimethylsiloxane with 11.1 g isophorone diisocyanate (IPDI) in 150 g of dry methyl ethyl ketone (MEK) in the presence of 0.063g of dibutyltindilaurate (DBTDL). The reaction is kept for 4.5 h at 40 C, forming IPDI-PDMS-IPDI. In the second step, a mixture of 164.8 g of a,w-bis(2-hydroxyethoxypropyl)-polydimethylsiloxane (Mn = 3000, Shin-Etsu, KF-6002) and 50 g of dry MEK are added dropwise to the IPDI-PDMS-IPDI solution to which has been added an additional 0.063 g of DBTDL. The reactor is held for 4.5 h at 40 C, forming HO-PDMS-IPDI-PDMS-IPDI-PDMS-OH. MEK is then removed under reduced pressure. In the third step, the terminal hydroxyl-groups are capped with methacryloyloxyethyl groups in a third step by addition of 7.77 g of isocyanatoethylmethacrylate (IEM) and an additional 0.063 g of DBTDL, forming IEM-PDMS-IPDI-PDMS-IPDI-PDMS-IEM.
Alternate Preparation of CE-PDMS Macromer with Terminal Methacrylate Groups 240.43 g of KF-6001 is added into a 1-L reactor equipped with stirring, thermometer, cryostat, dropping funnel, and nitrogen/vacuum inlet adapter, and then dried by application of high vacuum (2x10-2 mBar). Then, under an atmosphere of dry nitrogen, 320 g of distilled MEK is then added into the reactor and the mixture is stirred thoroughly.
0.235 g of DBTDL are added to the reactor. After the reactor is warmed to 45 C, 45.86 g of IPDI are added through an addition funnel over 10 minutes to the reactor under moderate stirring. The reaction is kept for 2 hours at 60 C. 630 g of KF-6002 dissolved in 452 g of distilled MEK are then added and stirred until a homogeneous solution is formed. 0.235 g of DBTDL are added, and the reactor is held at 55 C overnight under a blanket of dry nitrogen. The next day, MEK is removed by flash distillation. The reactor is cooled and 22.7 g of IEM are then charged to the reactor followed by 0.235 g of DBTDL. After 3 hours, an additional 3.3 g of IEM are added and the reaction is allowed to proceed overnight. The following day, the reaction mixture is cooled to 18 C to obtain CE-PDMS
macromer.
Example 4 Preparation of Lens Formulations Three lens formulations are prepared by dissolving, in 1-propanol, CE-PDMS
macromer prepared in Example 3 and other components as listed in Table 1.
Table 1 Compositions (% by weight) Components Formulation I Formulation ll Formulation Ill CE-PDMS 33.0 33.0 33.0 Tris-methacrylate 17.0 Tris-methacrylamide 17.0 Tris-acrylamide 17.0 DMA 24.0 24.0 24.0 L-PEG 2000 0.5 0.5 0.5 Darocur 1173 1.0 1.0 1.0 1-Propanol 24.5 24.5 24.5 Tris-methacrylate: tris(trimethylsiloxy)silylpropylmethacrylate Tris-methacrylamide: N4tris(trimethylsiloxy)silylpropylynethacrylamide Tris-acrylamide: N4tris(trimethylsiloxy)-silylpropyl]acrylamide DMA: N,N-dimethylacrylamide L-PEG 2000: N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-disteaoyl-sn-glycero-3-phosphoethanolamin, sodium salt) DC 1173: Darocur 1173 Studies of Curing Times of the Lens Formulations UV source is a Hamamatsu UV lamp manufactured by Hamamatsu K.K.. Light from the source is passed down a light guide and through a 330nm cut-off filter manufactured by Dunnschicht Technik GmbH Germany, before being impinged on the sample contained between two quartz microscope slides. The intensity of light that passes through the optical arrangement is measured with a ESE radiometer manufactured by ESE
GmbH / Germany.
Table 2 shows a 48% reduction in cure time by replacing Tris methacrylate with Tris methacrylamide and a 78% reduction by replacing Tris methacrylate with Tris acrylamide.
Table 2 Formulation No. UV-Intensity (mW/cm2) Irradiation Time (s) Modulus G' (KPa)*
4.1 110.0 41.0 II 4.1 57.0 80.0 III 4.0 24.0 110.
* G' is the storage modulus and is a measure of the energy stored in a polymer upon deformation. It is measured in the curing solvent Example 5 Lenses are prepared by cast-molding from formulation Ill prepared in Example 4 in a reusable mold, similar to the mold shown in Figs. 1-6 in U.S. patent Nos.7,384,590 and 7,387,759 (Figs. 1-6). The mold comprises a female mold half made of CaF2 and a male mold half made of PMMA. The UV irradiation source is a Hamamatsu lamp with the WG335 +TM297 cut off filter at an intensity of about 4 mW /cm2. The lens formulation in the mold is irradiated with UV irradition for about 25 seconds. Resultant lenses are extracted with isopropanol, rinsed in water, dipped in a propanol solution of polyacrylic acid, and hydrated in water. The obtained lenses are determined to have the following properties: ion permeability of about 8.0 to about 9.0 relative to Alsacon lens material;
apparent Dk (single point) of about 90 to 100; a water content of about 30% to about 33%; and an elastic modulus of about 0.60 MPa to about 0.65 MPa.
Example 6 Synthesis of Silicone-Containing Vinylic Macromer with Terminal Methacrylate Groups The macromer is prepared according to the procedures described in U.S. Patent No. 5,760,100 for preparation Macromer B (Examples B1 to B14).
51.5 g (50 mmol) of the perfluoropolyether Fomblin0 ZDOL (from Ausimont S.p.A, Milan) having a mean molecular weight of 1030 g/mol and containing 1.96 meq/g of hydroxyl groups according to end-group titration is introduced into a three-neck flask together with 50 mg of dibutyltin dilaurate. The flask contents are evacuated to about 20 mbar with stirring and subsequently decompressed with argon. This operation is repeated twice. 22.2g (0.1mol) of freshly distilled isophorone diisocyanate kept under argon are subsequently added in a counterstream of argon. The temperature in the flask is kept below 30 C by cooling with a waterbath. After stirring overnight at room temperature, the reaction is complete. lsocyanate titration gives an NCO content of 1.40 meq/g (theory: 1.35 meq/g).
202 g of the a,co-hydroxypropyl-terminated polydimethylsiloxane KF-6001 from Shin-Etsu having a mean molecular weight of 2000 g/mol (1.00 meq/g of hydroxyl groups according to titration) are introduced into a flask. The flask contents are evacuated to approx. 0.1mbar and decompressed with argon. This operation is repeated twice.
The degased siloxane is dissolved in 202 ml of freshly distilled toluene kept under argon, and 100 mg of dibutyltin dilaurate (DBTDL) are added. After complete homogenization of the solution, all the perfluoropolyether reacted with isophorone diisocyanate (IPDI) is added under argon. After stirring overnight at room temperature, the reaction is complete. The solvent is stripped off under a high vacuum at room temperature.
Microtitration shows 0.36 meq/g of hydroxyl groups (theory 0.37 meq/g).
13.78 g (88.9mmol) of 2-isocyanatoethyl methacrylate (IEM) are added under argon to 247 g of the a,co-hydroxypropyl-terminated polysiloxane-perfluoropolyether-polysiloxane three-block copolymer (a three-block copolymer on stoichiometric average, but other block lengths are also present). The mixture is stirred at room temperature for three days.
Microtitration then no longer shows any isocyanate groups (detection limit 0.01meq/g).
0.34 meq/g of methacryl groups are found (theory 0.34 meq/g).
The macromer prepared in this way has two terminal methacrylate groups is completely colourless and clear. It can be stored in air at room temperature in the absence of light for several months without any change in molecular weight.
Preparation of a Lens Forming Material The siloxane-containing macromer with two terminal methacrylate groups, which is prepared above, is used in preparation of two lens-forming materials.
Formulation 1 comprises 25.92% of the siloxane-containing macromer, 19.25% of TRIS (3-tris(trimethyl-siloxy)silylpropyl methacrylate), 28.88% of DMA (N,N-dimethylacrylamide), 24.95% of denatured ethanol, and 1.0% of 2-hydroxy-2-methyl-1-phenyl-1-propanone (Darocure 1173). Formulation 2 comprises 25.92% of the siloxane-containing macromer, 19.25% of TRIS-Am (Nqtris(trimethylsiloxy)-silylpropyl]acrylamide), 28.88% of DMA, 24.95% of denatured ethanol, and 1.0% of Darocure 1173.
Preparation of Lenses Female portions of polypropylene lens molds are filled with about 75 microliters of a lens-forming material prepared as above, and the molds are closed with the male portion of the polypropylene lens molds (base curve molds). Contact lenses are obtained by curing the closed molds for about 2 hours in a UV cure box equipped with Phillips lights (40 watt, F405) with the top light intensity of about 3.61 mW/cm2 and a bottom light intensity of about 3.54 mW/cm2. The oxygen permeability (Dk) and ion permeability (IP) of lenses are measured as described in Example 1. The properties of lenses are reported in Table 3.
Table 3 Formulation No.
H20 Dk P
Elongation Elastic I
(by weight) at break Modulus (MPa) 1 31.5% 66 5.4 240% 0.89 2 35.0% 49 8.1 220% 1.19 31394-91(S) Example 7 Various formulations are prepared by dissolving, in 1-hexanol, CE-PDMS
macromer TM
prepared in Example 3, DMA, TRIS-AM, a polymerizable UV-absorbing agent (Norbloc, (2-(2'hydroxy-51methacryloxyethylphenyl) -2H-benzotriazole)), a photoinitiator, and other components as listed in Table 4. Formulations are examined visually to make sure components are thoroughly mixed. If components do not mix (cloudy etc.), the formulation is heated to 40 C until formulation becomes clear and mixed. A control formulation is prepared to comprise no NorbloCu, 0.5 % of Darocur 1173, 33% of CE-PDMS, 17%
TRIS-AM, 24% DMA, and 24.5% 1hexanol.
Table 4 Formulatio Norbloc Initiator TRIS- DMA 1- CE
Methacrylami hexanol PDMS
de 74-1 1.28% 0.99% lrgacure 369 16.8% 23.7% 24.7%
32.6%
74-4 1.28% 0.99% lrgacure 379 16.8% 23.7% 24.7% 32.6%
74-7 1.28% 0.99% lrgacure 16.8% 23.7% 24.7% 32.6%
86-1* 1.28% 0.99% lrgacure 369 20.2% 22.7% 22.7%
31.1%
* the formulation contains 1% L-PEG2000 as a mold release agent.
Photo-rheology data are measured using the Hamamatsu lamp with either the 330 nm, 376 nm, or a stack of 330 and 395 nm high pass cutoff filters placed just before the sample. The intensity is measured by an IL1700 UV-detector with an SED005 sensor for the samples which used the 376 or 395 nm cutoff filter. For the control formulation the intensity is measured using an ESE detector with a 297 nm cutoff filter, then the 330 nm filter is place before the sample for curing the formulation. Examples of cure times measured by photorheology are provided in Table 5.
Table 5 Formulation Cutoff filter Lamp intensity Irradiation G' (nm) (mW/cm2) Time (s) (kPa) 74-1 376 17.7 75 97 74-4 376 17.7 80 90 74-7 376 17.7 95 100 86-1 376 17.7 90 95 86-1 395 4.2 150 93 control 330 4.07 82 80 Lenses from formulation 86-1 are prepared by cast-molding in a reusable mold.
The mold comprises a female mold half made of glass and a male mold half made of quartz. The UV irradiation source is a Hamamatsu lamp with the WG335 +TM297 +
+ TM395 nm cut off filters at an intensity of about 4.2 mW /cm2as measured by thell_1700 detector. The lens formulation in the mold is irradiated for about 150 seconds. Resultant lenses are extracted with isopropanol, rinsed in water, dipped in a propanol solution of polyacrylic acid, and hydrated in water. The UV/Vis spectrum of a lens is measured in phosphate-buffered saline (PBS). This lens has an average %T in the UVA and UVB
range of 3.2 and 0.11, respectively. These values are well within the requirement of <10%
Transmittance in the UVA range and <1%Transmittance in the UVB range.
Lens properties are also tested in addition to the above UV/Vis spectrum. The results are shown Table 6.
Table 6 Formulation Modulus (MPa) Ave %EtB* IP App. Dk H20 ((Yip) 86-1 0.51 390 5.8+/-0.7 91+/-2 30.2 control 0.64 240 4.1 82 32.5 * EtB = elongation to break Example 8 Various formulations are prepared by dissolving, in 1-propanol, CE-PDMS
macromer prepared in Example 3, DMA, TRIS-AM, a polymerizable UV-absorbing agent (Norbloc, (2- (2'hydroxy-5'methacryloxyethylphenyl) -2H-benzotriazole)), a photoinitiator, and other components as listed in Table 7.
Table 7 Formulatio Norbloc LPE lnitiato solvent TRIS- DMA CE
CuP
n G r AM PDMS
56-2 0.79% 0.5% 0.99% 23.3% 20.3% 22.8% 31.3% -Irgacu 1-re 369 nonanol 85-1 1.28% 0.49 0.99% 23.1% 20.2% 22.7% 31.1% 0.1%
% TPO 1-propanol 08-1 0.99% 0.5% 0.99% 23.3% 20.3% 22.8% 31.2% 0.1%
propanol TPO = 2,4,6-trimethylbenzoyldiphenylophosphine oxide; CuP = copper(II) phthalocyanine Photo-rheology data are measured using the Hamamatsu lamp with either a 380 nm, or a stack of 330 nm and 388 nm high pass cutoff filters, or a stack of 330 nm and 395 nm high pass cutoff filter placed just before the sample. The intensity is measured by an 11_1700 detector using a SED005 sensor from International light. Examples of cure times measured by photorheology are provided in Table 8 Table 8 (nm) (mW/cm2) Time (s) (kPa) 56-2 330 &395 4 48 116 85-1 330 &388 6 14 97 Lenses are made from formulation 85-1 using reusable molds described in Example 6. A stack of 330 and 388 nm cutoff filters between the light source and the mold. The formulation is cured for 27 seconds at an intensity of 6.1 mW/cm2. The lenses are extracted for 324 seconds in MEK (Methyl ethyl ketone), dipped in 0.1% DMPC
(1,2-dimyristoyl-sn-glycero-3-phosphocholine) solutions for a total of 100 seconds, then coated with a polyacrylic acid (PAA) by dipping in a isopropanol solution of PAA
(0.1% by weight, pH 2.5) and autoclaved. The UV/Vis spectrum of a lens is measured in phosphate-buffered saline (PBS). This lens has an average %T in the UVA and UVB range of 3.2 and 0.06, respectively. These values are well within the requirement of <10%
Transmittance in the UVA range and <1%Transmittance in the UVB range.
Lens properties are also tested in addition to the above UV/Vis spectrum. The results are shown Table 9.
Table 9 Formulation Modulus (MPa) Ave %EtB* IP App. Dk H20 ((Yip) 85-1 0.58 330 7.0+/-0.5 92+/- 15 33.0 * EtB = elongation to break
In( 1 - 2C(t)/C(0) ) = -2APt / Vd where: C(t) = concentration of sodium ions at time tin the receiving cell;
C(0) = initial concentration of sodium ions in donor cell; A = membrane area, i.e., lens area exposed to cells; V = volume of cell compartment (3.0 ml); d = average lens thickness in the area exposed; P = permeability coefficient.
An lonoflux Diffusion Coefficient, D, of greater than about 1.5 x 10-6 mm2/min is preferred, while greater than about 2.6 x 10-6 mm2/min is more preferred and greater than about 6.4 x 10-6 mm2/min is most preferred.
It is known that on-eye movement of the lens is required to ensure good tear exchange, and ultimately, to ensure good corneal health. Ion permeability is one of the predictors of on-eye movement, because the permeability of ions is believed to be directly proportional to the permeability of water.
In general, the invention is directed to a method for making silicone hydrogel contact lenses from a monomer mixture based on the Lightstream TechnologyTm.
The invention is partly based on the unexpected discovery that by selecting certain classes of vinylic monomers in preparing a monomer mixture for making silicone hydrogel contact lenses, the curing time of the monomer mixture in a mold can be greatly reduced so as to make the monomer mixture suitable for making silicone hydrogel contact lenses based on the Lightstream TechnologyTm. It is believed that a relatively longer curing time may adversely affect the quality of lens edge of contact lenses made according to the Lightstream TechnologyTm and can increase the product cost by lowering the production output. Although one might be able to shorten the curing time of a monomer mixture by increasing the curing light intensity and/or the concentration of a photoinitiator in the monomer mixture, the high curing light intensity and high photoinitiator concentration have limits and may not be sufficient to reduce the curing time enough for the Lightstream TechnologyTm. Further, these measures may cause resultant lenses with undesirable physical properties, such as, for example, fragile and high content of extractable due to unpolymerized monomers. With a monomer mixture of the invention, the curing time can be substantially reduced, for example, less than 30 seconds at a curing light intensity of about 4.0 mW/cm2. Silicone hydrogel contact lenses made from such monomer mixture according to the Lightstream Technology can have high lens edge quality and relatively low lens production cost because of the relatively short curing time.
The present invention, in one aspect, provides a method for producing silicone hydrogel contact lenses. The method comprises the steps of: providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining 31394-91(S) the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces; introduce a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises at least one hydrophilic amide-type vinylic monomer, at least one siloxane-containing (meth)acrylamide monomer, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5% by weight of a photoinitator, wherein the lens forming material is characterized by having an ability to be cured by a UV light having a UV-intensity of about 4.1 mW/cm2 within about 100 seconds; and irradiating, under a spatial limitation of actinic radiation, the lens-forming material in the mold for a time period of about 120 seconds or less, so as to crosslink the lens-forming material to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
Examples of reusable molds suitable for spatial limitation of radiation include without limitation those disclosed in U.S. Patent Nos. 6,800,225, 6,627,124, 7,384,590, and 7,387,759.
For example, a preferred reusable mold comprises a first mold half having a first molding surface and a second mold half having a second molding surface. The two mold halves of the preferred reusable mold are not touching each other, but there is a thin gap of annular design arranged between the two mold halves. The gap is connected to the mold cavity formed between the first and second molding surfaces, so that excess monomer mixture can flow into the gap. It is understood that gaps with any design can be used in the invention.
In a preferred embodiment, at least one of the first and second molding surfaces is permeable to a crosslinking radiatione.g., UV radiation). More preferably, one of the first and second molding surfaces is permeable to a crosslinking radiation (e.g., UV
radiation) while the other molding surface is poorly permeable to the crosslinking radiation (e.g., UV
radiation). For example, one of the mold halves can be made of a UV-permeable material, while the other mold half can be made of a material containing UV absorbing materials, such as, for example carbon black, as described in U.S. Patent Nos. 7,387,759 and 7,384,590.
The reusable mold preferably comprises a mask which is fixed, constructed or arranged in, at or on the mold half having the radiation-permeable molding surface. The mask is impermeable or at least of poor permeability compared with the permeability of the radiation-permeable molding surface. The mask extends inwardly right up to the mold 31394-91(S) cavity and surrounds the mold cavity so as to screen all areas behind the mask with the exception of the mold cavity.
Where the curing radiation is UV light, the mask may preferably be a thin chromium layer, which can be produced according to processes as known, for example, in photo and UV lithography. Other metals or metal oxides may also be suitable mask materials. The mask can also be coated with a protective layer, for example of silicon dioxide if the material used for the mould or mould half is quartz.
Alternatively, the mask can be a masking collar made of a material comprising a UV-absorber and substantially blocks curing energy therethrough as described in U.S.
Patent No. 7,387,759. In this preferred embodiment, the mold half with the mask comprises a generally circular disc-shaped transmissive portion and a masking collar having an inner diameter adapted to fit in close engagement with the transmissive portion, wherein said transmissive portion is made from an optically clear material and allows passage of curing energy therethrough, and wherein the masking collar is made from a material comprising a UV-blocker and substantially blocks passage of curing energy therethrough, wherein the masking collar generally resembles a washer or a doughnut, with a center hole for receiving the transmissive portion, wherein the transmissive portion is pressed into the center opening of the masking collar and the masking collar is mounted within a bushing sleeve.
Reusable molds can be made of quartz, glass, sapphire, CaF2, a cyclic olefin copolymer (such as for example, Topas COC grade 8007-S10 (clear amorphous copolymer of ethylene and norbornene) from Ticona GmbH of Frankfurt, Germany and Summit, New Jersey, Zeonex and Zeonor from Zeon Chemicals LP, Louisville, KY), polymethylmethacrylate (PMMA), polyoxymethylene from DuPont (Delrin), Ultem (polyetherimide) from G.E. Plastics, PrimoSpire , etc.. Because of the reusability of the mold halves, a relatively high outlay can be expended at the time of their production in order to obtain molds of extremely high precision and reproducibility. Since the mold halves do not touch each other in the region of the lens to be produced, i.e.
the cavity or actual molding surfaces, damage as a result of contact is ruled out. This ensures a high service life of the molds, which, in particular, also ensures high reproducibility of the contact lenses to be produced and high fidelity to the lens design.
Any hydrophilic amide-type vinylic monomers can be used in the invention.
Examples of hydrophilic amide-type vinylic monomers include without limitation acrylamidoglycolic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid or salt thereof, (3-acrylamidopropyl)trimethylammonium chloride, 3-acryloylamino-1-propanol, N-(butoxymethyl)acrylamide, N-tert-butylacrylamide, diacetone acrylamide, N,N-dimethylacrylamide, N-[3-(dimethylamino)propyl]methacrylamide, N-hydroxyethyl acrylamide, N-(hydroxymethyl)acrylamide, N-(isobutoxymethyl)acrylamide, N-isopropylacrylamide, N-isopropylmethacrylamide, methacrylamide, N-phenylacrylamide, N-[Tris(hydroxymethyl)methyl]acrylamide, N-methyl-3-methylene-2-pyrrolidone, and mixtures thereof. Preferably, the hydrophilic amide-type vinylic monomer is N,N-dimethylacrylamide (DMA), N,N-dimethylmethacrylamide (DMMA), 2-acrylamidoglycolic acid monohydrate, 3-acryloylamino-1-propanol, N-hydroxyethyl acrylamide, N-[T ris(hy dr oxy m ethy 1)m ethy I]a cry lamid e , N-methyl-3-methylene-2-pyrrolidone, and mixtures thereof.
It is found that a siloxane-containing vinylic monomer, especially a vinylic monomer having a tris(trialkylsilyloxy)silylalkyl group (for example, such as, tris(trimethylsilyloxy)-silylpropyl methacrylate (TRIS)), is critical to the elimination of optical defects derived from handling during manufacturing, especially when curing the monomer mixture in a mold within a relatively short time (e.g., less than about 300 seconds) with a UV
light. When TRIS is eliminated from a monomer mixture for making silicone hydrogel contact lenses, resultant lenses would develop permanent deformations (optics defects) due to handling.
Such deformation or optical defect refers to permanent folding marks observed on the lens by a Contact Lens Optical Quality Analyzer (CLOQA) after the lens is folded manually as described in Example 1. But, when TRIS is present, resultant lenses exhibit a 'healing' effect that eliminated the optical defects (i.e., the folding marks become transient and can disappear after a short time period, e.g., about 15 minutes or less). However, a monomer mixture comprising TRIS have a relatively long curing time. It is found that by replacing TRIS with a (meth)acrylamide having a tris(trimethylsilyloxy)silylalkyl group, the curing of a monomer mixture can be significantly reduced while still eliminating optical defects caused by handling during manufacturing.
Any siloxane-containing (meth)acrylamide monomers can be used in the invention.
Preferably, a siloxane-containing (meth)acrylamide monomer is represented by formula (1) y........ /R3 N
\
R R4 (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1¨ C6 alkyl, or a monovalent radical of formula (2) Ai *4Y 0) ( CH2)¨Si¨A3 m P i A2 (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) Bi I
¨0¨Si¨B3 I
B2 (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3).
Examples of siloxane-containing (meth)acrylamide monomers of formula (1) include without limitation N4tris(trimethylsiloxy)silylpropyl]methacrylamide, N4tris(trimethylsiloxy)-silylpropyl]acrylamide, N4tris(dimethylpropylsiloxy)silylpropyl]acrylamide, N-[tris(dimethylpropylsiloxy)silylpropyl]methacrylamide, N-[tris(dimethylphenylsiloxy)silylpropyl] acrylamide, N-[tris(dimethylphenylsiloxy)silylpropyl]methacrylamide, N-[tris(dimethylethylsiloxy)silylpropyl]acrylamide, Nqtris(dimethylethylsiloxy)silylpropyl]
methacrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propy1)-2-methyl acrylamide; N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl) acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl]-2-methyl acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl] acrylamide; N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propy1)-2-methyl acrylamide; N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl)acrylamide; N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]-2-methyl acrylamide; N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]acrylamide; N-[2-hydroxy-3-(3-(t-butyldimethylsilyppropyloxy)propyl]-2-methyl acrylamide; N42-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide; N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl acrylamide; N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide. Most preferred siloxane-containing (meth)acrylamide monomers of formula (1) are Nqtris(trimethylsiloxy)silylpropyl]acrylamide and N[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide.
Any polysiloxane-containing vinylic monomer or macromer" refers to a vinylic monomer or macromer containing at least one ehtylenically unsaturated group and a 31394-91(S) *-hi¨Of*
divalent radical of R2 n in which R1 and R2 are independently a monovalent C10 alkyl, a monovalent C1-C10 aminoalkyl, a monovalent of C1-C10 hydroxyalkyl, C1-C10 ether, C1-C10fluoroalkyl, C1-C10 fluoroether or C6-C18 aryl radical, ¨alk¨(OCH2CH2),/,--0R3, in which alk is Cl-C6 alkylene divalent radical, R3 is hydrogen or C1-C6 alkyl, and m is an integer of from 1 to 10; n is an integer of 3 or higher. Examples of such vinylic monomers or macromers are monomethacrylated or monoacrylated polydimethylsiloxanes of various molecular weight (e.g., mono-3-methacryloxypropyl terminated, mono-butyl terminated polydimethylsiloxane or mono-(3-methacryloxy-2-hydroxypropylm)propyl terminated, mono-butyl terminated polydimethylsiloxane); dimethacrylated or diacrylated polydimethylsiloxanes of various molecular weight; vinyl carbonate-terminated polydimethylsiloxanes; vinyl carbamate-terminated polydimethylsiloxane; vinyl terminated polydimethylsiloxanes of various molecular weight; methacrylamide-terminated polydimethylsiloxanes; acrylamide-terminated polydimethylsiloxanes; acrylate-terminated polydimethylsiloxanes; methacrylate-terminated polydimethylsiloxanes; bis-3-methacryloxy-2-hydroxypropyloxypropyl polydimethylsiloxane; N, N, N', N'-tetrakis(3-methacryloxy-2-hyclroxypropyl)-alpha,omega-bis-3-aminopropyl-polydimethylsiloxane;
polysiloxanylalkyl (meth)acrylic monomers; siloxane-containing macromer selected from the group consisting of Macromer A, Macromer B, Macromer C, and Macromer D described in US
5,760,100;
the reaction products of glycidyl methacrylate with amino-functional polydimethylsiloxanes; hydroxyl-fu nctionalized siloxane-containing vinylic monomers or macromers; polysiloxane-containing macromers disclosed in U.S. Patent Nos. 4,136,250, 4,153,641, 4,182,822, 4,189,546, 4,343,927, 4,254,248, 4,355,147, 4,276,402, 4,327,203, 4,341,889, 4,486,577, 4,543,398, 4,605,712, 4,661,575, 4,684,538, 4,703,097, 4,833,218, 4,837,289, 4,954,586, 4,954,587, 5,010,141, 5,034,461, 5,070,170, 5,079,319, 5039,761, 5,346,946, 5,358,995, 5,387,632, 5,416,132, 5,451,617, 5,486,579, 5,962,548, 5,981,675, 6,039,913, and 6,762,264;
polysiloxane-containing macromers disclosed in U.S.
Patent Nos. 4,259,467, 4,260,725, and 4,261,875.
Di and triblock macromers consisting of polydimethylsiloxane and polyalkyleneoxides could also be of utility. For example one might use methacrylate end capped polyethyleneoxide-block-polydimethylsiloxane-block-polyethyleneoxide to enhance oxygen permeability. Suitable monofunctional hydroxyl-functionalized siloxane-containing vinylic monomers/macromers and suitable multifunctional hydroxyl-functionalized siloxane-containing vinylic monomers/macromers are commercially available from Gelest, Inc, Morrisville, PA.
In a preferred embodiment, the monomer mixture comprises a polysiloxane-containing vinylic macromer of formula (4) o¨X1¨G1¨PDMS¨G2 X2¨Q) r (4) in which r is an integer of 0 or 1;
G1 and G2 independent of each other is a linear or branched C1-C10 alkylene divalent radical, a divalent radical of a4 1k1-0)¨alk¨i q n which q is an integer of from 1 to 5 and alk and alk' independent of each other is a C1-C6 alkylene divalent radical, or a divalent radical of -R'1-X.4-E-X5-R'2- in which R'1 and R'2 independent of each other is a linear or branched C1-C10 alkylene divalent radical or a divalent radical of 4alki-04¨alk¨
ci as defined above, X4 and X5 independent of each other are a IT 0 R' II I R' 0 I II
linkage selected from the group consisting of-O-, ¨N¨, ¨C¨N¨, ¨N¨C¨, R' 0 OR 0 0 0 I II II I II II II
¨N¨C¨NH¨, ¨HN¨C¨N¨, ¨0¨C¨NH¨, ¨HN¨C-0¨, ¨S¨C¨NH¨, II II II
¨0¨C¨, ¨C-0¨, -S-, and ¨HN¨C¨S¨ in which R' is H or C1-C8alkyl, E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain;
X1 and X2 independent of each other are a linkage selected from the group consisting R' OR' R' 0 R' 0 OR
II II II II II
¨0¨C¨NH¨, ¨HN¨C-0¨, ¨S¨C¨NH¨, ¨0¨C¨, ¨C-0¨, -S-, and o ii ¨HN¨C¨S¨ in which R' is H or C1-C8 alkyl;
PDMS is a polysiloxane divalent radical of formula (5) ¨Di-[-Ui¨D24U2¨D3).
(5) in which V is 0 or 1, CO is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of -R'1-X.4-E-X5-R'2- as defined above or a a¨(-1-0)¨alk¨
divalent radical of 1k q as defined above, D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of -(CH2CH20)1-CH2CH2- in which t is an integer of 3 to 40, -CF2-31394-91(S) (0CF2)a¨(0CF2CF2)b¨OCF2¨ in which a and b independent of each other is an integer of 0 to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) R3 R51 R7 Rg ¨Si-0j, 01 s, 0 ____________________ s, in I
R4 R6 Rg P Rio (6) in which R3, R4, R6', R6, R7, R3, R9 and Rio, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4- alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), ¨alk¨(OCH2CH2)a¨OR11 in which alk is C1-C6-alkylene divalent radical, Rii is C1-C6 alkyl and n is an integer from 1 to 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of Di, D2 and D3 is represented by formula (6); and Q is an organic radical containing an ethylenically unsaturated group.
Preferably, Q is an ethylenically unsaturated group of formula (7) ¨+Zi¨A5-4Z24¨C=C/
ql C12 1 \
R14 R16 (7) in which Zi and Z2 independent of each other are a linear or branched C1¨C12 alkylene divalent radical, a linear or branched C1¨C12 alkylene divalent radical having one or more hydroxyl groups, a radical of ¨(CH2CH20)d¨CH2CH2¨ in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or Ci-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is ¨0¨ or ¨N¨ in which R' is H or C1-C8 alkyl; qi and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, CI-at alkyl or halogen; R15 and R16 independent of each other are hydrogen, C1-C4 alkyl, 0 R' phenyl, carboxy, halogen, or a radical of ¨c¨X3¨R17 in which X3 IS ¨0¨, ¨N¨ as defined above or ¨S¨ and R17 is a C1¨C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical.
A polysiloxane-containing vinylic macromer of formula (4) can be prepared according to any known procedures, for example, those described in U.S. patent Nos.
4,136,250, 4,486,577, 4,605,712, 5,034,461, 5,416,132, and 5,760,100.
A photoinitiator can initiate free radical polymerization and/or crosslinking by the use of light. Suitable photoinitiators are benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide, 1-hydroxycyclohexyl phenyl ketone and Darocur and Irgacure types, preferably Darocur 1173 , lrgacure 369 , lrgacure 379 , and Irgacure 2959O.
31394-91(S) Examples of benzoylphosphine oxide initiators include 2,4,6-trimethylbenzoyldiphenylophosphine oxide (TP0); bis-(2,6-dichlorobenzoy1)-4-N-propylphenylphosphine oxide; and bis-(2,6-dichlorobenzoyI)-4-N-butylphenylphosphine oxide. Reactive photoinitiators which can be incorporated, for example, into a macromer or can be used as a special monomer are also suitable. Examples of reactive photoinitiators are those disclosed in EP 632 329. The polymerization can then be triggered off by actinic radiation, for example light, in particular UV light of a suitable wavelength. The spectral requirements can be controlled accordingly, if appropriate, by addition of suitable photosensitizers In accordance with the present invention, the monomer mixture can also comprise additional hydrophilic vinylic monomer other than amid-type vinylic monomer.
Nearly any hydrophilic vinylic monomer can be used in the invention. Suitable hydrophilic vinylic monomers are, without this being an exhaustive list, hydroxyl-substituted lower alkyl (C1 to C6) acrylates and methacrylates, hydroxyl-substituted lower alkyl vinyl ethers, N-vinylpyrrole, N-vinyl-2-pyrrolidone, 2-vinyloxazoline, 2-vinyl-4,4'-dialkyloxazolin-5-one, 2-and 4-vinylpyridine, olefinically unsaturated carboxylic acids having a total of 3 to 6 carbon atoms, amino(lower alkyl)- (where the term "amino" also includes quaternary ammonium), mono(lower alkylamino)(lower alkyl) and di(lower alkylamino)(lower alkyl)acrylates and methacrylates, ally! alcohol, N-vinyl alkylamide, N-vinyl-N-alkylamide, and the like. Among the preferred hydrophilic vinylic monomers are 2-hydroxyethylmethacrylate (HEMA), 2-hydroxyethyl acrylate (HEA), hydroxypropyl acrylate, hydroxypropyl methacrylate (HPMA), trimethylammonium 2-hydroxy propylmethacrylate hydrochloride, Aminopropyl methacrylate hydrochloride, dimethylaminoethyl methacrylate (DMAEMA), glycerol methacrylate (GMA), N-vinyl-2-pyrrolidone (NVP), allyl alcohol, vinylpyridine, acrylic acid, a Craralkoxy polyethylene glycol (meth)acrylate having a weight average molecular weight of from 200 to 1500, methacrylic acid, N-vinyl formamide, N-vinyl acetamide, N-vinyl isopropylamide, N-vinyl-N-methyl acetamide, allyl alcohol, and N-vinyl caprolactam. More preferably, the hydrophilic vinylic monomer other than amide-type vinylic monomer is an acrylate monomer.
A monomer mixture of the invention can also comprises a hydrophobic monomer different from the siloxane-containing vinylic monomer. By incorporating a certain amount of hydrophobic vinylic monomer in a monomer mixture, the mechanical properties (e.g., modulus of elasticity) of the resultant polymer may be improved. Nearly any hydrophobic vinylic monomer can be used in the actinically polymerizable composition for preparing the intermediary copolymer with pendant or terminal functional groups. Examples of preferred hydrophobic vinylic monomers include methylacrylate, ethyl-acrylate, propylacrylate, isopropylacrylate, cyclohexylacrylate, 2-ethylhexylacrylate, methylmethacrylate, ethylmethacrylate, propylmethacrylate, vinyl acetate, vinyl propionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyl toluene, vinyl ethyl ether, perfluorohexylethyl-thio-carbonyl-aminoethyl-methacrylate, isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoro-isopropyl methacrylate, hexafluorobutyl methacrylate.
It is understood that if the hydrophilic vinylic monomer other than amide-type vinylic monomer or hydrophobic vinylic monomer present in the monomer mixture is a methacrylate monomer, the total amount of methacrylate monomers is less than about 10% by weight, preferably, less than about 8% by weight, even more preferably less than about 5% by weight, most preferably less than about 1% by weight. Preferably, their amount is sufficient low so as to provide the lens forming composition with a characteristics of being able to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within a time period of less than about 100 seconds.
In accordance with the invention, the UV source can be a Hamamatsu UV lamp manufactured by Hamamatsu K.K.. Light from the source is passed down a light guide and through a 330nm cut-off filter manufactured by DOnnschicht Technik GmbH
Germany. The intensity of light that passes through the optical arrangement is preferably measured with a ESE radiometer manufactured by ESE GmbH / Germany.
In a preferred embodiment, the monomer mixture comprises a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent. By having a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent in the monomer mixture, silicone hydrogel lenses with UV-absorbing capability can be obtained. Such lenses may protect to some extent corneal from damages caused by ultra-violet ("UV") radiation.
Any suitable polymerizable UV-absorbing agents can be used in the invention.
Preferably, a polymerizable UV-absorbing agent comprises a benzotriazole-moiety or a benzophenone-moiety. Examples of preferred polymerizable UV absorbers include without limitation 2-(2-hydroxy-5-vinylphenyI)-2H-benzotriazole, 2-(2-hydroxy-5-acrylyloxyphenyI)-2H-benzotriazole, 2-(2-hydroxy-3-methacrylamido methyl-5-tert octylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyI)-5-chlorobenzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyI)-5-methoxybenzotriazole, 2-(2'-hydroxy-5'-methacryloxypropy1-3'-t-butyl-phenyl)-5-chlorobenzotriazo le, 2-(2'-hydroxy-5'-methacryloxyethylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacryloxypropylphenyl)benzotriazole, 2-hydroxy-4-acryloxy alkoxy benzophenone, 2-hydroxy-4-methacryloxy alkoxy benzophenone, allyI-2-hydroxybenzophenone, 2-hydroxy-4-methacryloxy benzophenone.
A polymerizable latent UV-absorbing agent can be prepared from a polymerizable UV-absorbing agent described above according to any known method known to a person skilled in the art. For example, a benzotriazole-moiety or a benzophenone-moiety can be reacted with a protected labile group to convert a UV-absorbing moiety into a latent UV-absorbing moiety.
For a benzotriazole-type of UV-absorbing agent, the hydroxyl radical of the phenol moiety in a benzotriazole moiety can be replaced with a protective labile group to render the agent essentially non-UV absorbing (i.e., the protective group essentially shifts the absorption properties of the compound so that the agent does not absorb as strongly in the 280 to 400 nm range). Examples of protective labile groups include without limitation acetyl radical, acetylalkylsilane, alkylether, and alkylester. These protective groups can be converted back to a hydroxyl radical according to any known method after the lens is cured, thus rendering the lens UV-absorbing. For example, removal of protective labile groups can be performed by soaking the cured lens in saturated bicarbonate solution and heating.
Similarly, at least one hydroxyl radical of the phenolic radical of a benzophenone moiety can be replaced with one of the aforementioned protective labile groups to form a latent UV-absorbing moiety. The latent UV-absorbing moiety can be converted to a UV-absorbing moiety by removing the protective labile group.
A polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent is generally is present in the monomer mixture in an amount sufficient to render a contact lens, which is obtained from the curing of the monomer mixture and is subjected to treatment to convert latent UV-absorbing moieties if applicable, absorbing at least about 80 percent of the UV light in the range of from about 280 nm to about 370 nm that impinges on the lens. A person skilled in the art will understand that the specific amount of UV-absorbing agent used in the monomer mixture will depend on the molecular weight of the UV-absorbing agent and its extinction coefficient in the range from about 280 to about 370 nm. In accordance with the invention, the monomer mixture comprises about 0.2%
to about 5.0%, preferably about 0.5% to about 2.5%, by weight of a UV-absorbing agent.
Where the monomer mixture comprises a polymerizable UV-absorbing agent, a benzoylphosphine oxide photoinitiator is preferably used as the photoinitiator in the invention. Preferred benzoylphosphine oxide photoinitiators include without limitation 2,4,6-trimethylbenzoyldiphenylophosphine oxide; bis-(2,6-dichlorobenzoyI)-4-N-propylphenylphosphine oxide; and bis-(2,6-dichlorobenzoyI)-4-N-butylphenylphosphine oxide. It is understood that any photoinitiators other than benzoylphosphine oxide initiators can be used in the invention.
A monomer mixture of the invention can further comprise an antimicrobial agent, preferably antimicrobial metal nanoparticles, more preferably silver nanoparticles.
In accordance with the present invention, a monomer mixture can further comprise various components, such as cross-linking agents, a chain transfer agent, initiator, inhibitors, fillers, visibility tinting agents (e.g., dyes, pigments, or mixtures thereof), a bioactive agent, a leachable lubricant, and the like, as known to a person skilled in the art.
Cross-linking agents are compounds having two or more ethylenically unsaturated groups and having a molecular weight of less than 700 Da!tons. Crosslinking agents may be used to improve structural integrity and mechanical strength. Examples of cross-linking agents include without limitation tetra(ethyleneglycol) diacrylate, tri(ethyleneglycol) diacrylate, ethyleneglycol diacylate, di(ethyleneglycol) diacrylate, tetraethyleneglycol dimethacrylate, triethyleneglycol dimethacrylate, ethyleneglycol dimethacylate, di(ethyleneglycol) dimethacrylate, trimethylopropane trimethacrylate, pentaerythritol tetramethacrylate, bisphenol A dimethacrylate, vinyl methacrylate, ethylenediamine dimethyacrylamide, glycerol dimethacrylate, triallyl isocyanurate, triallyl cyanurate, allylmethacrylate, and combinations thereof. A preferred cross-linking agent is tetra(ethyleneglycol) diacrylate, tri(ethyleneglycol) diacrylate, ethyleneglycol diacrylate, di(ethyleneglycol) diacrylate, triallyl isocyanurate, or triallyl cyanurate.
The amount of a cross-linking agent used is expressed in the weight content with respect to the total polymer and is preferably in the range from about 0.05%
to about 4%, and more preferably in the range from about 0.1% to about 2%.
Examples of preferred pigments include any colorant permitted in medical devices and approved by the FDA, such as D&C Blue No. 6, D&C Green No. 6, D&C Violet No. 2, carbazole violet, certain copper complexes, certain chromium oxides, various iron oxides, phthalocyanine green, phthalocyanine blue, titanium dioxides, etc. See Marmiom DM
Handbook of U.S. Colorants for a list of colorants that may be used with the present invention. A more preferred embodiment of a pigment include (C.I. is the color index no.), without limitation, for a blue color, phthalocyanine blue (pigment blue 15:3, al. 74160), cobalt blue (pigment blue 36, al. 77343), Toner cyan BG (Clariant), Permajet blue B2G
(Clariant); for a green color, phthalocyanine green (Pigment green 7, al.
74260) and chromium sesquioxide; for yellow, red, brown and black colors, various iron oxides; PR122, PY154, for violet, carbazole violet; for black, Monolith black C-K (CIBA
Specialty Chemicals).
The bioactive agent incorporated in the polymeric matrix is any compound that can prevent a malady in the eye or reduce the symptoms of an eye malady. The bioactive agent can be a drug, an amino acid (e.g., taurine, glycine, etc.), a polypeptide, a protein, a nucleic acid, or any combination thereof. Examples of drugs useful herein include, but are not limited to, rebamipide, ketotifen, olaptidine, cromoglycolate, cyclosporine, nedocromil, levocabastine, lodoxamide, ketotifen, or the pharmaceutically acceptable salt or ester thereof. Other examples of bioactive agents include 2-pyrrolidone-5-carboxylic acid (PCA), alpha hydroxyl acids (e.g., glycolic, lactic, malic, tartaric, mandelic and citric acids and salts thereof, etc.), linoleic and gamma linoleic acids, and vitamins (e.g., B5, A, B6, etc.).
Examples of leachable lubricants include without limitation mucin-like materials (e.g., polyglycolic acid) and non-crosllinkable hydrophilic polymers (i.e., without ethylenically unsaturated groups).
Any hydrophilic polymers or copolymers without any ethylenically unsaturated groups can be used as leachable lubricants. Preferred examples of non-crosslinkable hydrophilic polymers include, but are not limited to, polyvinyl alcohols (PVAs), polyamides, polyimides, polylactone, a homopolymer of a vinyl lactam, a copolymer of at least one vinyl lactam in the presence or in the absence of one or more hydrophilic vinylic comonomers, a homopolymer of acrylamide or methacrylamide, a copolymer of acrylamide or methacrylamide with one or more hydrophilic vinylic monomers, polyethylene oxide (i.e., polyethylene glycol (PEG)), a polyoxyethylene derivative, poly-N-N-dimethylacrylamide, polyacrylic acid, poly 2 ethyl oxazoline, heparin polysaccharides, polysaccharides, and mixtures thereof.
The number-average molecular weight Mn of the non-crosslinkable hydrophilic polymer is preferably from 5,000 to 500,000, more preferably from 10,000 to 300,000, even more preferably from 20,000 to 100,000.
In accordance with the invention, a lens-forming material is a composition which can be a solution or a melt at a temperature from about 20 C to about 85 C.
Preferably, a lens-forming material is a solution of all desirable components in water, or an organic solvent, or a mixture of water and one or more organic solvents.
A monomer mixture of the invention can be prepared by dissolving all of the desirable components in any suitable solvent known to a person skilled in the art. Example of suitable solvents includes without limitation, water, tetrahydrofuran, tripropylene glycol methyl ether, dipropylene glycol methyl ether, ethylene glycol n-butyl ether, ketones (e.g., acetone, methyl ethyl ketone, etc.), diethylene glycol n-butyl ether, diethylene glycol methyl ether, ethylene glycol phenyl ether, propylene glycol methyl ether, propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol n-propyl ether, dipropylene glycol n-propyl ether, tripropylene glycol n-butyl ether, propylene glycol n-butyl ether, dipropylene glycol n-butyl ether, tripropylene glycol n-butyl ether, propylene glycol phenyl ether dipropylene glycol dimetyl ether, polyethylene glycols, polypropylene glycols, ethyl acetate, butyl acetate, amyl acetate, methyl lactate, ethyl lactate, i-propyl lactate, methylene chloride, 2-butanol, 1-propanol, 2-propanol, menthol, cyclohexanol, cyclopentanol and exonorborneol, 2-pentanol, 3-pentanol, 2-hexanol, 3-hexanol, 3-methyl-2-butanol, 2-heptanol, 2-octanol, 2-nonanol, 2-decanol, 3-octanol, norborneol, tert-butanol, tert-amyl, alcohol, 2-methyl-2-pentanol, 2,3-dimethyl-2-butanol, 3-methyl-3-pentanol, 1-methylcyclohexanol, 2-methyl-2-hexanol, 3,7-dimethy1-3-octanol, 1-chloro-2-methyl-2-propanol, 2-methyl-2-heptanol, 2-methyl-2-octanol, 2-2-methyl-2-nonanol, 2-methyl-2-decanol, 3-methyl-3-hexanol, 3-methyl-3-heptanol, 4-methyl-4-heptanol, 3-methyl-3-octanol, 4-methyl-4-octanol, 3-methyl-3-nonanol, 4-methyl-4-nonanol, 3-methyl-3-octanol, 3-ethyl-3-hexanol, 3-methyl-3-heptanol, 4-ethyl-4-heptanol, 4-propy1-4-heptanol, 4-isopropyl-4-heptanol, 2,4-dimethyl-2-pentanol, 1-methylcyclopentanol, 1-ethylcyclopentanol, 1-ethylcyclopentanol, 3-hydroxy-3-methyl-1-butene, 4-hydroxy-4-methyl-1-cyclopentanol, 2-phenyl-2-propanol, 2-methoxy-2-methyl-2-propanol 2,3,4-trimethy1-3-pentanol, 3,7-dimethy1-3-octanol, 2-phenyl-2-butanol, 2-methyl-1-phenyl-2-propanol and 3-ethyl-3-pentanol, 1-ethoxy-2-propanol, 1-methyl-2-propanol, t-amyl alcohol, isopropanol, 1-methyl-2-pyrrolidone, N,N-dimethylpropionamide, dimethyl formamide, dimethyl acetamide, dimethyl propionamide, N-methyl pyrrolidinone, and mixtures thereof.
In a preferred embodiment, the monomer mixture of the invention comprises: (1) from about 5% to about 60% by weight, preferably from about 10% to about 50%
by weight, even more preferably from about 15% to about 45% by weight, even more preferably from about 20% to about 40% by weight, of a hydrophilic amide-type vinylic monomer; (2) from about 5% to about 50% by weight, preferably from about 10%
to about 40% by weight, more preferably from about 15% to about 30% by weight, of a siloxane-containing acrylate or acrylamide or methacrylamide monomer; (3) from about 5%
to about 50%, preferably from about 10% to about 40% by weight, more preferably from about 15%
to about 35% by weight, of a polysiloxane-containing vinylic macromer; (4) from about 0.05% to about 1.5% by weight, preferably from about 0.1% to 1.3% by weight, more preferably from about 0.5% to about 1.1% by weight, of a photoinitiator; and (5) from 0 to 5% by weight, preferably from about 0.2% to 5% by weight, more preferably from about 0.5% to about 2.5% by weight, of a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent. The foregoing range combinations are presented with the proviso that the listed components and any additional components add up to 100% by weight.
In accordance with the invention, the monomer mixture can be introduced (dispensed) into a cavity formed by a mold according to any known methods.
After the monomer mixture is dispensed into the mold, it is polymerized to produce a contact lens. Crosslinking may be initiated by exposing the monomer mixture in the mold to a spatial limitation of actinic radiation to crosslink the polymerizable components in the monomer mixture. The crosslinking according to the invention may be effected in a very short time, e.g. in about 120 seconds, preferably in about 80 seconds, more preferably 31394-91(S) in 50 about seconds, even more preferably in about 30 seconds, and most preferably in to 30 seconds.
Opening of the mold so that the molded lens can be removed from the mold may take place in a manner known per se.
5 The molded contact lens can be subject to lens extraction to remove unpolymerized vinylic monomers and macromers. The extraction solvent can be any solvent known to a person skilled in the art. Examples of suitable extraction solvent are those described above for preparing monomer mixtures. After extraction, lenses can be hydrated in a water or an aqueous solution of a wetting agent (e.g., a hydrophilic polymer).
The molded contact lenses can further subject to further processes, such as, for example, surface treatment (for example, such as, plasma treatment, chemical treatments, the grafting of hydrophilic monomers or macromers onto the surface of a lens, Layer-by-layer coating, etc.); packaging in lens packages with a packaging solution which can contain about 0.005% to about 5% by weight of a wetting agent (e.g., a hydrophilic polymer described above) and/or a viscosity-enhancing agent (e.g., methyl cellulose (MC), ethyl cellulose, hydroxymethylcellulose, hydroxyethyl cellulose (H EC), hydroxypropylcellulose (HPC), hydroxypropylmethyl cellulose (HPMC), or a mixture thereof);
sterilization; and the like.
Preferred surfaces treatments are LbL coating such as those described in US
Patent Ser. No. 6,451,871, 6,719,929, 6,793,973, 6,811,805, 6,896,926 and plasma treatment. A preferred plasma treatment is those processes in which an ionized gas is applied to the surface of an article as described in U.S. Pat. Nos. 4,312,575 and 4,632,844.
A contact lens of the invention has an oxygen permeability of preferably at least about 40 barrers, more preferably at least about 60 barrers, even more preferably at least about 80 barrers. In accordance with the invention, an oxygen permeability is an apparent (directly measured when testing a sample with a thickness of about 100 microns) oxygen permeability according to procedures described in Examples.
A contact lens of the invention has an elastic modulus of about 2.0 MPa or less, preferably about 1.5 MPa or less, more preferably about 1.2 or less, even more preferably from about 0.4 MPa to about 1.0 MPa.
A contact lens of the invention further has an lonoflux Diffusion Coefficient, D, of, preferably at least about 1.5 x 10-6 mm2/min, more preferably at least about 2.6 x 10-6 mm2/min, even more preferably at least about 6.4 x 10-6 mm2/min.
A contact lens of the invention further has a water content of preferably from about 15% to about 70%, more preferably from about 20% to about 50% by weight when fully 31394-91(S) hydrated. The water content of a silicone hydrogel contact lens can be measured according to Bulk Technique as disclosed in US5,849,811.
In another aspect, the invention provide a lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation. The lens-forming composition comprises at least one hydrophilic vinylic monomer, at least one siloxane-containing vinylic monomer selected from the group consisting of siloxane-containing acrylate, siloxane-containing acrylamide, siloxane-containing methacrylamide, and a mixture thereof, at least one polysiloxane vinylic monomer or macromer, and from about 0.05% to about 1.5% by weight of a photoinitator, provided that the total amount of all methacrylate monomer(s) in the lens-forming composition is less than about 10% by weight and is sufficient low so as to provide the lens forming composition with a characteristics of being able to be cured by a UV light having an UV-intensity of about 4.1 mW/cm2 within a time period of less than about 100 seconds.
In a preferred embodiment, the siloxane-containing vinylic monomer is a siloxane-containing acrylamide, a siloxane-containing methacrylamide or mixture thereof.
In a more preferred embodiment, the siloxane-containing vinylic monomer is a siloxane-containing acrylamide.
All of the various embodiments of the monomer mixture of the invention described above can be used in this aspect of the invention.
In a further aspect, the invention provides a silicone hydrogel contact lens obtained by the method of the invention.
All of the various embodiments of the molds, monomer mixture, and spatial limitation of radiation, and contact lens of the invention described above can be used in this aspect of the invention.
The previous disclosure will enable one having ordinary skill in the art to practice the invention. In order to better enable the reader to understand specific embodiments and the advantages thereof, reference to the following non-limiting examples is suggested.
However, the following examples should not be read to limit the scope of the invention.
Example 1 Oxygen Permeability Measurements The oxygen permeability of a lens and oxygen transmissibility of a lens material is determined according to a technique similar to the one described in U.S.
Patent No.
5,760,100 and in an article by Winterton et al., (The Cornea: Transactions of the World Congress on the Cornea 111, H.D. Cavanagh Ed., Raven Press: New York 1988, pp273-31394-91(S) 280). Oxygen fluxes (J) are measured at 34 C in a wet cell (i.e., gas streams are maintained at about 100%
relative humidity) using a Dk1000 instrument (available from Applied Design and Development Co., Norcross, GA), or similar analytical instrument. An air stream, having a known percentage of oxygen (e.g., 21%), is passed across one side of the lens at a rate of about 10 to 20 cm3 /min., while a nitrogen stream is passed on the opposite side of the lens at a rate of about 10 to 20 cm3 /min. A sample is equilibrated in a test media (i.e., saline or distilled water) at the prescribed test temperature for at least 30 minutes prior to measurement but not more than 45 minutes. Any test media used as the overlayer is equilibrated at the prescribed test temperature for at least 30 minutes prior to measurement but not more than 45 minutes. The stir motor's speed is set to 1200 50 rpm, corresponding to an indicated setting of 400 15 on the stepper motor controller. The barometric pressure surrounding the system, Pmeasured, is measured. The thickness (t) of the lens in the area being exposed for testing is determined by measuring about 10 locations with a Mitotoya micrometer VL-50, or similar instrument, and averaging the measurements. The oxygen concentration in the nitrogen stream (i.e., oxygen which diffuses through the lens) is measured using the DK1000 instrument. The apparent oxygen permeability of the lens material, Dkapp, is determined from the following formula:
Dkapp =Jt/(Poxygen) where J=oxygen flux [microliters 02 /cm2 -minute]
Poxygen :--(Pmeasured -Pwater vapor)=(%02 in air stream) [mm Hg]=partial pressure of oxygen in the air stream Pmeasured =barometric pressure (mm Hg) Pwater vapor =0 mm Hg at 34 C (in a dry cell) (mm Hg) Pwater vapor =40 mm Hg at 34 C (in a wet cell) (mm Hg) t=average thickness of the lens over the exposed test area (mm) Dkapp is expressed in units of barrers.
The oxygen transmissibility (Dk /t) of the material may be calculated by dividing the oxygen permeability (Dkapp) by the average thickness (t) of the lens.
Ion Permeability Measurements The ion permeability of a lens is measured according to procedures described in U.S. Patent No. 5,760,100. The values of ion permeability reported in the following examples are relative ionoflux diffusion coefficients (D/Drat) in reference to a lens material, Alsacorr, as reference material. Alsacorr has an ionoflux diffusion coefficient of 0.314X10-3 mm2/minute.
Water Contact Angle (WCA) Measurements Water contact angle (WCA) measurements are performed by the sessile drop method with a DSA 10 drop shape analysis system from Kruss GmbH, Germany with pure water (Fluka, surface tension 72.5 mN/m at 20 C). For measurement purposes a contact lens is taken off the storage solution with tweezers and excess storage solution is removed by gentle shaking. The contact lens are placed on the male part of a lens mold and gently blotted with a dry and clean cloth. A water droplet (approximately 1 pl) is then dosed on the lens apex, and the change of the contact angle over time of this water droplet (WCA(t), circle fitting mode) is monitored. The WCA is calculated by the extrapolation of the graph WCA(t) to t = 0.
Folding Mark Determination A Contact Lens Optical Quality Analyzer (CLOQA) is developed to determine optical distortions caused by surface deformations and other defects in the contact lens, based on the principle of the Foucault knife-edge test. A person skilled in the art understands how to select, align and arrange various optics elements to create collimating light, to illuminate a contact lens, and to capture an image with a device (for example, such as, a CCD camera). The test involves illuminating the contact lens with a near-collimated light, placing a Foucault knife edge near the focal point, moving the knife-edge to block off most of the focused light, and capturing the image of contact lens with a device, for example CCD camera behind the Foucault knife edge. Where there is no optical distortion in the contact lens, all light rays passing through the contact lens come to focus at the knife edge and most of the well-focused light will be blocked off. For areas outside the optical zone which has no focusing function, the knife-edge will block the light from half of the lens to make it dark, while the other half appear bright. If the contact lens has no optical distortions in its optical zone, the whole optical zone will be uniformly dark or bright depending on how much light is blocked by the knife-edge. Where there are optical distortions on the contact lens, light passing through such areas in general does not fall into the main focus and may be either blocked by the knife edge (appearing dark) or pass through freely (appearing bright). The level of contrast not only depends on the amplitude of the distortion, but also depends on the fine position of the knife-edge.
The defective areas appear as contrast features in the CLOQA image. The knife-edge test with CLOQA
is designed as a qualitative testing device for optical distortions in the optical zone.
Folding mark study is carried out as follows. Three autoclaved and/or not autoclaved contact lenses are used in the study. First, images of the contact lenses are taken with the CLOQA. Second, each lens is folded with fingers twice (creating two perpendicular fold lines) and then its image is taken immediately with the CLOQA. Third, the image of each contact lens about 15 minutes after folding is taken with the CLOQA.
Three types of CLOQA images are obtained: original one (i.e., without folding), immediately after folding, and about 15 minutes after folding. The folding mark study allows to determine the appearance of the folding line changing over time.
Example 2 Preparation of Polysiloxane Vinylic Macromer I with Terminal Acrylamide Groups In a 4-L beaker, 24.13 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloxane (Shin-Etsu, MW ca. 11500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 14.5 g of acryloyl chloride are dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.175 mEq/g of C=C double bonds.
Preparation of Polysiloxane Vinylic Macromer ll with Terminal Acrylamide Groups In a 4-L beaker, 61.73 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloaxane (Shin-Etsu, MW ca. 4500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 36.6 g of acryloyl chloride is dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.435 mEq/g of C=C double bonds.
Preparation of Polysiloxane Vinylic Macromer III with Terminal Acrylamide Groups In a 4-L beaker, 24.13 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloxane (Shin-Etsu, MW ca. 11500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 14.5 g of acryloyl chloride are dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.175 mEq/g of C=0 double bonds.
Preparation of Polysiloxane Vinylic Macromer IV with Terminal Acrylamide Groups In a 4-L beaker, 61.73 g of Na2CO3 and 80 g of NaCI are dissolved in 1.52 kg of deionized water. In a separate 4-L beaker, 700 g of bis-3-aminopropyl-polydimethylsiloaxane (Shin-Etsu, MW ca. 4500) are dissolved in 1000 g of hexane. A 4-L
reactor is equipped with overhead stirring with turbine agitator and a 250-mL
addition funnel with micro-flow controller. The two solutions are then charged to the reactor, and mixed for 15 minutes with heavy agitation to produce an emulsion. 36.6 g of acryloyl chloride is dissolved in 100 mL of hexane and charged to the addition funnel.
The acryloyl chloride solution is added dropwise to the emulsion under heavy agitation over one hour.
The emulsion is stirred for 30 minutes on completion of the addition and then agitation is stopped and the phases are allowed to separate overnight. The aqueous phase is decanted and the organic phase is washed twice with a mixture of 2.0 kg of 2.5% NaCI
dissolved in water. The organic phase is then dried over magnesium sulfate, filtered to 1.0 pm exclusion, and concentrated on a rotary evaporator. The resulting oil is further purified by high-vacuum drying to constant weight. Analysis of the resulting product by titration reveals 0.435 mEq/g of C=C double bonds.
Example 3 Preparation of Chain-Extended Polydimethylsiloxane Vinylic Macromer with Terminal Methacrylate Groups (CE-PDMS Macromer) In the first step, a,w-bis(2-hydroxyethoxypropyl)-polydimethylsiloxane (Mn =
2000, Shin-Etsu, KF-6001a) is capped with isophorone diisocyanate by reacting 49.85 g of a,w-bis(2-hydroxyethoxypropyl)-polydimethylsiloxane with 11.1 g isophorone diisocyanate (IPDI) in 150 g of dry methyl ethyl ketone (MEK) in the presence of 0.063g of dibutyltindilaurate (DBTDL). The reaction is kept for 4.5 h at 40 C, forming IPDI-PDMS-IPDI. In the second step, a mixture of 164.8 g of a,w-bis(2-hydroxyethoxypropyl)-polydimethylsiloxane (Mn = 3000, Shin-Etsu, KF-6002) and 50 g of dry MEK are added dropwise to the IPDI-PDMS-IPDI solution to which has been added an additional 0.063 g of DBTDL. The reactor is held for 4.5 h at 40 C, forming HO-PDMS-IPDI-PDMS-IPDI-PDMS-OH. MEK is then removed under reduced pressure. In the third step, the terminal hydroxyl-groups are capped with methacryloyloxyethyl groups in a third step by addition of 7.77 g of isocyanatoethylmethacrylate (IEM) and an additional 0.063 g of DBTDL, forming IEM-PDMS-IPDI-PDMS-IPDI-PDMS-IEM.
Alternate Preparation of CE-PDMS Macromer with Terminal Methacrylate Groups 240.43 g of KF-6001 is added into a 1-L reactor equipped with stirring, thermometer, cryostat, dropping funnel, and nitrogen/vacuum inlet adapter, and then dried by application of high vacuum (2x10-2 mBar). Then, under an atmosphere of dry nitrogen, 320 g of distilled MEK is then added into the reactor and the mixture is stirred thoroughly.
0.235 g of DBTDL are added to the reactor. After the reactor is warmed to 45 C, 45.86 g of IPDI are added through an addition funnel over 10 minutes to the reactor under moderate stirring. The reaction is kept for 2 hours at 60 C. 630 g of KF-6002 dissolved in 452 g of distilled MEK are then added and stirred until a homogeneous solution is formed. 0.235 g of DBTDL are added, and the reactor is held at 55 C overnight under a blanket of dry nitrogen. The next day, MEK is removed by flash distillation. The reactor is cooled and 22.7 g of IEM are then charged to the reactor followed by 0.235 g of DBTDL. After 3 hours, an additional 3.3 g of IEM are added and the reaction is allowed to proceed overnight. The following day, the reaction mixture is cooled to 18 C to obtain CE-PDMS
macromer.
Example 4 Preparation of Lens Formulations Three lens formulations are prepared by dissolving, in 1-propanol, CE-PDMS
macromer prepared in Example 3 and other components as listed in Table 1.
Table 1 Compositions (% by weight) Components Formulation I Formulation ll Formulation Ill CE-PDMS 33.0 33.0 33.0 Tris-methacrylate 17.0 Tris-methacrylamide 17.0 Tris-acrylamide 17.0 DMA 24.0 24.0 24.0 L-PEG 2000 0.5 0.5 0.5 Darocur 1173 1.0 1.0 1.0 1-Propanol 24.5 24.5 24.5 Tris-methacrylate: tris(trimethylsiloxy)silylpropylmethacrylate Tris-methacrylamide: N4tris(trimethylsiloxy)silylpropylynethacrylamide Tris-acrylamide: N4tris(trimethylsiloxy)-silylpropyl]acrylamide DMA: N,N-dimethylacrylamide L-PEG 2000: N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-disteaoyl-sn-glycero-3-phosphoethanolamin, sodium salt) DC 1173: Darocur 1173 Studies of Curing Times of the Lens Formulations UV source is a Hamamatsu UV lamp manufactured by Hamamatsu K.K.. Light from the source is passed down a light guide and through a 330nm cut-off filter manufactured by Dunnschicht Technik GmbH Germany, before being impinged on the sample contained between two quartz microscope slides. The intensity of light that passes through the optical arrangement is measured with a ESE radiometer manufactured by ESE
GmbH / Germany.
Table 2 shows a 48% reduction in cure time by replacing Tris methacrylate with Tris methacrylamide and a 78% reduction by replacing Tris methacrylate with Tris acrylamide.
Table 2 Formulation No. UV-Intensity (mW/cm2) Irradiation Time (s) Modulus G' (KPa)*
4.1 110.0 41.0 II 4.1 57.0 80.0 III 4.0 24.0 110.
* G' is the storage modulus and is a measure of the energy stored in a polymer upon deformation. It is measured in the curing solvent Example 5 Lenses are prepared by cast-molding from formulation Ill prepared in Example 4 in a reusable mold, similar to the mold shown in Figs. 1-6 in U.S. patent Nos.7,384,590 and 7,387,759 (Figs. 1-6). The mold comprises a female mold half made of CaF2 and a male mold half made of PMMA. The UV irradiation source is a Hamamatsu lamp with the WG335 +TM297 cut off filter at an intensity of about 4 mW /cm2. The lens formulation in the mold is irradiated with UV irradition for about 25 seconds. Resultant lenses are extracted with isopropanol, rinsed in water, dipped in a propanol solution of polyacrylic acid, and hydrated in water. The obtained lenses are determined to have the following properties: ion permeability of about 8.0 to about 9.0 relative to Alsacon lens material;
apparent Dk (single point) of about 90 to 100; a water content of about 30% to about 33%; and an elastic modulus of about 0.60 MPa to about 0.65 MPa.
Example 6 Synthesis of Silicone-Containing Vinylic Macromer with Terminal Methacrylate Groups The macromer is prepared according to the procedures described in U.S. Patent No. 5,760,100 for preparation Macromer B (Examples B1 to B14).
51.5 g (50 mmol) of the perfluoropolyether Fomblin0 ZDOL (from Ausimont S.p.A, Milan) having a mean molecular weight of 1030 g/mol and containing 1.96 meq/g of hydroxyl groups according to end-group titration is introduced into a three-neck flask together with 50 mg of dibutyltin dilaurate. The flask contents are evacuated to about 20 mbar with stirring and subsequently decompressed with argon. This operation is repeated twice. 22.2g (0.1mol) of freshly distilled isophorone diisocyanate kept under argon are subsequently added in a counterstream of argon. The temperature in the flask is kept below 30 C by cooling with a waterbath. After stirring overnight at room temperature, the reaction is complete. lsocyanate titration gives an NCO content of 1.40 meq/g (theory: 1.35 meq/g).
202 g of the a,co-hydroxypropyl-terminated polydimethylsiloxane KF-6001 from Shin-Etsu having a mean molecular weight of 2000 g/mol (1.00 meq/g of hydroxyl groups according to titration) are introduced into a flask. The flask contents are evacuated to approx. 0.1mbar and decompressed with argon. This operation is repeated twice.
The degased siloxane is dissolved in 202 ml of freshly distilled toluene kept under argon, and 100 mg of dibutyltin dilaurate (DBTDL) are added. After complete homogenization of the solution, all the perfluoropolyether reacted with isophorone diisocyanate (IPDI) is added under argon. After stirring overnight at room temperature, the reaction is complete. The solvent is stripped off under a high vacuum at room temperature.
Microtitration shows 0.36 meq/g of hydroxyl groups (theory 0.37 meq/g).
13.78 g (88.9mmol) of 2-isocyanatoethyl methacrylate (IEM) are added under argon to 247 g of the a,co-hydroxypropyl-terminated polysiloxane-perfluoropolyether-polysiloxane three-block copolymer (a three-block copolymer on stoichiometric average, but other block lengths are also present). The mixture is stirred at room temperature for three days.
Microtitration then no longer shows any isocyanate groups (detection limit 0.01meq/g).
0.34 meq/g of methacryl groups are found (theory 0.34 meq/g).
The macromer prepared in this way has two terminal methacrylate groups is completely colourless and clear. It can be stored in air at room temperature in the absence of light for several months without any change in molecular weight.
Preparation of a Lens Forming Material The siloxane-containing macromer with two terminal methacrylate groups, which is prepared above, is used in preparation of two lens-forming materials.
Formulation 1 comprises 25.92% of the siloxane-containing macromer, 19.25% of TRIS (3-tris(trimethyl-siloxy)silylpropyl methacrylate), 28.88% of DMA (N,N-dimethylacrylamide), 24.95% of denatured ethanol, and 1.0% of 2-hydroxy-2-methyl-1-phenyl-1-propanone (Darocure 1173). Formulation 2 comprises 25.92% of the siloxane-containing macromer, 19.25% of TRIS-Am (Nqtris(trimethylsiloxy)-silylpropyl]acrylamide), 28.88% of DMA, 24.95% of denatured ethanol, and 1.0% of Darocure 1173.
Preparation of Lenses Female portions of polypropylene lens molds are filled with about 75 microliters of a lens-forming material prepared as above, and the molds are closed with the male portion of the polypropylene lens molds (base curve molds). Contact lenses are obtained by curing the closed molds for about 2 hours in a UV cure box equipped with Phillips lights (40 watt, F405) with the top light intensity of about 3.61 mW/cm2 and a bottom light intensity of about 3.54 mW/cm2. The oxygen permeability (Dk) and ion permeability (IP) of lenses are measured as described in Example 1. The properties of lenses are reported in Table 3.
Table 3 Formulation No.
H20 Dk P
Elongation Elastic I
(by weight) at break Modulus (MPa) 1 31.5% 66 5.4 240% 0.89 2 35.0% 49 8.1 220% 1.19 31394-91(S) Example 7 Various formulations are prepared by dissolving, in 1-hexanol, CE-PDMS
macromer TM
prepared in Example 3, DMA, TRIS-AM, a polymerizable UV-absorbing agent (Norbloc, (2-(2'hydroxy-51methacryloxyethylphenyl) -2H-benzotriazole)), a photoinitiator, and other components as listed in Table 4. Formulations are examined visually to make sure components are thoroughly mixed. If components do not mix (cloudy etc.), the formulation is heated to 40 C until formulation becomes clear and mixed. A control formulation is prepared to comprise no NorbloCu, 0.5 % of Darocur 1173, 33% of CE-PDMS, 17%
TRIS-AM, 24% DMA, and 24.5% 1hexanol.
Table 4 Formulatio Norbloc Initiator TRIS- DMA 1- CE
Methacrylami hexanol PDMS
de 74-1 1.28% 0.99% lrgacure 369 16.8% 23.7% 24.7%
32.6%
74-4 1.28% 0.99% lrgacure 379 16.8% 23.7% 24.7% 32.6%
74-7 1.28% 0.99% lrgacure 16.8% 23.7% 24.7% 32.6%
86-1* 1.28% 0.99% lrgacure 369 20.2% 22.7% 22.7%
31.1%
* the formulation contains 1% L-PEG2000 as a mold release agent.
Photo-rheology data are measured using the Hamamatsu lamp with either the 330 nm, 376 nm, or a stack of 330 and 395 nm high pass cutoff filters placed just before the sample. The intensity is measured by an IL1700 UV-detector with an SED005 sensor for the samples which used the 376 or 395 nm cutoff filter. For the control formulation the intensity is measured using an ESE detector with a 297 nm cutoff filter, then the 330 nm filter is place before the sample for curing the formulation. Examples of cure times measured by photorheology are provided in Table 5.
Table 5 Formulation Cutoff filter Lamp intensity Irradiation G' (nm) (mW/cm2) Time (s) (kPa) 74-1 376 17.7 75 97 74-4 376 17.7 80 90 74-7 376 17.7 95 100 86-1 376 17.7 90 95 86-1 395 4.2 150 93 control 330 4.07 82 80 Lenses from formulation 86-1 are prepared by cast-molding in a reusable mold.
The mold comprises a female mold half made of glass and a male mold half made of quartz. The UV irradiation source is a Hamamatsu lamp with the WG335 +TM297 +
+ TM395 nm cut off filters at an intensity of about 4.2 mW /cm2as measured by thell_1700 detector. The lens formulation in the mold is irradiated for about 150 seconds. Resultant lenses are extracted with isopropanol, rinsed in water, dipped in a propanol solution of polyacrylic acid, and hydrated in water. The UV/Vis spectrum of a lens is measured in phosphate-buffered saline (PBS). This lens has an average %T in the UVA and UVB
range of 3.2 and 0.11, respectively. These values are well within the requirement of <10%
Transmittance in the UVA range and <1%Transmittance in the UVB range.
Lens properties are also tested in addition to the above UV/Vis spectrum. The results are shown Table 6.
Table 6 Formulation Modulus (MPa) Ave %EtB* IP App. Dk H20 ((Yip) 86-1 0.51 390 5.8+/-0.7 91+/-2 30.2 control 0.64 240 4.1 82 32.5 * EtB = elongation to break Example 8 Various formulations are prepared by dissolving, in 1-propanol, CE-PDMS
macromer prepared in Example 3, DMA, TRIS-AM, a polymerizable UV-absorbing agent (Norbloc, (2- (2'hydroxy-5'methacryloxyethylphenyl) -2H-benzotriazole)), a photoinitiator, and other components as listed in Table 7.
Table 7 Formulatio Norbloc LPE lnitiato solvent TRIS- DMA CE
CuP
n G r AM PDMS
56-2 0.79% 0.5% 0.99% 23.3% 20.3% 22.8% 31.3% -Irgacu 1-re 369 nonanol 85-1 1.28% 0.49 0.99% 23.1% 20.2% 22.7% 31.1% 0.1%
% TPO 1-propanol 08-1 0.99% 0.5% 0.99% 23.3% 20.3% 22.8% 31.2% 0.1%
propanol TPO = 2,4,6-trimethylbenzoyldiphenylophosphine oxide; CuP = copper(II) phthalocyanine Photo-rheology data are measured using the Hamamatsu lamp with either a 380 nm, or a stack of 330 nm and 388 nm high pass cutoff filters, or a stack of 330 nm and 395 nm high pass cutoff filter placed just before the sample. The intensity is measured by an 11_1700 detector using a SED005 sensor from International light. Examples of cure times measured by photorheology are provided in Table 8 Table 8 (nm) (mW/cm2) Time (s) (kPa) 56-2 330 &395 4 48 116 85-1 330 &388 6 14 97 Lenses are made from formulation 85-1 using reusable molds described in Example 6. A stack of 330 and 388 nm cutoff filters between the light source and the mold. The formulation is cured for 27 seconds at an intensity of 6.1 mW/cm2. The lenses are extracted for 324 seconds in MEK (Methyl ethyl ketone), dipped in 0.1% DMPC
(1,2-dimyristoyl-sn-glycero-3-phosphocholine) solutions for a total of 100 seconds, then coated with a polyacrylic acid (PAA) by dipping in a isopropanol solution of PAA
(0.1% by weight, pH 2.5) and autoclaved. The UV/Vis spectrum of a lens is measured in phosphate-buffered saline (PBS). This lens has an average %T in the UVA and UVB range of 3.2 and 0.06, respectively. These values are well within the requirement of <10%
Transmittance in the UVA range and <1%Transmittance in the UVB range.
Lens properties are also tested in addition to the above UV/Vis spectrum. The results are shown Table 9.
Table 9 Formulation Modulus (MPa) Ave %EtB* IP App. Dk H20 ((Yip) 85-1 0.58 330 7.0+/-0.5 92+/- 15 33.0 * EtB = elongation to break
Claims (15)
1. A method for producing silicone hydrogel contact lenses, comprising the steps of:
(I) providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces;
(II) introducing a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises (a) from 5% to 60% by weight of a hydrophilic amide-type vinylic monomer having partial formula of - in which X is a covalent bond, hydrogen, or a methyl radical, (b) from 5% to 50% by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3), (c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) in which r is 1;
G1 and G2 independent of each other are a linear or branched C1¨C10 alkylene divalent radical, a divalent radical of formula in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a C1¨C6 alkylene divalent radical, or a divalent radical of formula ¨R'1¨X4¨E¨X5¨R'2¨
in which R'1 and R'2 independent of each other are a linear or branched C1¨C10 alkylene divalent radical or a divalent radical of formula as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting of is H or C1-C8alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain;
X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, and - in which R' is H or C1-C8 alkyl;
PDMS is a polysiloxane divalent radical of formula (5) in which v is 0 or 1, .omega. is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula ¨R'1¨X4¨E¨X5¨R'2¨
as defined above or a divalent radical of formula as defined above, and D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of ¨(CH2CH2O)t¨CH2CH2¨ in which t is an integer of 3 to 40, ¨CF2¨(OCF2)a¨(OCF2CF2)b¨OCF2¨ in which a and b independent of each other are an integer of 0 to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) in which R3, R4, R5, R5, R7, R8, R9 and R10, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), or ¨alk¨(OCH2CH2)n¨OR11 in which alk is C1-C6-alkylene divalent radical, R11 is C1-C6 alkyl and n is an integer from 1 to 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q is an ethylenically unsaturated group of formula (7) in which Z1 and Z2 independent of each other are a linear or branched C1-C12 alkylene divalent radical, a linear or branched C1-C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH2O)d-CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is -O- or in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen;
and R15 and R16 independent of each other are hydrogen, C1-C4 alkyl, phenyl, carboxy, halogen, or a radical of in which X3 is -O-, as defined above or -S-and R17 is a C1-C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or radical, and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the monomer mixture can be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within 100 seconds; and (III) irradiating, under a spatial limitation of actinic radiation, the monomer mixture in the mold for a time period of 120 seconds or less, so as to crosslink the monomer mixture to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
(I) providing a mold for making a soft contact lens, wherein the mold has a first mold half with a first molding surface defining the anterior surface of a contact lens and a second mold half with a second molding surface defining the posterior surface of the contact lens, wherein said first and second mold halves are configured to receive each other such that a cavity is formed between said first and second molding surfaces;
(II) introducing a monomer mixture of lens-forming materials into the cavity, wherein the monomer mixture comprises (a) from 5% to 60% by weight of a hydrophilic amide-type vinylic monomer having partial formula of - in which X is a covalent bond, hydrogen, or a methyl radical, (b) from 5% to 50% by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3), (c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) in which r is 1;
G1 and G2 independent of each other are a linear or branched C1¨C10 alkylene divalent radical, a divalent radical of formula in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a C1¨C6 alkylene divalent radical, or a divalent radical of formula ¨R'1¨X4¨E¨X5¨R'2¨
in which R'1 and R'2 independent of each other are a linear or branched C1¨C10 alkylene divalent radical or a divalent radical of formula as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting of is H or C1-C8alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain;
X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, and - in which R' is H or C1-C8 alkyl;
PDMS is a polysiloxane divalent radical of formula (5) in which v is 0 or 1, .omega. is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula ¨R'1¨X4¨E¨X5¨R'2¨
as defined above or a divalent radical of formula as defined above, and D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of ¨(CH2CH2O)t¨CH2CH2¨ in which t is an integer of 3 to 40, ¨CF2¨(OCF2)a¨(OCF2CF2)b¨OCF2¨ in which a and b independent of each other are an integer of 0 to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) in which R3, R4, R5, R5, R7, R8, R9 and R10, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), or ¨alk¨(OCH2CH2)n¨OR11 in which alk is C1-C6-alkylene divalent radical, R11 is C1-C6 alkyl and n is an integer from 1 to 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q is an ethylenically unsaturated group of formula (7) in which Z1 and Z2 independent of each other are a linear or branched C1-C12 alkylene divalent radical, a linear or branched C1-C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH2O)d-CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is -O- or in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen;
and R15 and R16 independent of each other are hydrogen, C1-C4 alkyl, phenyl, carboxy, halogen, or a radical of in which X3 is -O-, as defined above or -S-and R17 is a C1-C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or radical, and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the monomer mixture can be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within 100 seconds; and (III) irradiating, under a spatial limitation of actinic radiation, the monomer mixture in the mold for a time period of 120 seconds or less, so as to crosslink the monomer mixture to form the silicone hydrogel contact lens, wherein the produced contact lens comprises an anterior surface defined by the first molding surface, an opposite posterior surface defined by the second molding surface, and a lens edge defined by the spatial limitation of actinic radiation.
2. The method of claim 1, wherein the hydrophilic amide-type vinylic monomer is selected from the group consisting of 2-acrylamidoglycolic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid, 2-acrylamido-2-methyl-1-propanesulfonic acid or salt thereof, (3-acrylamidopropyl)trimethylammonium chloride, 3-acryloylamino-1-propanol, N-(butoxymethyl)acrylamide, N-tert-butylacrylamide, diacetone acrylamide, N,N-dimethylacrylamide, N,N-dimethylmethacrylamide, N-[3-(dimethylamino)propyl]methacrylamide, N-hydroxyethyl acrylamide, N-(hydroxymethyl)acrylamide, N-(isobutoxymethyl)acrylamide, N-isopropylacrylamide, N-isopropylmethacrylamide, methacrylamide, N-phenylacrylamide, N-[Tris(hydroxymethyl)methyl]acrylamide, N-methyl-3-methylene-2-pyrrolidone, and a mixture thereof.
3. The method of claim 1 or 2, wherein the siloxane-containing (meth)acrylamide monomer is selected from the group consisting of N-[tris(trimethylsiloxy)silylpropyl]methacrylamide, N-[tris(trimethylsiloxy)-silylpropyl]acrylamide, N-[tris(dimethylpropylsiloxy)silylpropyl] acrylamide, Nqtris(dimethylpropylsiloxy)silylpropyl] methacrylamide, N-[tris(dimethyl-phenylsiloxy)silylpropyl] acrylamide, N-[tris(dimethylphenylsiloxy)silylpropyl]
methacrylamide, N-[tris(dimethylethylsiloxy)silylpropyl]acrylamide, N-[tris(dimethylethylsiloxy)silylpropyl] methacrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl)-2-methyl acrylamide; N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl) acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl]-2-methyl acrylamide;
N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl]
acrylamide;
N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl)-2-methyl acrylamide;
N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl)acrylamide;
N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]-2-methyl acrylamide;
N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]acrylamide; N-[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl acrylamide; N-[2-hydroxy-3-(3-(t-butyldimethylsilyppropyloxy)propyl]acrylamide; N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl acrylamide; and N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide.
methacrylamide, N-[tris(dimethylethylsiloxy)silylpropyl]acrylamide, N-[tris(dimethylethylsiloxy)silylpropyl] methacrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl)-2-methyl acrylamide; N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl) acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl]-2-methyl acrylamide;
N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl]
acrylamide;
N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl)-2-methyl acrylamide;
N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl)acrylamide;
N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]-2-methyl acrylamide;
N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl]acrylamide; N-[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl acrylamide; N-[2-hydroxy-3-(3-(t-butyldimethylsilyppropyloxy)propyl]acrylamide; N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl acrylamide; and N,N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]acrylamide.
4. The method of claim 3, wherein the monomer mixture comprises a polysiloxane-containing vinylic macromer of formula (4) in which D1, D2 and D3 independently of each other are a divalent radical of formula (6).
5. The method of claim 1, 2, 3, or 4 wherein the monomer mixture further comprises a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent in an amount from 0.2% to 5.0% by weight.
6. The method of claim 5, wherein the monomer mixture comprises the polymerizable UV-absorbing agent which comprises a benzotriazole- and/or benzophenone-moiety.
7. The method of claim 5, wherein the photoinitiator is a benzoylphosphine oxide photoinitiator.
8. The method of claim 5, wherein the monomer mixture comprises the polymerizable latent UV-absorbing agent.
9. The method of any one of claims 1 to 8, wherein at least one of the first and second molding surfaces is permeable to UV radiation and optionally the other molding surface is poorly permeable to UV radiation.
10. The method of claim 9, wherein the mold is a reusable mold comprising a mask which is fixed, constructed or arranged in, at or on the mold half having the radiation-permeable molding surface, wherein the mask extends inwardly right up to the mold cavity and surrounds the mold cavity so as to screen all areas behind the mask with the exception of the mold cavity.
11. The method of claim 10, wherein the monomer mixture in the mold is irradiated under the spatial limitation of actinic radiation for a time period of 50 seconds or less.
12. The method of any one of claims 1 to 11, wherein the monomer mixture comprises (1) from 10% to about 50% by weight of the hydrophilic amide-type vinylic monomer; (2) from 10% to 40% by weight of the siloxane-containing acrylamide or methacrylamide monomer; (3) from 10% to 40% by weight of the polysiloxane-containing vinylic macromer; (4) from 0.1% to 1.3% by weight of the photoinitiator;
and (5) additionally from 0 to 5% by weight of a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent, provided that components (1) to (5) and any additional components add up to 100% by weight.
and (5) additionally from 0 to 5% by weight of a polymerizable UV-absorbing agent or a polymerizable latent UV-absorbing agent, provided that components (1) to (5) and any additional components add up to 100% by weight.
13. A silicone hydrogel contact lens obtained according to any one of claims 1 to 12.
14. The silicone hydrogel contact lens of claim 13, wherein the contact lens has at least one property selected from the group consisting of an oxygen permeability of at least 40 barrers, an elastic modulus of 2.0 MPa or less, an lonoflux Diffusion Coefficient, D, of at least 1.5 x 10 -6 mm2/min, and a water content of from
15% to 70% by weight.
15. A lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation, comprising:
(a) from 5% to 60% by weight of a hydrophilic amide-type vinylic monomer having partial formula of - in which X is a covalent bond, hydrogen, or a methyl radical;
(b) from 5% to 50% by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3);
(c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) in which r is 1;
G1 and G2 independent of each other are a linear or branched C1-C10 alkylene divalent radical, a divalent radical of formula in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a alkylene divalent radical, or a divalent radical of formula -R'1-X4-E-X5-R'2-in which R'1 and R'2 independent of each other are a linear or branched C1-C10 alkylene divalent radical or a divalent radical of formula as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting of in which R' is H or C1-C8alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain;
X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, in which R' is H or C1-C8alkyl;
PDMS is a polysiloxane divalent radical of formula (5) in which v is 0 or 1, .omega. is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula -R'1-X4-E-X5-R'2-as defined above or a divalent radical of formula as defined above, and D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of -(CH2CH2O)t-CH2CH2- in which t is an integer of 3 to 40, -CF2-(OCF2)a-(OCF2CF2)b-OCF2- in which a and b independent of each other are an integer of 0 to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) in which R3, R4, R5, R6, R7, R8, R9 and R10, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), or -alk-(OCH2CH2)n-OR11 in which alk is C1-C6-alkylene divalent radical, R11 is C1-C6 alkyl and n is an integer from 1 to 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q is an ethylenically unsaturated group of formula (7) in which Z1 and Z2 independent of each other are a linear or branched C1-C12 alkylene divalent radical, a linear or branched C1-C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH2O)d-CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is -O- or in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen;
and R15 and R16 independent of each other are hydrogen, C1-C4 alkyl, phenyl, carboxy, halogen, or a radical of in which X3 is -O-, as defined above or -S-and R17 is a C1-C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical;
and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the lens forming composition is characterized by having an ability to be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within 100 seconds.
15. A lens-forming composition suitable for making silicone hydrogel contact lenses according to a curing method based on a spatial limitation of actinic radiation, comprising:
(a) from 5% to 60% by weight of a hydrophilic amide-type vinylic monomer having partial formula of - in which X is a covalent bond, hydrogen, or a methyl radical;
(b) from 5% to 50% by weight of a siloxane-containing (meth)acrylamide monomer of formula (1) in which R is H or CH3, R3 and R4 independently of each other are H, C1-C6 alkyl, or a monovalent radical of formula (2) in which Y is a C1-C6 alkylene divalent radical or a C1-C6 alkylene divalent radical containing one or more hydroxyl groups, m is an integer of 0 to 5, p is an integer of 1 to 6, and A1, A2 and A3 independent of each other are C1-C6 alkyl, phenyl, benzyl, or a radical of formula (3) in which B1, B2 and B3 independent of each other are C1-C6 alkyl, phenyl, or benzyl, provided that at least one of R3 and R4 is a radical of formula (2), and provided that at least two of A1, A2 and A3 are radicals of formula (3);
(c) from 5% to 50% by weight of a polysiloxane vinylic monomer or macromer of formula (4) in which r is 1;
G1 and G2 independent of each other are a linear or branched C1-C10 alkylene divalent radical, a divalent radical of formula in which q is an integer of from 1 to 5 and alk and alk' independent of each other are a alkylene divalent radical, or a divalent radical of formula -R'1-X4-E-X5-R'2-in which R'1 and R'2 independent of each other are a linear or branched C1-C10 alkylene divalent radical or a divalent radical of formula as defined above, X4 and X5 independent of each other are a linkage selected from the group consisting of in which R' is H or C1-C8alkyl, and E is an alkyl diradical, a cycloalkyl diradical, an alkylcycloalkyl diradical, an alkylaryl diradical, or an aryl diradical with up to 40 carbon atoms which may have ether, thio, or amine linkages in the main chain;
X1 and X2 independent of each other are a linkage selected from the group consisting of a direct bond, in which R' is H or C1-C8alkyl;
PDMS is a polysiloxane divalent radical of formula (5) in which v is 0 or 1, .omega. is an integer of from 0 to 5, U1 and U2 independent of each other represent a divalent radical of formula -R'1-X4-E-X5-R'2-as defined above or a divalent radical of formula as defined above, and D1, D2 and D3 independently of each other are a divalent radical selected from the group consisting of -(CH2CH2O)t-CH2CH2- in which t is an integer of 3 to 40, -CF2-(OCF2)a-(OCF2CF2)b-OCF2- in which a and b independent of each other are an integer of 0 to 10 provided that a+b is a number in the range of 10 to 30, and a divalent group of formula (6) in which R3, R4, R5, R6, R7, R8, R9 and R10, independently of one another, are C1-C8-alkyl, C1-C4 alkyl- or C1-C4-alkoxy-substituted phenyl, fluoro(C1-C18-alkyl), cyano(C1-C12-alkyl), or -alk-(OCH2CH2)n-OR11 in which alk is C1-C6-alkylene divalent radical, R11 is C1-C6 alkyl and n is an integer from 1 to 10, m and p independently of each other are an integer of from 2 to 698 and (m+p) is from 5 to 700, provided that at least one of D1, D2 and D3 is represented by formula (6); and Q is an ethylenically unsaturated group of formula (7) in which Z1 and Z2 independent of each other are a linear or branched C1-C12 alkylene divalent radical, a linear or branched C1-C12 alkylene divalent radical having one or more hydroxyl groups, a radical of formula -(CH2CH2O)d-CH2CH2 in which d is an integer of 1 to 10, unsubstituted phenylene divalent radical, C1-C4 alkyl or C1-C4 alkoxy substituted phenylene divalent radical or C7-C12 aralkylene divalent radical; A5 is -O- or in which R' is H or C1-C8 alkyl; q1 and q2 independent of each other are an integer of 0 or 1; R14 is hydrogen, C1-C4 alkyl or halogen;
and R15 and R16 independent of each other are hydrogen, C1-C4 alkyl, phenyl, carboxy, halogen, or a radical of in which X3 is -O-, as defined above or -S-and R17 is a C1-C12 alkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl radical;
and (d) from 0.05% to 1.5% by weight of a photoinitiator, wherein the lens forming composition is characterized by having an ability to be cured by a UV light having an UV-intensity of 4.1 mW/cm2 within 100 seconds.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/316,993 US7780879B2 (en) | 2007-12-20 | 2008-12-18 | Method for making contact lenses |
US12/316,993 | 2008-12-18 | ||
US21262309P | 2009-04-14 | 2009-04-14 | |
US61/212,623 | 2009-04-14 | ||
PCT/US2009/047428 WO2010071691A1 (en) | 2008-12-18 | 2009-06-16 | Method for making silicone hydrogel contact lenses |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2747355A1 CA2747355A1 (en) | 2010-06-24 |
CA2747355C true CA2747355C (en) | 2014-10-21 |
Family
ID=41050482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2747355 Expired - Fee Related CA2747355C (en) | 2008-12-18 | 2009-06-16 | Method for making silicone hydrogel contact lenses |
Country Status (16)
Country | Link |
---|---|
US (2) | US8163206B2 (en) |
EP (1) | EP2374031A1 (en) |
JP (2) | JP5713265B2 (en) |
KR (2) | KR101422900B1 (en) |
CN (2) | CN102257408B (en) |
AR (1) | AR072151A1 (en) |
AU (1) | AU2009327484B2 (en) |
BR (1) | BRPI0923037A2 (en) |
CA (1) | CA2747355C (en) |
MX (1) | MX2011006601A (en) |
MY (1) | MY150782A (en) |
NZ (1) | NZ592674A (en) |
RU (1) | RU2499288C2 (en) |
SG (1) | SG172081A1 (en) |
TW (2) | TWI613067B (en) |
WO (1) | WO2010071691A1 (en) |
Families Citing this family (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008032066A1 (en) * | 2008-07-08 | 2010-01-14 | Byk-Chemie Gmbh | Polyhydroxy-functional polysiloxanes as anti-adhesive and dirt-repellent additives in coatings, polymeric molding compounds and thermoplastics, process for their preparation and their use |
DE102008032064A1 (en) * | 2008-07-08 | 2010-01-14 | Byk-Chemie Gmbh | Polyhydroxy-functional polysiloxanes for increasing the surface energy of thermoplastics, processes for their preparation and their use |
JP5720103B2 (en) | 2010-03-18 | 2015-05-20 | 東レ株式会社 | Silicone hydrogels, ophthalmic lenses and contact lenses |
US9522980B2 (en) | 2010-05-06 | 2016-12-20 | Johnson & Johnson Vision Care, Inc. | Non-reactive, hydrophilic polymers having terminal siloxanes and methods for making and using the same |
US8480227B2 (en) * | 2010-07-30 | 2013-07-09 | Novartis Ag | Silicone hydrogel lenses with water-rich surfaces |
CA2802486C (en) | 2010-07-30 | 2015-01-06 | Novartis Ag | Amphiphilic polysiloxane prepolymers and uses thereof |
AU2014221267B2 (en) * | 2010-07-30 | 2016-05-12 | Alcon Inc. | Silicone hydrogel lenses with water-rich surfaces |
AU2016201366B2 (en) * | 2010-07-30 | 2017-05-25 | Alcon Inc. | Silicone hydrogel lenses with water-rich surfaces |
US9067372B2 (en) | 2010-12-01 | 2015-06-30 | Novartis Ag | Lens molds having atmospheric plasma coatings thereon |
US8618187B2 (en) * | 2011-04-01 | 2013-12-31 | Novartis Ag | Composition for forming a contact lens |
US9170349B2 (en) * | 2011-05-04 | 2015-10-27 | Johnson & Johnson Vision Care, Inc. | Medical devices having homogeneous charge density and methods for making same |
US9358735B2 (en) | 2011-11-29 | 2016-06-07 | Novartis Ag | Method of treating a lens forming surface of at least one mold half of a mold for molding ophthalmic lenses |
KR101338391B1 (en) * | 2011-12-28 | 2013-12-10 | 한국과학기술원 | Contact lenses for diagnosis of diseases and process for preparing the same |
TWI434865B (en) | 2011-12-29 | 2014-04-21 | Pegavision Corp | Method for manufacturing hydrophilic silicone macromer |
CN103183830B (en) * | 2011-12-29 | 2015-06-10 | 晶硕光学股份有限公司 | Preparation method for hydrophilic silicone macromer |
MY164100A (en) * | 2011-12-31 | 2017-11-30 | Novartis Ag | Method of making contact lenses with identifying mark |
JP6502246B2 (en) | 2012-03-22 | 2019-04-17 | モメンティブ パフォーマンス マテリアルズ インコーポレイテッドMomentive Performance Materials Inc. | Hydrophilic silicone monomer, process for preparing the same and thin film containing the same |
WO2013142062A2 (en) * | 2012-03-22 | 2013-09-26 | Momentive Performance Materials Inc. | Hydrophilic macromers and hydrogels comprising the same |
US20130313733A1 (en) * | 2012-05-25 | 2013-11-28 | Ivan Nunez | Method of making a fully polymerized uv blocking silicone hydrogel lens |
US9244196B2 (en) | 2012-05-25 | 2016-01-26 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
US10073192B2 (en) | 2012-05-25 | 2018-09-11 | Johnson & Johnson Vision Care, Inc. | Polymers and nanogel materials and methods for making and using the same |
CN104380148B (en) * | 2012-05-25 | 2018-09-28 | 博士伦公司 | The silicone hydrogel lenses for the barrier ultraviolet light polymerizeing completely |
US9075187B2 (en) * | 2012-05-25 | 2015-07-07 | Bausch & Lomb Incorporated | Fully polymerized UV blocking silicone hydrogel lens |
TW201428245A (en) | 2012-09-10 | 2014-07-16 | Bluelight Analytics Inc | Devices and methods for measuring light |
CA2978612C (en) | 2012-12-14 | 2020-03-24 | Novartis Ag | Amphiphilic siloxane-containing vinylic monomers and uses thereof |
US9097840B2 (en) * | 2012-12-14 | 2015-08-04 | Novartis Ag | Amphiphilic siloxane-containing (meth)acrylamides and uses thereof |
CN104871036B (en) | 2012-12-17 | 2019-12-10 | 诺华股份有限公司 | Method for making improved UV-absorbing ophthalmic lenses |
ES2688532T3 (en) | 2013-01-18 | 2018-11-05 | Basf Se | Acrylic dispersion based coating compositions |
TWI535793B (en) * | 2013-01-31 | 2016-06-01 | 明基材料股份有限公司 | Material for contact lenses, method for manufacturing contact lenses and contact lenses obtained thereby |
US9352493B2 (en) * | 2013-02-08 | 2016-05-31 | Johnson & Johnson Vision Care, Inc. | Casting cup assembly for forming an ophthalmic device |
JP6132723B2 (en) * | 2013-09-25 | 2017-05-24 | 信越化学工業株式会社 | Radical polymerizable group-containing silicone compound and method for producing the same |
MY179469A (en) | 2013-09-30 | 2020-11-06 | Alcon Inc | Method for making uv-absorbing ophthalmic lenses |
US9568645B2 (en) | 2013-09-30 | 2017-02-14 | Novartis Ag | Silicone hydrogel lenses with relatively-long thermal stability |
HUE043628T2 (en) * | 2013-09-30 | 2019-08-28 | Novartis Ag | Silicone hydrogel lenses with relatively-long thermal stability |
MY175124A (en) * | 2013-10-31 | 2020-06-09 | Alcon Inc | Method for producing ophthalmic lenses |
CN104628943B (en) * | 2013-11-15 | 2016-09-21 | 中国石油化工股份有限公司 | A kind of acrylamide based copolymer and its preparation method and application |
CN105793022B (en) | 2013-12-13 | 2017-09-19 | 诺华股份有限公司 | Method for preparing haptic lens |
EP3086162B1 (en) | 2013-12-16 | 2019-04-17 | Menicon Co., Ltd. | Ocular lens |
JP6053960B2 (en) | 2013-12-16 | 2016-12-27 | 株式会社メニコン | Polysiloxane macromonomer for ophthalmic lens and ophthalmic lens using the same |
HUE038809T2 (en) | 2013-12-17 | 2018-11-28 | Novartis Ag | A silicone hydrogel lens with a crosslinked hydrophilic coating |
MY177298A (en) | 2013-12-20 | 2020-09-11 | Alcon Inc | Molds for making contact lenses |
CN105829082B (en) | 2013-12-20 | 2019-06-07 | 诺华股份有限公司 | The casting mould that can be reused and the method for preparing such mold |
WO2015134449A1 (en) | 2014-03-05 | 2015-09-11 | Novartis Ag | Method for automatic inspection of contact lenses |
AU2015201371A1 (en) | 2014-03-31 | 2015-10-15 | Johnson & Johnson Vision Care, Inc. | Silicone acrylamide copolymer |
AU2015201321A1 (en) | 2014-03-31 | 2015-10-15 | Johnson & Johnson Vision Care, Inc. | Silicone acrylamide copolymer |
CA2940581C (en) | 2014-04-08 | 2018-05-15 | Novartis Ag | Ophthalmic lenses with oxygen-generating elements therein |
JP6351385B2 (en) * | 2014-06-03 | 2018-07-04 | 株式会社メニコン | Contact lens manufacturing method |
JP6351384B2 (en) * | 2014-06-03 | 2018-07-04 | 株式会社メニコン | Contact lens and manufacturing method thereof |
KR102366047B1 (en) | 2014-08-26 | 2022-02-23 | 알콘 인코포레이티드 | Method for applying stable coating on silicone hydrogel contact lenses |
WO2016054292A1 (en) | 2014-10-03 | 2016-04-07 | Soft Health Technologies Llc | Systems and methods for incontinence control |
JP6195419B2 (en) * | 2014-10-17 | 2017-09-13 | 信越化学工業株式会社 | Radical polymerizable group-containing silicone compound and method for producing the same |
CN105713153B (en) * | 2014-12-05 | 2019-05-10 | 晶硕光学股份有限公司 | Obstruct the silicon glue composition of ultraviolet light and the silicon glue eyeglass comprising it |
US9482788B2 (en) | 2014-12-05 | 2016-11-01 | Pegavision Corporation | UV-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof |
EP3029081A1 (en) * | 2014-12-05 | 2016-06-08 | Pegavision Corporation | Uv-blocking silicone hydrogel composition and silicone hydrogel contact lens containing thereof |
WO2016100450A1 (en) | 2014-12-17 | 2016-06-23 | Novartis Ag | Reusable lens molds and methods of use thereof |
WO2016100448A1 (en) | 2014-12-17 | 2016-06-23 | Novartis Ag | Reusable lens molds and methods of use thereof |
WO2016100457A1 (en) | 2014-12-17 | 2016-06-23 | Novartis Ag | Reusable lens molds and methods of use thereof |
WO2016143565A1 (en) * | 2015-03-12 | 2016-09-15 | 旭硝子株式会社 | Method for producing laminate, laminate and photocurable composition |
JP6333211B2 (en) * | 2015-04-23 | 2018-05-30 | 信越化学工業株式会社 | Silicone for ophthalmic device manufacturing |
CN104945570B (en) * | 2015-07-03 | 2017-06-09 | 东南大学 | A kind of Silica hydrogel contact lens and its surface reversion processing method |
SG11201803711SA (en) * | 2015-12-15 | 2018-06-28 | Novartis Ag | Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof |
CA3003986C (en) | 2015-12-15 | 2020-07-21 | Novartis Ag | Polymerizable polysiloxanes with hydrophilic substituents |
CN108369291B (en) | 2015-12-15 | 2021-07-20 | 爱尔康公司 | Method for applying a stable coating on a silicone hydrogel contact lens |
US10138316B2 (en) | 2015-12-15 | 2018-11-27 | Novartis Ag | Amphiphilic branched polydiorganosiloxane macromers |
SG11201803723QA (en) | 2015-12-17 | 2018-07-30 | Novartis Ag | Reusable lens molds and methods of use thereof |
KR101841016B1 (en) * | 2016-02-18 | 2018-03-22 | 주식회사 인터로조 | Siloxane monomers, compositions for the production of silicone hydrogel lenses containing the same, and silicone hydrogel lenses |
KR102134675B1 (en) * | 2016-04-11 | 2020-07-16 | 닛산 가가쿠 가부시키가이샤 | Polymerizable composition comprising phenanthrene ring-containing reactive silsesquioxane compound |
KR101861814B1 (en) * | 2016-06-08 | 2018-05-29 | 한국원자력연구원 | ion conductive silicon hydrogel and its preparation method |
US11021558B2 (en) | 2016-08-05 | 2021-06-01 | Johnson & Johnson Vision Care, Inc. | Polymer compositions containing grafted polymeric networks and processes for their preparation and use |
US10676575B2 (en) | 2016-10-06 | 2020-06-09 | Johnson & Johnson Vision Care, Inc. | Tri-block prepolymers and their use in silicone hydrogels |
EP3526277B1 (en) | 2016-10-11 | 2020-08-12 | Alcon Inc. | Polymerizable polydimethylsiloxane-polyoxyalkylene block copolymers |
JP6859432B2 (en) | 2016-10-11 | 2021-04-14 | アルコン インク. | Chain Extension Polydimethylsiloxane Vinyl Crosslinker and Its Use |
EP3532519A1 (en) | 2016-10-26 | 2019-09-04 | Novartis AG | Amphiphilic branched polydiorganosiloxane macromers |
HUE055667T2 (en) | 2017-06-07 | 2021-12-28 | Alcon Inc | Method for producing silicone hydrogel contact lenses |
TWI720509B (en) | 2017-06-07 | 2021-03-01 | 瑞士商愛爾康公司 | Silicone hydrogel contact lenses |
JP6831020B2 (en) | 2017-06-07 | 2021-02-17 | アルコン インク. | Silicone hydrogel contact lenses |
US10752720B2 (en) | 2017-06-26 | 2020-08-25 | Johnson & Johnson Vision Care, Inc. | Polymerizable blockers of high energy light |
US10723732B2 (en) | 2017-06-30 | 2020-07-28 | Johnson & Johnson Vision Care, Inc. | Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light |
US10526296B2 (en) | 2017-06-30 | 2020-01-07 | Johnson & Johnson Vision Care, Inc. | Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light |
US11029538B2 (en) | 2017-10-25 | 2021-06-08 | Coopervision International Limited | Contact lenses having an ion-impermeable portion and related methods |
EP3724698B1 (en) | 2017-12-13 | 2021-12-15 | Alcon Inc. | Method for producing mps-compatible water gradient contact lenses |
US10961341B2 (en) | 2018-01-30 | 2021-03-30 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use |
US11034789B2 (en) | 2018-01-30 | 2021-06-15 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices containing localized grafted networks and processes for their preparation and use |
US20210061934A1 (en) | 2019-08-30 | 2021-03-04 | Johnson & Johnson Vision Care, Inc. | Contact lens displaying improved vision attributes |
US10935695B2 (en) | 2018-03-02 | 2021-03-02 | Johnson & Johnson Vision Care, Inc. | Polymerizable absorbers of UV and high energy visible light |
US10996491B2 (en) | 2018-03-23 | 2021-05-04 | Johnson & Johnson Vision Care, Inc. | Ink composition for cosmetic contact lenses |
US11046636B2 (en) | 2018-06-29 | 2021-06-29 | Johnson & Johnson Vision Care, Inc. | Polymerizable absorbers of UV and high energy visible light |
US11493668B2 (en) | 2018-09-26 | 2022-11-08 | Johnson & Johnson Vision Care, Inc. | Polymerizable absorbers of UV and high energy visible light |
TWI685545B (en) * | 2018-11-30 | 2020-02-21 | 晶碩光學股份有限公司 | Silicone hydrogel composition, silicone hydrogel lens, and method of manufacturing silicone hydrogel lens |
EP3858393A4 (en) * | 2018-12-12 | 2022-06-29 | Toray Industries, Inc. | Medical device |
US11578176B2 (en) | 2019-06-24 | 2023-02-14 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogel contact lenses having non-uniform morphology |
US20200407324A1 (en) | 2019-06-28 | 2020-12-31 | Johnson & Johnson Vision Care, Inc. | Polymerizable fused tricyclic compounds as absorbers of uv and visible light |
US11958824B2 (en) | 2019-06-28 | 2024-04-16 | Johnson & Johnson Vision Care, Inc. | Photostable mimics of macular pigment |
US20210003754A1 (en) | 2019-07-02 | 2021-01-07 | Johnson & Johnson Vision Care, Inc. | Core-shell particles and methods of making and using thereof |
US11543683B2 (en) | 2019-08-30 | 2023-01-03 | Johnson & Johnson Vision Care, Inc. | Multifocal contact lens displaying improved vision attributes |
US11891526B2 (en) | 2019-09-12 | 2024-02-06 | Johnson & Johnson Vision Care, Inc. | Ink composition for cosmetic contact lenses |
US11759980B2 (en) | 2019-10-31 | 2023-09-19 | Alcon Inc. | Method for removing lens forming material deposited on a lens forming surface |
US11360240B2 (en) | 2019-12-19 | 2022-06-14 | Johnson & Johnson Vision Care, Inc. | Contact lens containing photosensitive chromophore and package therefor |
US20210301088A1 (en) | 2020-03-18 | 2021-09-30 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices containing transition metal complexes as high energy visible light filters |
US20210347929A1 (en) | 2020-05-07 | 2021-11-11 | Alcon Inc. | Method for producing silicone hydrogel contact lenses |
US20210371731A1 (en) | 2020-06-02 | 2021-12-02 | Alcon Inc. | Method for making photochromic contact lenses |
US11853013B2 (en) | 2020-06-15 | 2023-12-26 | Johnson & Johnson Vision Care, Inc. | Systems and methods for indicating the time elapsed since the occurrence of a triggering event |
US20210388141A1 (en) | 2020-06-16 | 2021-12-16 | Johnson & Johnson Vision Care, Inc. | Imidazolium zwitterion polymerizable compounds and ophthalmic devices incorporating them |
KR102334225B1 (en) * | 2020-10-27 | 2021-12-02 | 신성호 | Manufacturing method of ionized soft contact lens using microwave |
WO2022090967A1 (en) | 2020-10-28 | 2022-05-05 | Alcon Inc. | Method for making photochromic contact lenses |
EP4240579A1 (en) | 2020-11-04 | 2023-09-13 | Alcon Inc. | Method for making photochromic contact lenses |
US11886045B2 (en) | 2020-11-04 | 2024-01-30 | Alcon Inc. | Method for making photochromic contact lenses |
WO2022130089A1 (en) | 2020-12-18 | 2022-06-23 | Johnson & Johnson Vision Care, Inc. | Photostable mimics of macular pigment |
CN112812307B (en) * | 2020-12-31 | 2022-06-17 | 江苏海伦隐形眼镜有限公司 | Single-end-capped amphiphilic organosiloxane macromonomer, silicone hydrogel, corneal contact lens and preparation method |
WO2022172154A1 (en) | 2021-02-09 | 2022-08-18 | Alcon Inc. | Hydrophilized polydiorganosiloxane vinylic crosslinkers |
EP4304842A1 (en) | 2021-03-08 | 2024-01-17 | Alcon Inc. | Method for making photofunctional contact lenses |
KR20230128126A (en) | 2021-03-11 | 2023-09-01 | 알콘 인코포레이티드 | Ophthalmic lens with cosmetic film inside |
EP4313567A1 (en) | 2021-04-01 | 2024-02-07 | Alcon Inc. | Method for making photochromic contact lenses |
US20230037781A1 (en) | 2021-06-30 | 2023-02-09 | Johnson & Johnson Vision Care, Inc. | Transition metal complexes as visible light absorbers |
WO2023052889A1 (en) | 2021-09-29 | 2023-04-06 | Johnson & Johnson Vision Care, Inc. | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses |
WO2023052890A1 (en) | 2021-09-29 | 2023-04-06 | Johnson & Johnson Vision Care, Inc. | Anthraquinone-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses |
US20230176251A1 (en) | 2021-09-29 | 2023-06-08 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lenses and their manufacture by in-mold modification |
US11912800B2 (en) | 2021-09-29 | 2024-02-27 | Johnson & Johnson Vision Care, Inc. | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses |
US20230296807A1 (en) | 2021-12-20 | 2023-09-21 | Johnson & Johnson Vision Care, Inc. | Contact lenses containing light absorbing regions and methods for their preparation |
US20230348718A1 (en) | 2022-04-28 | 2023-11-02 | Johnson & Johnson Vision Care, Inc. | Light-filtering materials for biomaterial integration and methods thereof |
US11733440B1 (en) | 2022-04-28 | 2023-08-22 | Johnson & Johnson Vision Care, Inc. | Thermally stable nanoparticles and methods thereof |
US20230364832A1 (en) | 2022-04-28 | 2023-11-16 | Alcon Inc. | Method for making uv and hevl-absorbing ophthalmic lenses |
US20230350230A1 (en) | 2022-04-28 | 2023-11-02 | Johnson & Johnson Vision Care, Inc. | Using particles for light filtering |
US20230350099A1 (en) | 2022-04-28 | 2023-11-02 | Johnson & Johnson Vision Care, Inc. | Shape engineering of particles to create a narrow spectral filter against a specific portion of the light spectrum |
US20230348717A1 (en) | 2022-04-28 | 2023-11-02 | Johnson & Johnson Vision Care, Inc. | Particle surface modification to increase compatibility and stability in hydrogels |
US20230350100A1 (en) | 2022-04-29 | 2023-11-02 | Alcon Inc. | Method for making silicone hydrogel contact lenses |
US20230374306A1 (en) | 2022-05-23 | 2023-11-23 | Alcon Inc. | Uv/hevl-filtering contact lenses |
US20230374225A1 (en) | 2022-05-23 | 2023-11-23 | Alcon Inc. | Method for making hevl-filtering contact lenses |
WO2023242688A1 (en) | 2022-06-16 | 2023-12-21 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices containing photostable mimics of macular pigment and other visible light filters |
WO2024038390A1 (en) | 2022-08-17 | 2024-02-22 | Alcon Inc. | A contact lens with a hydrogel coating thereon |
GB2622890A (en) * | 2022-09-27 | 2024-04-03 | Coopervision Int Ltd | Sustained fatty acid release from contact lens |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4343927A (en) * | 1976-11-08 | 1982-08-10 | Chang Sing Hsiung | Hydrophilic, soft and oxygen permeable copolymer compositions |
US4182822A (en) * | 1976-11-08 | 1980-01-08 | Chang Sing Hsiung | Hydrophilic, soft and oxygen permeable copolymer composition |
US4136250A (en) * | 1977-07-20 | 1979-01-23 | Ciba-Geigy Corporation | Polysiloxane hydrogels |
US4189546A (en) * | 1977-07-25 | 1980-02-19 | Bausch & Lomb Incorporated | Polysiloxane shaped article for use in biomedical applications |
US4153641A (en) * | 1977-07-25 | 1979-05-08 | Bausch & Lomb Incorporated | Polysiloxane composition and contact lens |
US4130706A (en) * | 1977-08-08 | 1978-12-19 | E. I. Du Pont De Nemours And Company | Hydrophilic, oxygen permeable contact lens |
US4261875A (en) * | 1979-01-31 | 1981-04-14 | American Optical Corporation | Contact lenses containing hydrophilic silicone polymers |
US4254248A (en) * | 1979-09-13 | 1981-03-03 | Bausch & Lomb Incorporated | Contact lens made from polymers of polysiloxane and polycyclic esters of acrylic acid or methacrylic acid |
US4276402A (en) * | 1979-09-13 | 1981-06-30 | Bausch & Lomb Incorporated | Polysiloxane/acrylic acid/polcyclic esters of methacrylic acid polymer contact lens |
US4312575A (en) * | 1979-09-18 | 1982-01-26 | Peyman Gholam A | Soft corneal contact lens with tightly cross-linked polymer coating and method of making same |
US4259467A (en) * | 1979-12-10 | 1981-03-31 | Bausch & Lomb Incorporated | Hydrophilic contact lens made from polysiloxanes containing hydrophilic sidechains |
US4260725A (en) * | 1979-12-10 | 1981-04-07 | Bausch & Lomb Incorporated | Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains |
US4355147A (en) * | 1981-02-26 | 1982-10-19 | Bausch & Lomb Incorporated | Polysiloxane with polycyclic modifier composition and biomedical devices |
US4327203A (en) * | 1981-02-26 | 1982-04-27 | Bausch & Lomb Incorporated | Polysiloxane with cycloalkyl modifier composition and biomedical devices |
US4341889A (en) * | 1981-02-26 | 1982-07-27 | Bausch & Lomb Incorporated | Polysiloxane composition and biomedical devices |
US4495313A (en) * | 1981-04-30 | 1985-01-22 | Mia Lens Production A/S | Preparation of hydrogel for soft contact lens with water displaceable boric acid ester |
US4661575A (en) * | 1982-01-25 | 1987-04-28 | Hercules Incorporated | Dicyclopentadiene polymer product |
US4486577A (en) * | 1982-10-12 | 1984-12-04 | Ciba-Geigy Corporation | Strong, silicone containing polymers with high oxygen permeability |
US4543398A (en) * | 1983-04-28 | 1985-09-24 | Minnesota Mining And Manufacturing Company | Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols |
CS239282B1 (en) * | 1983-08-17 | 1986-01-16 | Otto Wichterle | Preparation method of objects made from hydrophilic gelsnamely contact lences by polymer casting |
GB2152064B (en) * | 1983-12-27 | 1986-12-03 | Toyo Contact Lens Co Ltd | Water-absorptive contact lenses |
JPS60163901A (en) * | 1984-02-04 | 1985-08-26 | Japan Synthetic Rubber Co Ltd | Plasma polymerization treatment |
US4605712A (en) | 1984-09-24 | 1986-08-12 | Ciba-Geigy Corporation | Unsaturated polysiloxanes and polymers thereof |
US4833218A (en) * | 1984-12-18 | 1989-05-23 | Dow Corning Corporation | Hydrophilic silicone-organic copolymer elastomers containing bioactine agent |
US4711943A (en) * | 1985-04-26 | 1987-12-08 | Sola U.S.A. Inc. | Hydrophilic siloxane monomers and dimers for contact lens materials, and contact lenses fabricated therefrom |
DE3531913A1 (en) * | 1985-09-07 | 1987-03-19 | Roehm Gmbh | HARDENABLE CAST RESIN |
US4684538A (en) * | 1986-02-21 | 1987-08-04 | Loctite Corporation | Polysiloxane urethane compounds and adhesive compositions, and method of making and using the same |
DE3708308A1 (en) * | 1986-04-10 | 1987-10-22 | Bayer Ag | CONTACT OPTICAL ITEMS |
US4837289A (en) * | 1987-04-30 | 1989-06-06 | Ciba-Geigy Corporation | UV- and heat curable terminal polyvinyl functional macromers and polymers thereof |
US5070170A (en) * | 1988-02-26 | 1991-12-03 | Ciba-Geigy Corporation | Wettable, rigid gas permeable, substantially non-swellable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units, and use thereof |
US4954587A (en) * | 1988-07-05 | 1990-09-04 | Ciba-Geigy Corporation | Dimethylacrylamide-copolymer hydrogels with high oxygen permeability |
JPH0651795B2 (en) * | 1988-09-16 | 1994-07-06 | 信越化学工業株式会社 | Methacryl functional dimethyl polysiloxane |
US5039459A (en) * | 1988-11-25 | 1991-08-13 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses |
US4889664A (en) | 1988-11-25 | 1989-12-26 | Vistakon, Inc. | Method of forming shaped hydrogel articles including contact lenses |
US4954586A (en) * | 1989-01-17 | 1990-09-04 | Menicon Co., Ltd | Soft ocular lens material |
US5034461A (en) * | 1989-06-07 | 1991-07-23 | Bausch & Lomb Incorporated | Novel prepolymers useful in biomedical devices |
US4983332A (en) * | 1989-08-21 | 1991-01-08 | Bausch & Lomb Incorporated | Method for manufacturing hydrophilic contact lenses |
DE3927667A1 (en) * | 1989-08-22 | 1991-02-28 | Espe Stiftung | USE OF PHOTOPOLYMERIZABLE MATERIALS AS INTROCULAR LENS FILLING MATERIAL IN THE FIGHT AGAINST CATARACT AND OTHER EYE DISEASES |
US5010141A (en) * | 1989-10-25 | 1991-04-23 | Ciba-Geigy Corporation | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof |
US5079319A (en) * | 1989-10-25 | 1992-01-07 | Ciba-Geigy Corporation | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof |
US5480946A (en) * | 1990-04-26 | 1996-01-02 | Ciba Geigy Corporation | Unsaturated urea polysiloxanes |
US5194556A (en) * | 1991-01-09 | 1993-03-16 | Ciba-Geigy Corporation | Rigid contact lenses with improved oxygen permeability |
US5559163A (en) * | 1991-01-28 | 1996-09-24 | The Sherwin-Williams Company | UV curable coatings having improved weatherability |
US5352753A (en) * | 1991-04-25 | 1994-10-04 | Allergan, Inc. | Ultraviolet light absorbing compounds, silicone compositions and methods for making same |
US5164462A (en) * | 1991-04-25 | 1992-11-17 | Allergan, Inc. | Ultraviolet light absorbing compounds and silicone compositions |
US5264161A (en) * | 1991-09-05 | 1993-11-23 | Bausch & Lomb Incorporated | Method of using surfactants as contact lens processing aids |
ES2098531T3 (en) * | 1991-09-12 | 1997-05-01 | Bausch & Lomb | HUMECTABLE HYDROGEL COMPOSITIONS CONTAINING SILICONE AND METHODS. |
US5196458A (en) * | 1991-10-15 | 1993-03-23 | Johnson & Johnson Vision Products, Inc. | Soft, high oxygen permeability ophthalmic lens |
WO1993009154A1 (en) * | 1991-11-05 | 1993-05-13 | Bausch & Lomb Incorporated | Wettable silicone hydrogel compositions and methods for their manufacture |
US5358995A (en) * | 1992-05-15 | 1994-10-25 | Bausch & Lomb Incorporated | Surface wettable silicone hydrogels |
JP3195662B2 (en) * | 1992-08-24 | 2001-08-06 | 株式会社メニコン | Ophthalmic lens materials |
JP2774233B2 (en) * | 1992-08-26 | 1998-07-09 | 株式会社メニコン | Ophthalmic lens materials |
KR100209818B1 (en) * | 1992-09-04 | 1999-07-15 | 사또 아끼오 | Degradable adhesive film and degradable resin composition |
US5336797A (en) * | 1992-12-30 | 1994-08-09 | Bausch & Lomb Incorporated | Siloxane macromonomers |
TW328535B (en) * | 1993-07-02 | 1998-03-21 | Novartis Ag | Functional photoinitiators and their manufacture |
US6800225B1 (en) * | 1994-07-14 | 2004-10-05 | Novartis Ag | Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process |
TW272976B (en) * | 1993-08-06 | 1996-03-21 | Ciba Geigy Ag | |
TW303379B (en) * | 1994-03-02 | 1997-04-21 | Ciba Sc Holding Ag | |
TW381106B (en) * | 1994-09-02 | 2000-02-01 | Ciba Sc Holding Ag | Alkoxyphenyl-substituted bisacylphosphine oxides |
US7468398B2 (en) * | 1994-09-06 | 2008-12-23 | Ciba Vision Corporation | Extended wear ophthalmic lens |
US5760100B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
GB9504996D0 (en) | 1995-03-11 | 1995-04-26 | Zeneca Ltd | Compositions |
TW393498B (en) * | 1995-04-04 | 2000-06-11 | Novartis Ag | The preparation and use of Polysiloxane-comprising perfluoroalkyl ethers |
CH691970A5 (en) * | 1996-03-04 | 2001-12-14 | Ciba Sc Holding Ag | Photoinitiator mixture for photopolymerising compounds having ethylenically unsaturated double bonds |
US6361925B1 (en) * | 1996-03-04 | 2002-03-26 | Ciba Specialty Chemicals Corporation | Photoinitiator mixtures and compositions with alkylphenylbisacylphosphine oxides |
EP0975693B2 (en) * | 1997-04-22 | 2006-01-18 | Koninklijke DSM N.V. | Liquid curable resin composition |
US6359025B1 (en) * | 1997-05-16 | 2002-03-19 | Dsm N.V. | Radiation-curable liquid resin composition for coating optical fibers |
US5989462A (en) * | 1997-07-31 | 1999-11-23 | Q2100, Inc. | Method and composition for producing ultraviolent blocking lenses |
US6015842A (en) * | 1997-08-07 | 2000-01-18 | Alcon Laboratories, Inc. | Method of preparing foldable hydrophilic ophthalmic device materials |
US6020445A (en) | 1997-10-09 | 2000-02-01 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
TW429327B (en) | 1997-10-21 | 2001-04-11 | Novartis Ag | Single mould alignment |
US6451871B1 (en) * | 1998-11-25 | 2002-09-17 | Novartis Ag | Methods of modifying surface characteristics |
US5998498A (en) | 1998-03-02 | 1999-12-07 | Johnson & Johnson Vision Products, Inc. | Soft contact lenses |
US7052131B2 (en) * | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US5962548A (en) * | 1998-03-02 | 1999-10-05 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
US6218463B1 (en) * | 1998-04-20 | 2001-04-17 | Johnson & Johnson Vision Care, Inc. | Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers |
US5945465A (en) | 1998-05-15 | 1999-08-31 | Bausch & Lomb Incorporated | Method for polymerizing contact lenses having UV absorbing properties |
US5914355A (en) * | 1998-05-15 | 1999-06-22 | Bausch & Lomb Incorporated | Method for making contact lenses having UV absorbing properties |
US6359024B2 (en) * | 1998-05-15 | 2002-03-19 | Bausch & Lomb Incorporated | Method for polymerizing contact lenses |
US6039913A (en) * | 1998-08-27 | 2000-03-21 | Novartis Ag | Process for the manufacture of an ophthalmic molding |
US5981675A (en) * | 1998-12-07 | 1999-11-09 | Bausch & Lomb Incorporated | Silicone-containing macromonomers and low water materials |
AU766109B2 (en) * | 1999-07-27 | 2003-10-09 | Bausch & Lomb Incorporated | Contact lens material |
US6793973B2 (en) * | 2000-02-04 | 2004-09-21 | Novartis Ag | Single-dip process for achieving a layer-by-layer-like coating |
US6719929B2 (en) * | 2000-02-04 | 2004-04-13 | Novartis Ag | Method for modifying a surface |
ES2222373T3 (en) * | 2000-03-24 | 2005-02-01 | Novartis Ag | RETICULAR OR POLYMERIZABLE PREPOLIMEROS. |
US6811805B2 (en) * | 2001-05-30 | 2004-11-02 | Novatis Ag | Method for applying a coating |
US6896926B2 (en) * | 2002-09-11 | 2005-05-24 | Novartis Ag | Method for applying an LbL coating onto a medical device |
US7384590B2 (en) | 2002-12-17 | 2008-06-10 | Novartis Ag | System and method for curing polymeric moldings |
US7387759B2 (en) * | 2002-12-17 | 2008-06-17 | Novartis Ag | System and method for curing polymeric moldings having a masking collar |
DK1581272T3 (en) * | 2003-01-09 | 2006-10-02 | Alcon Inc | Dual function UV absorbers for ophthalmic lens materials |
EP1582910B1 (en) * | 2003-01-10 | 2011-04-27 | Menicon Co., Ltd. | Highly safe silicone-containing material for ocular lens and process for producing the same |
US20050056954A1 (en) * | 2003-09-12 | 2005-03-17 | Devlin Brian Gerrard | Method for making contact lenses |
US7214809B2 (en) * | 2004-02-11 | 2007-05-08 | Johnson & Johnson Vision Care, Inc. | (Meth)acrylamide monomers containing hydroxy and silicone functionalities |
US8147728B2 (en) | 2004-04-01 | 2012-04-03 | Novartis Ag | Pad transfer printing of silicone hydrogel lenses using colored ink |
PT1756625E (en) * | 2004-04-21 | 2014-09-03 | Novartis Ag | Curable colored inks for making colored silicone hydrogel lenses |
US9248614B2 (en) * | 2004-06-30 | 2016-02-02 | Novartis Ag | Method for lathing silicone hydrogel lenses |
US20060142525A1 (en) * | 2004-12-29 | 2006-06-29 | Bausch & Lomb Incorporated | Hydrogel copolymers for biomedical devices |
US20060252850A1 (en) * | 2005-05-04 | 2006-11-09 | Bausch & Lomb Incorporated | Radiation-absorbing polymeric materials and ophthalmic devices comprising same |
EP1913029A1 (en) * | 2005-08-10 | 2008-04-23 | Novartis AG | Silicone hydrogels |
US20070037897A1 (en) * | 2005-08-12 | 2007-02-15 | Guigui Wang | Method for making contact lenses |
US7858000B2 (en) * | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
PL2038310T3 (en) * | 2006-07-12 | 2010-11-30 | Novartis Ag | Actinically crosslinkable copolymers for manufacturing contact lenses |
AR064286A1 (en) | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH |
CA2671740C (en) | 2006-12-13 | 2015-08-11 | Novartis Ag | Actinically curable silicone hydrogel copolymers and uses thereof |
RU2462361C2 (en) | 2007-03-22 | 2012-09-27 | Новартис Аг | Prepolymers with pendant polysiloxane-containing polymer chains |
KR101514472B1 (en) * | 2007-03-22 | 2015-04-22 | 노파르티스 아게 | - silicone-containing prepolymers with hydrophilic polymeric chains |
KR101231181B1 (en) * | 2007-06-25 | 2013-02-07 | 남택인 | Silicone-hydrogel compound for soft contact lens and soft contact lens produced using the compound |
US8044111B2 (en) | 2007-11-30 | 2011-10-25 | Novartis Ag | Actinically-crosslinkable silicone-containing block copolymers |
CN101903807B (en) * | 2007-12-20 | 2013-01-09 | 诺瓦提斯公司 | Method for making contact lenses |
EP2356497B8 (en) | 2008-11-13 | 2020-03-11 | Alcon Inc. | Silicone hydrogel materials with chemically bound wetting agents |
AU2009314169B9 (en) | 2008-11-13 | 2012-11-01 | Novartis Ag | Polysiloxane copolymers with terminal hydrophilic polymer chains |
-
2009
- 2009-06-16 JP JP2011542147A patent/JP5713265B2/en not_active Expired - Fee Related
- 2009-06-16 CN CN200980150636.1A patent/CN102257408B/en active Active
- 2009-06-16 TW TW104123506A patent/TWI613067B/en active
- 2009-06-16 KR KR1020117016544A patent/KR101422900B1/en active IP Right Grant
- 2009-06-16 KR KR1020147006249A patent/KR101506430B1/en not_active IP Right Cessation
- 2009-06-16 CA CA 2747355 patent/CA2747355C/en not_active Expired - Fee Related
- 2009-06-16 MX MX2011006601A patent/MX2011006601A/en active IP Right Grant
- 2009-06-16 EP EP09789823A patent/EP2374031A1/en active Pending
- 2009-06-16 AR ARP090102170 patent/AR072151A1/en not_active Application Discontinuation
- 2009-06-16 TW TW098120172A patent/TWI505929B/en active
- 2009-06-16 WO PCT/US2009/047428 patent/WO2010071691A1/en active Application Filing
- 2009-06-16 BR BRPI0923037A patent/BRPI0923037A2/en not_active IP Right Cessation
- 2009-06-16 AU AU2009327484A patent/AU2009327484B2/en not_active Ceased
- 2009-06-16 US US12/456,364 patent/US8163206B2/en active Active
- 2009-06-16 RU RU2011129220/28A patent/RU2499288C2/en not_active IP Right Cessation
- 2009-06-16 MY MYPI20112792 patent/MY150782A/en unknown
- 2009-06-16 SG SG2011042462A patent/SG172081A1/en unknown
- 2009-06-16 NZ NZ59267409A patent/NZ592674A/en not_active IP Right Cessation
- 2009-06-16 CN CN201410228921.3A patent/CN103969706B/en active Active
-
2012
- 2012-03-14 US US13/419,509 patent/US9097839B2/en active Active
-
2014
- 2014-08-22 JP JP2014169291A patent/JP5982724B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102257408B (en) | 2014-07-09 |
CN102257408A (en) | 2011-11-23 |
AU2009327484A1 (en) | 2011-06-30 |
SG172081A1 (en) | 2011-07-28 |
CN103969706B (en) | 2017-08-25 |
US8163206B2 (en) | 2012-04-24 |
BRPI0923037A2 (en) | 2015-12-15 |
JP2014238609A (en) | 2014-12-18 |
TWI505929B (en) | 2015-11-01 |
TWI613067B (en) | 2018-02-01 |
KR20140052019A (en) | 2014-05-02 |
TW201024083A (en) | 2010-07-01 |
TW201540487A (en) | 2015-11-01 |
KR101422900B1 (en) | 2014-07-30 |
JP5982724B2 (en) | 2016-08-31 |
NZ592674A (en) | 2012-08-31 |
AU2009327484B2 (en) | 2012-08-09 |
JP2012513042A (en) | 2012-06-07 |
RU2499288C2 (en) | 2013-11-20 |
CA2747355A1 (en) | 2010-06-24 |
US20100258961A1 (en) | 2010-10-14 |
US9097839B2 (en) | 2015-08-04 |
KR20110105813A (en) | 2011-09-27 |
WO2010071691A1 (en) | 2010-06-24 |
US20120172478A1 (en) | 2012-07-05 |
EP2374031A1 (en) | 2011-10-12 |
MX2011006601A (en) | 2011-06-30 |
KR101506430B1 (en) | 2015-03-26 |
RU2011129220A (en) | 2013-01-27 |
JP5713265B2 (en) | 2015-05-07 |
AR072151A1 (en) | 2010-08-11 |
CN103969706A (en) | 2014-08-06 |
MY150782A (en) | 2014-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2747355C (en) | Method for making silicone hydrogel contact lenses | |
AU2010295773B2 (en) | Prepolymers suitable for making ultra-violet absorbing contact lenses | |
EP2432821B1 (en) | Actinically-crosslinkable siloxane-containing copolymers | |
US8383744B2 (en) | Actinically-crosslinkable siloxane-containing copolymers | |
US8845935B2 (en) | Method for cast molding contact lenses | |
CA2731159A1 (en) | Silicone hydrogel contact lenses with convertible comfort agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20131017 |
|
MKLA | Lapsed |
Effective date: 20200831 |